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Zusammenfassung 
Der Ablauf des Zellzyklus wird durch die phasen-spezifischen Aktivitäten von 
Proteinkinasen und Proteinphosphatasen entscheidend gesteuert. Die Cyclin-abhängige 
Kinase Cdk1/Cyclin B ist insbesondere für den Eintritt in die Mitose und frühe Phasen 
der Mitose erforderlich. Umgekehrt erfordert der Austritt aus der Mitose eine 
Inaktivierung dieser mitotischen Kinase, sowie die Dephosphorylierung von Substraten, 
die durch Cdk1/Cyclin B modifiziert worden waren. Für den Austritt aus der Mitose ist 
in der Bäckerhefe die nukleoläre Phosphatase Cdc14 (yCdc14) essentiell. yCdc14 
dephosphoryliert zum einen Substratproteine an mitotischen Cdk1 Zielsequenzen, und 
fördert dadurch den Abbau von Proteinen, die die Mitose steuern und vorantreiben, und  
inaktiviert zum anderen mitotische Cdk/Cyclin Komplexe. Obwohl Cdc14 in der 
Bäckerhefe gut charakterisiert ist, ist wenig über die homologe Phosphatase im Mensch 
bekannt. Die vorliegende Arbeit hatte zum Ziel, eine Funktion von hCdc14B in der 
Regulation der Mitose in Menschzellen zu untersuchen. Dies wurde mit verschiedenen 
experimentellen Ansätzen erforscht. Hierzu gehörten die Herstellung transgener 
menschlicher Zelllinien, RNAi zur Inhibition der Genexpression, verschiedene Protein-
Protein-Interaktionsstudien, die Bestimmung der Aktivität von Phosphatasen und 
Kinasen, die Isolierung and Größenfraktionierung zellulärer Proteinkomplcxe, sowie 
Chromatinimmunpräzipitationsversuche (ChIP) und Fluoreszenzmikroskopie.  
Es wurden HeLa and U2OS Zelllinien generiert, die Flag-, Flag-HA-, or TAP- 
hCdc14B Wildtyp bzw. eine katalytisch defekte Punktmutante, hCdc14BPD, 
exprimieren Die Analysis von U2OS Zellinien, die stabil unter der Kontrolle eines mit 
Tetrazyklin induzierbaren Promotors exprimieren zeigte, dass die Überexpression von 
hCdc14B Wildtyp den Eintritt in die Mitose verzögert, während durch Überexpression 
der enzymatisch inaktiven Punktmutante die Mitose verlängert oder der Austritt aus der 
Mitose verzögert wird. Diese Befunde wurden maßgeblich durch siRNA-Experimente 
erhärtet, die zeigten, dass die zelluläre Depletion von hCdc14B zu einer Anhäufung von 
zwei- und mehrkernigen Zellen führt, zu einer Verzögerung des Übertritts von der 
Metaphase in die Anaphase, sowie, letztendlich, zur Arretierung in der Mitose und zum 
Zelltod.  
Zur Identifizierung der molekularen Mechanismen wurden der 
Phosphorylierungsgrad und die Aktivität ausgewählter Regulatoren der Mitose 
untersucht. Dies zeigte, dass hCdc14B die mitotische Phosphatase Cdc25, die sowohl 
für die Aktivierung von Cdk1/Cyclin B an der G2/M-Grenze als auch für den korrekten 
Ablauf der frühen Mitosestadien erforderlich ist, dephosphoryliert. Die Überexpression 
von hCdc14B führte zur Hemmung von Cdc25, zur Akkumulierung von Cdk1, die an 
T14/Y15 inhibitorisch phosphoryliert war und daher zu einer erheblichen Verzögerung 
der Aktivierung des Cdk1/Cyclin B Komplexes. Andererseits fehlte die zeitgerechte 
Inaktivierung von Cdk1/Cyclin B in Zellen, in denen hCdc14B durch siRNAs depletiert 
worden war. Diese Ergebnisse weisen darauf hin, dass hCdc14B die positive Feedback 
Schleife zwischen Cdc25 und Cdk1/Cyclin B zerstört und so das Durchschreiten der 
späten Stadien der Mitose vorantreibt.  
Chromatinimmunpräzipitationsversuche zeigten, dass hCdc14B bevorzugt mit 
dem „Intergenen Spacer“ (IGS) der ribosomalen RNA Gene (rDNA) assoziiert ist. Die 
Binding an die rDNA erfolgt zellzyklus-spezifisch, da hCdc14B nur während der 
Intrphase, nicht jedoch während der Mitose mit rDNA assoziiert war. Auch durch 
Fraktionierung von Zellextrakten konnte die zellzyklus-abhängige nachgewiesen 
werden, dass sich die subzelluläre Lokalisation von hCdc14B während des Zellzyklus 
ändert. hCdc14B ist in der Interphase an Chromatin gebunden, jedoch von der 
Prometaphase der Mitose bis zur frühen G1-Phase löslich.  
Die native Größenbestimmung von hCdc14B durch Gelfiltration zeigte, dass 
hCdc14B in der Interphase in einen hochmolekularen, ca. 500 kDa großen 
Proteinkomplexes integriert ist. Während der Mitose hingegen liegt hCdc14B 
größtenteils als Monomer vor, eine Subfraktion von hCdc14B ist jedoch auch mit 
Proteinkomplexen unterschiedlicher Größen assoziiert. Diese Ergebnisse deuten darauf 
hin, dass hCdc14B während des Zellzyklus mit verschiedenen Proteinpartnern 
interagiert. 
Um Interaktionspartner und Substrate von hCdc14B zu identifizieren, wurden 
hCdc14B Proteinkomplexe durch sequentielle Immunpräzipitation aus 
Menschzelllinien, die Flag-HA-hCdc14B exprimieren, isoliert und assoziierte Proteine 
durch Massenspektrometrie analysiert. In diesen Untersuchungen wurden APC1, die 
größte Untereinheit des „Anaphase-Promoting-Complex/Cyclosome“ (APC/C), sowie 
ELP1, ein RNA Polymerase II-spezifischer Elongationsfaktor, identifiziert. Die 
Interaktion zwischen hCdc14B und APC/C wurde durch Co-
immunopräzipitationsversuche bestätigt. Es konnte darüber hinaus gezeigt werden, dass 
hCdc14B mit einer bestimmten Form des APC/C Komplexes, nämlich APC/CCdh1, 
assoziiert. Dieser Komplex wird während der späten Mitose gebildet, reguliert den 
Proteasomen-abhängigen Abbau wichtiger mitotischer Regulatoren und ist essentiell 
für den Austritt aus der Mitose.  
Die in dieser Arbeit durchgeführten Studien zeigten zum ersten Mal, dass die 
Phosphatase hCdc14B einen essentieller Regulator der Mitose darstellt. Es konnten 
molekulare Mechanismen aufgedeckt werden, die der Regulation der Mitose durch 
hCdc14B zugrunde liegen.  
 
Teile dieser Arbeiten sind zur Veröffentlichung bei „The EMBO Journal“ eingereicht: 
Tumurbaatar, I., Fritsch, S., Cizmecioglu, O., Hoffmann, I., Grummt, I., and Voit, R. 
Human Cdc14B phosphatase regulates progression through mitosis by 
dephosphorylating Cdc25. 
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Summary 
Progression through the cell cycle requires coordinated activity of kinases and 
phosphatases. Cdk1/cyclin B is a major kinase that promotes entry into and progression 
through early mitosis. Exit from mitosis requires down-regulation of Cdk1/cyclin B as 
well as reversal of Cdk1/cyclin B-mediated phosphorylations. In budding yeast, the 
nucleolar phosphatase Cdc14 (yCdc14) triggers mitotic exit by dephosphorylating 
mitotic Cdk/cyclin target proteins, promoting degradation of mitotic regulators, and 
inactivating mitotic Cdk/cyclin complexes. In contrast to yeast, hCdc14B, a human 
homologue of yCdc14, is poorly characterized. The aim of this study was to investigate 
a potential regulatory function of hCdc14B in mitosis. To address this issue, a variety of 
experimental approaches were used, including the generation of transgenic human cell 
lines, gene silencing by RNAi, protein-interaction assays, determination of phosphatase 
and kinase activities, purification and size fractionation of cellular protein complexes as 
well as chromatin immunoprecipitation assay (ChIP) and fluorescence microscopy.  
HeLa and U2OS cell lines were established that express Flag-, Flag-HA-, or 
TAP-tagged wildtype hCdc14B or a catalytically defective mutant, called hCdc14BPD. 
Analysis of U2OS cell lines that stably express either wildtype hCdc14B or the 
phosphatase-deficient mutant under the control of a tetracycline-inducible promoter 
showed that ectopic hCdc14B caused a delay in mitotic entry, while overexpression of 
the enzymatic inactive form prolonged mitosis and delayed exit from mitosis. These 
data were supported by siRNA-directed silencing of hCdc14B expression, 
demonstrating that ablation of hCdc14B leads to accumulation of bi- and multinucleated 
cells, delay in meta- to anaphase transition and finally to mitotic arrest and cell death.  
To dissect the molecular mechanism underlying hCdc14B function, the 
phosphorylation state and activity of selected key regulators of mitosis were analyzed. 
These studies revealed that hCdc14B dephosphorylates the mitotic phosphatase Cdc25, 
which is required for activation of Cdk1/cyclin B at the G2/M transition and during 
early stages of mitosis. Overexpression of hCdc14B suppressed Cdc25 activity, leading 
to accumulation of Cdk1 phosphorylated at T14/Y15 and a substantial delay in 
Cdk1/cyclin B activation. In contrast, Cdk1/cyclin B activity remained elevated in cells 
depleted of hCdc14B. The results suggest that hCdc14B interrupts the positive feedback 
loop between Cdc25 and Cdk1/cyclin B and promotes progression through late mitosis.  
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ChIP revealed a preferred binding of hCdc14B to the intergenic spacer region of 
ribosomal RNA genes (rDNA). Binding to rDNA was abrogated during mitosis, 
indicating that hCdc14B associates with rDNA in a cell cycle-dependent fashion. In 
support of this, analysis of the subcellular distribution of hCdc14B throughout the cell 
cycle revealed that hCdc14B is bound to chromatin during interphase and released from 
chromatin from prometaphase until early G1-phase.  
Size fractionation by gel filtration revealed that hCdc14B is contained in one 
major protein complex with a molecular weight of 400-600 kDa. During mitosis the 
majority of hCdc14B was monomeric with a small portion being contained in different 
protein complexes suggesting that during the cell cycle hCdc14B associates with 
different interaction partners.  
To identify proteins that interact with and are dephosphorylated by hCdc14B, 
hCdc14B complexes were isolated from human cells that overexpress Flag-HA-tagged 
hCdc14B by sequential immunopurification, and co-purifying proteins were subjected 
to mass spectrometry. This analysis identified APC1, the largest subunit of the 
anaphase-promoting complex/cyclosome (APC/C), and ELP1, an RNA polymerase II 
specific elongation factor. The interaction between hCdc14B and APC/C was confirmed 
by co-immunoprecipitation experiments revealing that hCdc14B interacts with a distinct 
subform of the APC/C complex, APC/CCdh1 that forms during late mitosis and regulates 
proteosome-dependent degradation of mitotic regulators at the exit from mitosis and 
during G1-phase. Studies carried out in the present work provide first evidence that 
hCdc14B is an essential regulator of late mitotic events and reveal the molecular 
mechanisms underlying hCdc14B function.  
 
Part of this work has been submitted for publication to The EMBO Journal. 
Tumurbaatar, I., Fritsch, S., Cizmecioglu, O., Hoffmann, I., Grummt, I., and Voit, R. 
Human Cdc14B phosphatase regulates progression through mitosis by 
dephosphorylating Cdc25. 
 
 
  Introduction 
 3
1 Introduction 
1.1 The cell cycle-an overview 
The size of a cell population is determined by the rates of three processes occurring in 
each cell population: division, growth and death. Newly divided cells grow to resume 
the size typical for a particular cell type. Under appropriate physiological and 
environmental conditions the genome will be replicated and the cell will divide into two 
daughter cells. This cycle of growth and division, known as the cell cycle, represents the 
basic mechanism by which all living organisms propagate. The cell cycle is a highly 
regulated process. During evolution complex control systems developed that regulate 
the cell cycle. If any of these control systems fail the cell cycle will continue in an 
unregulated fashion and may cause cancer.  
The eukaryotic cell cycle is divided into 4 phases: G1, S, G2 and M. During S-
phase the DNA is replicated. Chromosome segregation and cell division occur during 
mitosis (M-phase). S- and M-phase are separated by two gap phases: G1 between M- 
and S-phase and G2 between S- and M-phase. The two gap phases provide time for the 
cell to monitor the external environment for the presence of growth factors or cell 
density as well as the internal environment for DNA damage or abnormal cellular 
structure. Under certain conditions cells can exit the cell cycle during the early G1-phase 
to remain in G0, e.g. in the absence of growth stimuli or after terminal differentiation.  
The G1-, S- and G2-phases comprise the interphase. In typical mammalian cells 
the interphase takes about 24 hours, whereas passage through mitotis is accomplished 
within 1 hour. The M-phase is subdivided into 5 stages: prophase, pro-/metaphase, 
anaphase, telophase and cytokinesis. During prophase the chromatin becomes highly 
condensed and the nuclear envelope breaks down. In metaphase sister chromatids align 
at the equatorial plate of the bipolar spindle. Anaphase starts with separation of the 
sister chromatids to the two poles of the spindle. The nuclear envelope is rebuilt during 
telophase and chromosomes start to decondense. Finally, during cytokinesis the mother 
cell divides into two daughter cells each containing the same genetic information.  
The cell cycle is driven by a complex regulatory system that generates waves of 
cyclin-dependent kinase (Cdk) activities that in turn trigger cell cycle events (Morgan, 
1997). Activation and inactivation of phase-specific Cdk complexes is achieved by 
different mechanisms (Desai et al., 1995; Morgan, 1995; Pavletich, 1999; Obaya and 
Sedivy, 2002). Activation requires positive phosphorylation and removal of inhibitory 
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phosphates from Cdks, as well as association of Cdks with the corresponding cyclins in 
a cell cycle-specific manner. Likewise, inactivation is achieved by different molecular 
mechanisms including ubiquitin-dependent degradation of cyclins, inhibitory 
phosphorylation of Cdks and/or association with Cdk inhibitors (CKIs) (Glotzer et al., 
1991; Zachariae et al., 1998; Obaya and Sedivy, 2002).  
 
1.2 The Cyclin-dependent kinases (Cdks) 
Cdks represent a family of proline-directed serine/threonine protein kinases with a size 
of appr. 34-40 kDa. For activation, Cdks must associate with their respective cyclins. 
Cdk/cyclin complexes phosphorylate a large number of substrates. In particular during 
mitosis, when many aspects of cellular structure and metabolism are altered, Cdks 
phosphorylate hundreds of proteins. Cdk substrates are phosphorylated at serine (S) or 
threonine (T) residues followed by a proline residue (P). The optimal target sites have a 
basic amino acid two positions carboxy-terminal to the phosphorylated residue. The 
consensus phosphorylation site for Cdks is [S/T]-P-X-[K/R]. 
Although originally identified as enzymes that control cell cycle events, 
members of the Cdk family also regulate additional cellular processes. Only four (Cdk1, 
Cdk2, Cdk4 and Cdk6) out of nine mammalian Cdks are directly involved in the cell 
cycle regulation. Cdk1 binds to cyclin B forming the M-phase promoting factor, which 
is the key kinase for mitosis (Hunt, 1989; Takizawa and Morgan, 2000). Cdk2/cyclin E 
represents the main regulator of the G1/S transition. Cdk2 binds also to cyclin A at the 
beginning of S-phase and promotes DNA replication. Cdk4 and Cdk6 associate with 
cyclin D and are required for G0/G1 transition as well as G1-progression (Lucibello et al., 
1993; Matsuoka et al., 1994). Cdk7 contributes indirectly to the cell cycle regulation by 
activating other Cdks (Makela et al., 1994; Tassan et al., 1995). Besides this function, 
Cdk7 is a part of the basal transcription factor complex TFIIH being required for RNA 
polymerase II-dependent transcription ( Fisher and Morgan, 1994; Fisher, 2005). 
Likewise, Cdk8 and Cdk9 are regulators of the RNA polymerase II transcription 
machinery as components of the mediator and the transcription elongation complex, 
respectively (Pei et al., 2003). Cdk5 regulates a variety of processes such as neural 
differentiation, intracellular transport and DNA repair (Dhavan and Tsai, 2001; Smith 
and Tsai, 2002). 
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Despite their differences in the mode of function, the structure of Cdks is highly 
conserved (Fig. 1.1). All Cdks have a common tertiary structure comprising a small N-
terminal lobe and a larger C-terminal lobe. The ATP fits snugly in the cleft between the 
two lobes in such a way that the phosphate is oriented towards the mouth of the cleft. 
The protein substrate binds at the entrance of the cleft and mainly interacts with the 
surface of the C-terminal lobe. Residues adjacent to this site catalyze the transfer of the 
terminal -phosphate of ATP to the hydroxyl oxygen in the protein substrate.  
              
 
                       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.2.1 The cyclin family 
Cyclins are the essential activators of Cdks. More than 18 cyclins have been identified 
in mammals. They contain a highly conserved cyclin box, which mediates the 
association with the Cdks and consists of about 100 amino acids that are folded in a 
five-helix bundle ( Hunt, 1991; Brown et al., 1995; Jeffrey et al., 1995; Kim et al., 1996; 
Morgan, 1997). The most characteristic feature of cyclins is their periodical synthesis 
and degradation (Evans et al., 1983). Cyclin degradation requires a polyubiquitination at 
a short sequence motif called destruction box, which contains nine highly conserved 
Figure 1.1. Crystal structure 
of Cdk2. Cdk2 is composed of 
two lobes. The smaller N-
terminal lobe (top) consists of 
-sheets and the PSTAIRE 
helix. The larger C-terminal 
lobe (bottom) is primarily made 
of  helices. The ATP is shown 
as a ball-and-stick model 
locating deep within the active 
site cleft between the two lobes. 
In the cyclin unbound state, the 
cleft is blocked by the T-loop 
(green). Upon binding of the 
cyclin, helix L12 changes its 
conformation rendering the 
active site accessible (Morgan, 
2007). 
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amino acid residues with the consensus sequence -RXALGXIXN- (Glotzer et al., 1991). 
Polyubiquitination targets the cyclins to proteasome-mediated degradation. Each cyclin 
binds a defined Cdk, which in turn determines the specificity of the kinase complex. In 
Table 1.1 cyclins, their binding partners and their functions are summarized. 
 
Cyclins Associated Cdk Function 
A1 Cdk1, Cdk2 testis differentiation 
A2 Cdk1, Cdk2 S-phase entry 
B1, B2 Cdk1 G2/M transition 
C Cdk8 transcription regulation 
D1, D2, D3 Cdk4, Cdk6 G0/G1 transition 
E Cdk2 G1/S transition 
F ? G2/M transition 
G1, G2 ? DNA damage response 
H Cdk7 CAK activity, 
transcription regulation 
I ? ? 
K ? Cdk activation, 
transcription regulation 
T1, T2 Cdk9 transcription regulation 
 
Table 1.1. Diversity of cyclins and their functions. 
 
 
1.2.2 Mechanism of Cdk regulation 
Cdks are regulated at multiple levels: association with cyclins, reversible 
phosphorylation of Cdks, and binding to specific inhibitors (Fig. 1.2.). Studies of the 
three-dimensional structure of the Cdk2/cyclin A complex revealed the molecular 
mechanism of Cdk2 activation by cyclin A in detail (De Bondt et al., 1993; Brown et al., 
1995). In the absence of the cyclin, the phosphotransfer reaction is severely restrained 
by two mechanisms. First, the ATP molecule is incorrectly bound to the active site and 
second, the T-loop or activation–loop blocks the access of the peptide substrate to the 
active site. Binding of cyclin A displaces the T-loop allowing access of the substrate. In 
addition, cyclin A directly interacts with the PSTAIRE helix of Cdk2 and moves it 
toward the cleft causing a reorientation of residues that interact with ATP. Full 
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activation of the Cdk2/cyclin A complex occurs upon phosphorylation of threonine at 
position 160 by the Cdk-activating kinase (CAK) resulting in a shift of the T-loop closer 
to the cyclin.  
 
         A 
 
 
 
 
         B 
 
 
 
 
 
         C 
 
 
 
 
 
Figure 1.2. Mechanisms of Cdk regulation. A) In the absence of cyclin, the active site is blocked by the 
T-loop. The binding of cyclin to Cdk results in a movement of the T-loop and in partial activation of the 
Cdk/cyclin complex. Full activation requires the phosphorylation of threonine 160 by CAK, which further 
changes the relative position of the T-loop, improving the binding of the substrate. B) The activity of 
Cdk/cyclin is turned off, when Wee1 and Myt 1 kinases phosphorylate threonine 14 and tyrosine 15. 
Removal of these phosphates by the Cdc25 phosphatases results in re-activation of the Cdk/cyclin 
complex. C) The Cdk inhibitor p27/Kip1 binds to both the Cdk and cyclin distorting the active site of the 
Cdk. It also inserts into the ATP-binding site and inhibits the enzymatic activity. 
 
 
The activity of Cdk1/2 can be inhibited by phosphorylation at threonine (T14) 
and tyrosine (Y15) residues by the Myt1 and Wee1 kinases. These phosphorylations 
block both the phosphate transfer to the bound substrate and the ATP binding 
(Atherton-Fessler et al., 1993; Booher et al., 1997). The Cdc25 dual-phosphatases 
remove these inhibitory phosphates thereby activating the Cdk/cyclin complex (Boutros 
et al., 2006; Trinkle-Mulcahy and Lamond, 2006; Rudolph, 2007) . 
T160P 
Wee1, Myt 1 kinases 
pT160 pT160 
Cdc25 phosphatase 
T160P T160P 
p27 
cyclin CAK 
T14P Y15
P T14 Y15 
T160 
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Besides proteasome-mediated degradation of cyclins, the Cdk/cyclin complexes 
are also downregulated by binding to Cdk inhibitors (CKI). There are two classes of 
CKIs in mammalian cells. The Ink4 family includes Ink4a or p16. The ankyrin repeat of 
p16 competes with cyclin D for binding to the Cdks. The second class of CKIs 
represents the Cip/Kip family, composed of p21/Cip, p27/Kip1 and p57/Kip2. They 
share a homologous inhibitory domain and act by binding to the Cdk in a stoichiometric 
manner. They inhibit all G1-Cdks with a strong preference for Cdk2 (Gu et al., 1992; 
Morgan, 1995; Zerfass-Thome et al., 1997). However, these inhibitors are not as 
specific as p16, since they also play a role in the G2- to M-phase transition of the cell 
cycle.  
 
1.3 The Cdc25 phosphatases 
Cdc25 phosphatases play a crucial role in activating Cdks. They are dual-specificity 
phosphatases that can dephosphorylate Cdks at phospho-tyrosine (pY15) as well as 
phospho-threonine (pT14) thereby activating the Cdks (Dunphy and Kumagai, 1991; 
Honda et al., 1993; Sebastian et al., 1993). Cdc25 was first identified in the fission yeast 
as a dose-dependent inducer of mitosis. Yeast cells carrying a temperature-sensitive 
Cdc25 allele arrest in G2 at the non-permissive temperature (Russell and Nurse, 1986). 
Mammalian cells have three isoforms of Cdc25, called Cdc25A, Cdc25B and Cdc25C, 
which are app. 60% identical in their C-terminal regions, which comprises the catalytical 
core. The catalytical core contains the CX5R motif, which is common to protein tyrosine 
phosphatases. In contrast, sequence identity within the N-terminal regulatory domains is 
only app. 20%. The N-terminus contains sites for various post-translational 
modifications such as phosphorylation and ubiquitination, and is involved in interaction 
with regulatory proteins such as 14-3-3. These modifications and interactions are critical 
for regulating Cdc25 phosphatases both during the cell cycle and checkpoint responses. 
Additionally, all Cdc25 proteins have a nuclear localization signal (NLS) and a nuclear 
export signal (NES) that contribute to the regulation of their cellular localization.  
Despite sharing common mechanisms of action, each Cdc25 family member has 
unique characteristics. Cdc25A regulates both early (G1/S) and late (G2/M) cell cycle 
transitions. Microinjection of -Cdc25A antibodies leads to arrest in G1-phase in serum-
stimulated cells and overexpression of Cdc25A accelerates S-phase entry (Molinari et al., 
2000; Zhao et al., 2002). These results suggested that Cdc25A regulates S-phase entry. 
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Recent studies showed that Cdc25A protein levels increased from late G1-phase until 
mitosis and that its overexpression induced unscheduled mitosis suggesting an additional 
role of Cdc25A in later cell cycle events. Moreover, siRNA-mediated silencing of 
Cdc25A caused a decrease in the amount of mitotic cells (Lindqvist et al., 2005).  
Cdc25A is an unstable protein, whose cellular level is regulated by balanced de 
novo synthesis and degradation through the ubiquitin-proteasome pathway (Donzelli et 
al., 2002). During late G1-phase, transcription factors like E2F-1 and c-Myc stimulate 
expression of Cdc25A. In early mitosis, Cdk1/cyclin B phosphorylates Cdc25A on two 
serine residues, S17 and S115, preventing ubiquitination and thereby stabilizing Cdc25A 
(Mailand et al., 2002a). In late mitosis, APC/C initiates the degradation of Cdc25A in an 
ubiquitin-dependent fashion.  
Both Cdc25B and Cdc25C are regulators of G2/M transition. However, it seems 
that they function in different pathways. The activity of Cdc25B peaks before that of 
Cdc25C and its overexpression induces premature mitosis more efficiently than 
overexpression of Cdc25C. It was suggested that Cdc25B initially activates a pool of 
Cdk1/cyclin B, which is located at the centrosomes and that Cdc25C contributes to 
activation of the residual pool of Cdk1/cyclin B (Karlsson et al., 1999; Lindqvist et al., 
2005). Cdc25B and Cdc25C are regulated in different ways during the cell cycle. During 
interphase, Cdc25B is sequestered in the cytoplasm by 14-3-3 proteins ( Peng et al., 
1997; Dalal et al., 1999; Takizawa and Morgan, 2000). In late G2, Aurora A/Ajuba 
kinase phosphorylates Cdc25B causing its release from 14-3-3. During mitosis, 
Cdk1/cyclin B phosphorylates Cdc25B, which activates and stabilizes Cdc25B (Gabrielli 
et al., 1997; Lammer et al., 1998). 
Unlike Cdc25B, protein levels of Cdc25C do not change during the cell cycle. 
Cdc25C is regulated by cellular localization and hyper/hypophosphorylation. Cdc25C is 
phosphorylated at S216 during interphase and checkpoint activation that promotes its 
binding to 14-3-3. At the transition to mitosis, pS216 is dephosphorylated and 14-3-3 is 
released. Cdk1/cyclin B phosphorylates Cdc25C at S214 and blocks the inhibitory 
phosphorylation at S216 during mitosis. The polo-like kinase Plk1 also positively 
phosphorylates Cdc25C and contributes to its full activation (Toyoshima-Morimoto et 
al., 2002). 
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1.4 Cell cycle transitions  
1.4.1 The G1/S transition 
In quiescent cells and during the early G1-phase the activity of Cdk/cyclin complexes is 
down-regulated. Rb (retinoblastoma protein) binds to the transcription factor E2F and 
blocks transcription of G1/S and S-phase specific cyclins. The presence of growth factors 
triggers signal transduction via the ERK pathway leading to activation of critical 
transcription factors, such as c-FOS and AP-1 that stimulate synthesis of cyclin D 
promoting the assembly of Cdk4/cyclin D or Cdk6/cyclin D ( Brown et al., 1998; 
Albanese et al., 1999). Cdk/cyclin D complexes phosphorylate Rb and de-repress the 
transcriptional activity of E2F (Nevins et al., 1997; Brehm et al., 1999; Harbour and 
Dean, 2000; Kaye, 2002) that in turn activates transcription of many genes including 
cyclin E and c-Myc. Cyclin E binds to Cdk2, c-Myc transactivates cyclin D expression 
resulting in the accumulation of Cdk4/cyclin D and/or Cdk6/cyclin D complexes. 
Furthermore, accumulation of Cdk/cyclin D causes redistribution of Cip/Kip from 
Cdk2/cyclin E leading to its activation. Activated Cdk2/cyclin E hyperphosphorylates 
Rb triggering release and activation of E2F and, in turn, expression of cyclin A. High 
levels of cyclin A lead to competition with cyclin E for binding to Cdk2. Cdk2/cyclin A 
phosphorylates Cdc6, which is required for initiation of DNA replication (Petersen et al., 
1999). 
 
1.4.2 The G2/M transition 
Entry into mitosis requires activation of Cdk1/cyclin B by Cdc25 phosphatases at late G2. 
Active Cdk1/cyclin B phosphorylates Cdc25 phosphatases and creates a positive 
feedback loop leading to its rapid activation (Okamoto and Sagata, 2007). Rapid 
activation of Cdk1/cyclin B is a prerequisite of M-phase entry. Moreover, onset of 
mitosis requires importin  and importin  -mediated translocation of active Cdk1/cyclin 
B from the cytoplasm to the nucleus, where it targets hundreds of substrates and 
promotes progression through the early stages of mitosis (Moore et al., 1999; Takizawa 
and Morgan, 2000). 
Polo-like kinase 1 (Plk1) represents another important regulator of M-phase entry. 
In mammalian cells, Plk1 protein levels increase as cells approach M-phase, and its 
activity peaks during mitosis. Plk1 plays an important role in phosphorylation-dependent 
activation of Cdc25C. Many additional mitotic Plk1 substrates have been identified 
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including cyclin B, a cohesin subunit of the mitotic spindle, subunits of the APC/C, 
mammalian kinesin-like protein 1 (MKLP-1), and several kinesin related motor proteins 
(Nigg, 1998). The variety of its substrates points to the multiple roles of Plk1 in 
promoting mitosis.  
 
1.5 Mitosis 
Early mitosis 
Mitosis starts with chromatin condensation in prophase. During prophase Cdk1/cyclin B 
phosphorylates condensin subunits triggering the assembly of condensin complexes on 
DNA and chromosome condensation. In addition, histone H1 and H3 are phosphorylated 
by Cdk1/cyclin B and Aurora kinases. These histone modifications also contribute to 
chromosome condensation (Nigg, 2001). Also, during prophase the mitotic spindle starts 
to assemble. During prometaphase Cdk1/cyclin B phosphorylates B-type lamins of the 
nuclear lamina and initiates breakdown of the nuclear envelope into vesicles (Peter et al., 
1990; Ward and Kirschner, 1990). After breakdown of the nuclear envelope (NEB), 
microtubules attach to the kinetochores that are located at the centromeric regions of the 
chromosomes, and the mitotic spindle is being stabilized. After each kinetochore has 
been attached to the microtubules extending from the opposite spindle poles, the sister 
chromatids are aligned at the equatorial plate of the spindle becoming ready to be 
separated to the opposing poles of the bioriented spindle. 
 
Late mitosis 
The separation of the sister chromatids is triggered by cleavage of cohesin, a complex 
that holds the sister chromatids together ( Uhlmann, 2003; Nasmyth and Haering, 2005). 
The anaphase-promoting complex/cyclosome APC/CCdc20 initiates degradation of 
cohesion: APC/CCdc20 ubiquitinates securin, an inhibitor of separase, releasing active 
separase. Separase cleaves the SCC1 subunit of the cohesion complex and thereby 
dissolves the complex that kept the sister chromatids together (Nasmyth et al., 2001; 
Peters, 2006). Besides securin, APC/CCdc20 ubiquitinates cyclin B leading to its 
degradation. During progression through late mitosis, the amount of Cdc20 declines, 
whereas Cdh1, another co-activator or APC/C, is up-regulated leading to formation of 
the APC/CCdh1 complex. APC/CCdh1 targets are variety of substates for degradation 
including cyclin B, securing, cyclin A, Plk 1, and Cdc20. During telophase, the 
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phosphatase PP1 dephosphorylates lamin B initiating polymerization of the nuclear 
lamina and reassembly of the nuclear membrane, which forms around the separated 
chromatids ( Steen et al., 2000; Steen and Collas, 2001; Steen et al., 2003). Mitosis is 
successfully completed after cytokinesis, which physically divides the mother cell into 
two daughter cells by abscission (Field et al., 1999).  
 
Spindle assembly checkpoint  
The spindle assembly checkpoint (SAC) prevents chromosome missegregation and 
aneuploidy ensuring the fidelity of chromosome segregation during mitosis. The SAC 
negatively regulates the ability of Cdc20 to initiate the APC/C-mediated 
polyubiquitination of cyclin B and securin, thereby preventing their degradation by the 
26S proteasome (Musacchio and Hardwick, 2002; Peters, 2006). The kinetochore is 
thought to act as a catalytic site for the production of signals that activate the SAC. 
Remarkably, the presence of a single kinetochore that is not attached to spindle 
microtubules is sufficient to initiate the SAC. In 1991, two independent yeast screens 
identified the Mad1-3 (Mitotic-arrest defective) genes and the Bub1, 3 and R1 (Budding 
inhibited by benzimidazole) genes, mutations of which bypassed the ability of wild-type 
S. cerevisiae cells to arrest in mitosis in the presence of the microtubule polymerization 
inhibitor benomyl (Hoyt et al., 1991; Li and Murray, 1991). The Mad and Bub proteins 
are highly conserved among eukaryotes. Mad2 and BubR1 have been shown to interact 
directly with APC/CCdc20 in vivo and to inhibit its ubiquitination activity in vitro (Peters, 
2006). BubR1 performs its function as a part of the mitotic checkpoint complex (MCC) 
(Sudakin et al., 2001). The MCC consists of Mad2, BubR1 and Bub3, which sequester 
Cdc20 to the kinetochore preventing formation of APC/CCdc20. Additional SAC proteins 
such as Mad1, Bub1, MPS1 (multipolar spindle-1) and Aurora B are required to amplify 
the SAC signal and the rate of MCC formation (Abrieu et al., 2001; Ditchfield et al., 
2003). SAC is inactivated when each sister kinetochore is attached to the spindle 
microtubules in a bioriented fashion. In addition to attachment of the microtubules to 
the kinetochore, tension is important for the SAC inactivation ( Nicklas et al., 1995; Li 
and Nicklas, 1997). It has been shown that the SAC activity is turned on when 
metaphase HeLa cells are treated with taxol or low doses of vinblastine, which represses 
kinetochore-microtubule dynamics and reduces the tension (Musacchio and Hardwick, 
2002). 
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1.6 Cdc14 phosphatases 
1.6.1 Yeast Cdc14 phosphatase 
The dual-specificity phosphatase Cdc14 was first identified in the budding yeast. In S. 
cerevisiae, yCdc14 is part of the nucleolar RENT (REgulator of Nucleolar silencing and 
Telophase exit) complex. The RENT complex consists of Net1, yCdc14 and the NAD-
dependent deacetylase Sir2 (Shou et al., 1999). Net1 binds directly to rDNA and is 
required for the nucleolar localization of Sir2 and yCdc14 ( Straight et al., 1999; Huang 
and Moazed, 2003). The main function of yCdc14 comprises regulation of exit from 
mitosis (Visintin et al., 1999).  Throughout G1, S, G2 and early mitosis yCdc14 is 
sequestered in the nucleolus by Net1 in an inactive form. yCdc14 is released from the 
RENT complex during mitosis by two distinct mechanisms acting at different time 
points during mitosis. The FEAR (Cdc Fourteen Early Anaphase Release) network 
mediates release of a minor portion of yCdc14 at early anaphase. Recent work has 
shown that the FEAR-dependent release of yCdc14 is accomplished by mitotic Cdk-
mediated phosphorylation of Net1 (Azzam et al., 2004).  
Full release of yCdc14 is achieved at late anaphase and depends on activation of 
the Mitotic Exit Network (MEN) (Jaspersen et al., 1998; Stegmeier et al., 2002). The 
MEN represents a huge signalling cascade comprising a variety of players, which 
include the GTPase Tem 1, the protein kinases Cdc15, Dbf2 and Cdc5, Mob1, the 
GTPase-activation protein Bub2-Bfa1/Byr4, the guanidine-nucleotide exchange factor 
Lte1, and the scaffold protein Nud 1 (Bardin and Amon, 2001). The MEN ensures that 
mitotic exit occurs only after sister-chromatid separation is completed and the genetic 
material has been segregated. It has been suggested that the phosphatase PP2A prevents 
premature release of Cdc14 from the nucleolus prior to anaphase ( Yellman and Burke, 
2004; Queralt et al., 2006). Upon release, yCdc14 is involved in regulation of a variety 
of mitotic events and ensures mitotic exit (Bosl and Li, 2005; Torres-Rosell et al., 2005). 
yCdc14 activity is essential for antagonizing mitotic Cdk activity during late mitosis. 
yCdc14 performs this function on different levels. It stabilizes and upregulates 
transcription of the mitotic Cdk inhibitor Sic1 and dephosphorylates Cdh1/Hct1, an 
activator of the anaphase promoting complex (APC) leading to APC-dependent mitotic 
cyclin degradation (Knapp et al., 1996; Toyn et al., 1997; Visintin et al., 1998). Also, 
yCdc14 directly dephosphorylates substrates, which have been phosphorylated by 
mitotic Cdks. yCdc14 is required for proper segregation of rDNA and telomeric regions, 
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being involved in targeting condensin to the rDNA (Sullivan et al., 2004; Wang et al., 
2004). Recently it has been shown that yCdc14 positively regulates spindle midzone 
assembly by desphorylating microtubule-bundling protein Ase1 (Khmelinskii et al., 
2007). 
A homologue of the S. cerevisiae Cdc14 has been identified in S. pombe, called 
Clp1/Flp1 (Cdc14-like protein1) (Cueille et al., 2001; Trautmann et al., 2001). Like 
yCdc14, Clp1/Flp1 localizes to the nucleolus and the spindle pole body during G1 -and 
S-phase. Clp1/Flp1 is released during early mitosis, and initially moves to the mitotic 
spindle and kinetochores. Later, Clp1/Flp1 localizes to the medial ring. It has been 
suggested that Clp1, together with Aurora kinase, functions in repairing mono-
orientation of the sister kinetochores to ensure proper chromosome segregation 
(Trautmann et al., 2004). The Septic Initiation Network (SIN) keeps Clp1 in the 
released state during mitosis (Bardin and Amon, 2001). Prior to anaphase, Cdk1 
phosphorylates and inhibits the catalytic activity of Clp1. As Cdk1 activity declines 
during anaphase progression, Clp1 auto-dephosphorylates itself to stimulate its own 
activity (Wolfe et al., 2006). Upon activation Clp1 targets the mitotic inducer Cdc25, 
and inactivates and destabilizes Cdc25 (Esteban et al., 2004; Wolfe and Gould, 2004).  
 
1.6.2 Cdc14 in non-mammalian metazoans 
Cdc14 is highly conserved in the genomes of all metazoans. However, little is known 
about the function of Cdc14 in these organisms. C. elegans Cdc14 (CeCdc14) localizes 
to the spindle midzone in anaphase and the midbody during telophase, while during 
interphase and early mitosis no distinct localization was observed. siRNA mediated 
depletion of CeCdc14 in embryonic cells blocked cytokinesis leading to multinucleated 
cells (Gruneberg et al., 2002). Therefore, it was suggested that during embryogenesis 
CeCdc14 is involved in cytokinesis rather than in mitotic exit. Despite this defect, 
timing of the cell cycle appeared similar to that in embryos with functional CeCdc14. 
The functional role of CeCdc14 in adult cells, however, is not yet known. 
X. laevis cells have two Cdc14 isoforms, XCdc14A and XCdc14B (Kaiser et al., 
2004; Krasinska et al., 2007). Ectopically expressed XCdc14A is centrosomal during 
interphase and is recruited to the midbody at the end of mitosis. XCdc14A can 
dephosphorylate Cdc25 in Xenopus egg extracts that were induced to enter mitosis. In 
addition, ectopic expression of XCdc14A inhibited recruitment of SNARE/exocyst 
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complexes, which are required for abscission (Krasinska et al., 2007). Nothing is known 
about the physiological role of the second isoform, XCdc14B. 
 
1.6.3 Human Cdc14 phosphatases 
In human cells two homologues of yeast Cdc14 have been identified (Li et al., 1997). 
hCdc14A (623 aa) and hCdc14B (498 aa) are encoded by two different genes and 
display 50% amino acid sequence identity. The structure of human Cdc14 phosphatases 
is similar to that of yeast Cdc14 (Fig. 1.3.A). All share a conserved core domain of appr. 
350 amino acids containing the protein tyrosine phosphatase (PTP) motif C(X)5R. A 
nuclear export signal is embedded in the C-terminal domain that differs in size among 
the isoforms and orthologues. The N-terminal part of the core domain contributes to 
substrate specificity and is not required for catalytic activity. hCdc14B has unique 
extension at the N-terminus that comprises the nucleolar targeting sequence (Kaiser et 
al., 2002; Mailand et al., 2002b). Both human Cdc14 isoforms can rescue Clp1-deficient 
fission yeast strains indicating that basal functional properties have been conserved 
throughout evolution (Vazquez-Novelle et al., 2005). In vitro studies have shown that 
hCdc14 phosphatases exhibit a strong preference for substrates of the proline-directed 
kinases e.g. proteins phosphorylated at S/T-P sites (Gray et al., 2003). 
Though both isoforms target the same proteins in vitro, they presumably exert 
different functions in vivo. hCdc14A localizes to the centrosomes and is mostly 
cytoplasmic (Mailand et al., 2002b). The cytoplasmic localization of hCdc14A is 
regulated by Crm1-dependent nuclear export, since treatment of cells with the Crm1 
inhibitor leptomycin B causes redistribution of hCdc14A. Loss of the nuclear export 
sequence (NES) results in nuclear retention of hCdc14A and aberrant centrosome 
duplication suggesting that the nuclear export is a prerequisite for the function of 
hCdc14A (Bembenek et al., 2005). Overexpression of hCdc14A leads to premature 
centrosome splitting and erroneous formation of the mitotic spindles. Consistently, 
down regulation of endogenous hCdc14A by siRNAs resulted in mitotic defects 
including failure of chromosome segregation, non-productive cytokinesis and 
multinucleation (Kaiser et al., 2002; Mailand et al., 2002b). Though several in vitro 
targets of hCdc14A have been identified, it is not known, whether those proteins 
represent physiological targets. hCdc14A interacts in vitro with p53 and 
dephosphorylates the Cdk1/cyclin B-phosphorylation site of p53 (Li et al., 2000). 
hCdc14A is also able to dephosphorylate INCENP in vitro suggesting that it may 
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regulate the translocation of chromosomal passenger proteins (Bembenek et al., 2001). 
Moreover, hCdc14A dephosphorylates Cdh1 and activates APC/CCdh1 in vitro 
(Bembenek and Yu, 2001). It was recently shown that hCdc14A dephosphorylates in 
vitro the Cdk1/cyclin B-dependent phosphorylation sites of Cdc25A and targets it for 
degredation (Esteban et al., 2006).  
 
          A 
 
 
         
          B 
 
 
Figure 1.3. Structure of hCdc14B phosphatase. A) Structural relationship between Cdc14 phosphatases. 
The conserved core domains of Cdc14 are shown in blue, the C-ternimal domains in yellow. The N-
terminal extension of hCdc14B phosphatase that contains the nucleolar targeting sequence is coloured in 
pink. The positions of the nuclear export signal (NES) are indicated. The protein tyrosine phosphatase 
(PTP) motif is located in the catalytic site (yellow box). In S. cerevisiae Cdc14p the catalytic site also 
comprises the interaction site for Net1. B) Ribbon diagram of the core domain of hCdc14B encompassing 
amino acid residues 44-386. The A- and B-domains are green and cyan, respectively, and the -helical 
inter-domain is yellow. The phosphopeptide substrate is shown as a red coil, and key catalytic loops are 
labelled (from Gray et al., 2003). 
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In contrast to hCdc14A, hCdc14B is a nucleolar protein. Crystal structure analysis of 
the central core domain revealed that hCdc14B is composed of two similar sized 
domains, called A- and B-domain, which are arranged in tandem (Gray et al., 2003). 
The B-domain contains the PTP motif, which is located within a long groove at the 
interface between the A- and B-domain. Residues of two loops of the A-domain, the 
extended WPD (Trp-Pro-Asp)-loop and the 5A/6A loops create one side of the 
groove. The WPD- and the Q-loop of the B-domain form the opposite face of the 
groove, whereas the inter-domain linker -helix is positioned at the entrance of one end 
of the groove. This region of the -helix is rich in acidic residues that cluster to generate 
an acidic groove forming the catalytic site. The catalytic site provides the specificity for 
pSer and pThr residues followed by a proline residue (Fig. 1.3.B). The function of 
hCdc14B is barely characterized. A recent study has shown that hCdc14B can bind, 
bundle and stabilize microtubules in vitro independently of its catalytic activity (Cho et 
al., 2005). hCdc14B that contains mutations in the nucleolar targeting domain 
accumulated in the cytoplasm and caused bundling and stabilization of microtubules 
during interphase. Moreover, nucleation of microtubules from the microtubule 
organization center was delayed in those cells. These observations suggested that 
hCdc14B may play a role in assembly and disassembly of the mitotic spindle.  
 
 
1.7 Objectives 
Entry into mitosis and exit from mitosis are tightly regulated processes. In S. cerevisiae, 
the phosphatase yCdc14 has been identified as a crucial regulator of mitotic exit that 
inhibits mitotic Cdk1 activity and reverses mitotic Cdk1-dependent phosphorylations 
during late mitosis, and thereby triggers mitotic exit (Stegmeier and Amon, 2004). 
Though the Cdc14 family is highly conserved, the functions of Cdc14 phosphatases in 
higher eukaryotes are ill-defined. Human cells have two homologues of yCdc14, called 
hCdc14A and hCdc14B. Previous studies have shown that both human Cdc14 proteins 
can functionally complement yCdc14 suggesting that hCdc14A/B regulate mitotic 
events in human cells. In line with this, hCdc14A, which is associated with centrosomes, 
is required for cytokinesis, correct centrosome duplication and centrosome splitting 
(Kaiser et al., 2002; Mailand et al., 2002b). In contrast, the function of hCdc14B, which 
is located in the nucleolus like yCdc14, is largely unknown. Previous work suggested 
that hCdc14B might be required for progression through mitosis (Tumurbaatar, 2003; 
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Fritsch, 2004). Based on these preliminary studies, the aim of this project was to 
investigate the role of hCdc14B in mitotic events. The following experiments should 
reveal the function of hCdc14B.  
• Cell cycle progression should be measured in human cell lines that stably and 
inducibly overexpress the wildtype form of hCdc14B or a phosphatase-dead mutant, 
hCdc14BPD. It should be analyzed whether overexpression of the different 
hCdc14B proteins affects mitotic entry, progression, or exit.  
• Knock-down of hCdc14B by siRNA had to be established. Cell cycle progression 
should be analyzed in cells depleted of hCdc14B by siRNA. In particular, it should 
be analyzed whether knock-down of hCdc14B leads to defects in cell division, 
mitotic arrest or cell death.  
• The capability of hCdc14B to inactivate mitotic Cdk1/cyclin B had to be tested 
both in vitro and in vivo. Given that hCdc14B would inactivate Cdk1/cyclin B it 
should be investigated whether this is accomplished in a direct or indirect fashion.  
• The sub-cellular localization and chromatin association of hCdc14B at different 
phases of the cell cycle had to be analyzed in fractionated cell extracts. Chromatin 
immunoprecipitation should reveal whether hCdc14B is bound to distinct regions 
of the rDNA.  
• The native molecular mass of cellular hCdc14B should be analyzed by size 
exclusion chromatography and it should be determined whether the native size 
changes during the cell cycle. 
• Finally, hCdc14B associated proteins should be isolated to get information about 
putative target proteins of hCdc14B. hCdc14B complexes had to be purified in 
large scale to allow subsequent analysis of hCdc14B-associated factors by mass 
spectrometry.  
 
.
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2. Materials and Methods 
2.1 Materials 
2.1.1 Standard buffers and solutions 
 
TE buffer 10 mM Tris-HCl, pH 8.0 
 1 mM EDTA, pH 8.0 
TAE buffer 40 mM Tris-acetate, pH 7.8 
 5 mM Na-acetate 
 1 mM EDTA, pH 8.0 
PBS buffer 137 mM NaCl 
 2.7 mM KCl 
 4.3 mM Na2HPO4 
 1.4 mM KH2PO4, pH 7.3 
Laemmli sample buffer (6x) 300 mM Tris-HCl, pH 6.8 
 30% glycerol (v/v) 
 12% SDS (w/v) 
 0.6 mM DTT 
 0.012% bromphenol blue (w/v) 
SDS-PAGE electrophoresis buffer 0.1% SDS (w/v) 
 25 mM Tris-HCl, pH6.8 
 250 mM glycine 
AM-X buffer 20 mM Tris-HCl, pH 7.9 
 5 mM MgCl2 
 0.2 mM EDTA 
 10% glycerol (v/v) 
 x mM KCl 
Ponceau staining solution 0.5% Ponceau S (w/v) 
 1% acetic acid (v/v) 
Coomassie staining solution 0.1% Coomassie Brilliant Blue R 250 (w/v) 
 45% methanol (v/v) 
 10% acetic acid (v/v) 
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Destaining solution 10% methanol (v/v) 
 10% acetic acid (v/v) 
 
2.1.2 Antibodies 
 
Antigen Source Species Dilution  
APC-1 Kind gift from J.M. Peters mouse 1:1000 
Actin Sigma AC-40 mouse  1:5000 
Cdc14A home made rabbit 1:500 
Cdc14B Zymed rabbit 1:1000 
Cdc20 Santa Cruz Biotechnology (H-175) rabbit 1:500 
Cdc27 BD Transduction Laboratories mouse 1:1000 
Cdh1 NeoVision mouse 1:300 
Cyclin A Oncogene (AB-2) rabbit 1:1000 
Cyclin B Santa Cruz Biotechnology (GNS1) mouse 1:1000 
Cyclin D Santa Cruz Biotechnology (sc-HD11) mouse 1:1000 
Cyclin E Santa Cruz Biotechnology (F-6) rabbit 1:1000 
Cdk1 Santa Cruz Biotechnology (sc-054) mouse 1:1000 
Flag   Sigma (M2) mouse 1:2000 
GFP  Santa Cruz Biotechnology (sc-8334 
FL) 
rabbit 1:1000 
HA  Produced by E. Krammer, GSF 
Munich (12CA5), 
mouse 1:1000 
H3-phospho-Ser10  Upstate (06-570) rabbit 1:1000 
RPA-116 Produced by P. Seither rabbit 1:1000 
UBF (K8) Produced by R. Voit mouse 1:1000 
 
Secondary antibodies: 
Anti-mouse: Peroxidase-conjugated AffiniPure goat anti-mouse IgG (H+L), Jackson 
Immunoresearch laboratories, Inc 
Anti-rabbit: Peroxidase-conjugated AffiniPure goat anti-rabbit IgG (H+L), Jackson 
Immunoresearch laboratories, Inc 
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IgGs: 
Mouse IgG: ChromPure Mouse IgG, whole molecule (11.2 mg/ml), Dianova  
Rabbit IgG: ChromPure Rabbit IgG, whole molecule (10.1 mg/ml), Dianova  
 
2.1.3 shRNAs and siRNAs 
 
shRNA targeting sequences are highlighted in bold. Nucleotide positions of the target 
sequences on the coding region of the mRNA are shown in Appendix 1. 
 
Nucleotide positions of the siRNA target sequences on the coding region of mRNA are shown 
in Appendix 2. 
 
shRNA shRNA DNA-oligonucleotide sequence  
sh-651 
sense 
5’-GATCCCTTGGATAATACCAGACCGATTCAAGAGATCGGTCTG 
GTATTATCCAATTTTTGGAAA-3’ 
sh-651 
antisense 
5’-AGCTTTTCCAAAAATTGGATAATACCAGACCGATCTCTTGAAT 
CGGTCTGGTATTATCCAAGG-3’ 
sh-510 
sense 
5’-GATCCCGGAAGTTGCAATTTCTACATTCAAGAGATGTAGAAA 
TTGCAACTTCCTTTTTGGAAA-3’ 
sh-510 
antisense 
5’-AGCTTTTCCAAAAAGGAAGTTGCAATTTCTACATCTCTTGAAT 
GTAGAAATTGCAACTTCCGG-3’ 
sh-640 
sense 
5’-GATCCCGGAGATTTAAATTGGATAATTCAAGAGATTATCCAAT 
TTAAATCTCCTTTTTGGAAA-3’ 
sh-640 
antisense 
5’-AGCTTTTCCAAAAAGGAGATTTAAATTGGATAATCTCTTGAAT 
TATCCAATTTAAATCTCCGG-3’ 
sh-892 
sense 
5’-GATCCCATTCCTAGATATCTGTGAATTCAAGAGATTCACAGAT 
ATCTAGGAATTTTTTGGAAA-3’ 
sh-892 
antisense 
5’-AGCTTTTCCAAAAAATTCCTAGATATCTGTGAATCTCTTGAATT 
CACAGATATCTAGGAATGG-3’ 
sh-GFP 
sense 
5’-GATCCCGGCTACGTCCAGGAGCGCACCTTCAAGAGAGGTGCG 
CTCCTGGACGTAGCCTTTTTGGAAA-3’ 
sh-GFP 
antisense 
5’-AGCTTTTCCAAAAAGGCTACGTCCAGGAGCGCACCTCTCTTGA 
AGGTGCGCTCCTGGACGTAGCCGG-3’ 
siRNA sense sequence antisense sequence 
hCdc14B(#1) GGGUGCCAUUGCAGUACAUTT AUGUACUGCAAUGGCACCCTT 
hCdc14B(#2) GAAGCAGCAUAUAGAAUAUTT AUAUUCUAUAUGCUGCUUCTT 
hCdc14B(#3) GAGCAGCCUUCUCCAAACUTT AGUUUGGAGAAGGCUGCUCTT 
GFP GGCUACGUCCAGGAGCGCACCTT GGUGCGCUCCUGGACGUAGCCTT 
hCdc14B510 GGAAGUUGCAAUUUCUACATT UGUAGAAAUUGCAACUUCCTT 
hCdc14B640 GGAGAUUUAAAUUGGAUAATT UUAUCCAAUUUAAAUCUCCTT 
non-targeting 
siRNA pool 1 
Dharmacon, sequences are not available 
Cdc14B 
Smart pool 
Dharmacon, sequences are not available 
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2.1.4 Plasmids 
 
Plasmid name Source 
pRc/CMV-Flag-hCdc14B C. Eckert 
pRc/CMV-Flag-hCdc14B(C326S/A328L) 1 S. Fritsch 
pGEX-hCdc14B R. Voit  
pGEX2T-hCdc14BPD This work 
pX-HA-Cdc25A A kind gift from I. Hoffmann 
pcDNA3-HA-Cdc25B3 A kind gift from I. Hoffmann 
pCMX-GFP-Cdc25C A kind gift from I. Hoffmann 
pGEX2T-GST-Cdc25A A kind gift from I. Hoffmann 
pGEX4T3-GST-Cdc5B2 A kind gift from I. Hoffmann 
pGEX-2T’6/hsCdc25C A kind gift from I. Hoffmann 
pT-Flag-hCdc14B R. Voit 
pT-Flag-hCdc14B(C326S/A328L) 2 S. Fritsch 
pXCdc2/hs P. Jansen-Dürr 
pCMX-Cyclin B R. Voit 
pcDNA4/TO-Flag-Cdc14BWT S. Fritsch 
pcDNA4/TO-Flag-Cdc14B(C326S/A328L)3 S. Fritsch 
pcDNA4/TO-Flag-HA-hCdc14BWT This work 
pcDNA4/TO-Flag-HA-hCdc14BPD This work 
pcDNA4/TO-TAP-hCdc14BPD This work 
pZOME-1-N-hCdc14BWT This work 
pZOME-1-N-hCdc14BPD This work 
pTER+ A kind gift from M. van de 
Wetering 
pTER-hCdc14B-sh4074 This work 
pTER-hCdc14B-sh510 This work 
pTER-hCdc14B-sh640 This work 
pTER-hCdc14B-sh892 This work 
                                                
1 This construct was renamed pRc/CMV-Flag-hCdc14BPD. 
2 This construct was renamed pTß-Flag-hCdc14BPD. 
3 This construct was renamed pcDNA4/TO-Flag-hCdc14BPD. 
4 This construct was renamed pTER-hCdc14B-sh651. 
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pTER-GFP-shRNA This work 
pMSCV/puro-U6-shCdc14B-64 This work 
pMSCV/puro-U6-shCdc14B-2311 This work 
 
2.2 Methods 
2.2.1 DNA methods 
2.2.1.1 Standard procedures 
Preparation of chemically competent bacteria, transformation, amplification of plasmid 
DNA in bacteria, purification, concentration determination, restriction enzyme digestion, 
ligation of DNA fragments, analysis of DNA on agarose and polyacrylamide gels, and 
amplification of DNA by PCR were performed according to standard protocols 
(Sambrook et al., 1989). 
 
2.2.1.2 Construction of shRNA expression plasmids  
The plasmid pTER+ that contains the human RNA polymerase III-dependent H1 
promoter was used to clone DNA oligonucleotides that comprised sequences 
complementary to 19-21 nt long stretches of the hCdc14B mRNA. 
 
Designing shRNA oligonucleotides 
The shRNA target sequences were selected according to criteria described by Reynolds 
et al. (2004). For cloning into the vector pTER+ (van de Wetering et al., 2003) DNA 
oligonucleotides were synthesized that correspond to shRNA target sequences, hairpin 
loop sequences, and 5’- and 3’-flanking sequences as follows:  
Sense shRNA DNA-oligo: 5’-GATCCC-19 nt sense target sequence-TTCAAGAGA-19 
nt antisense target sequence-TTTTTGGAAA-3’ 
Antisense shRNA DNA-oligo: 5’-AGCTTTCCAAAAA-19 nt sense target sequence-
TCTCTTGAA-19 nt antisense target sequence-GG-3’ 
 
Preparation of pTER
+
 plasmid for cloning 
The pTER+ plasmid DNA was digested with Hind III and Bgl II, dephosphorylated, and 
purified by agarose gel electrophoresis and gel extraction using the Qiaquick Gel 
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Extraction Kit (Qiagen). The concentration of the extracted DNA was measured by 
spectrophotometer at 260 nm. 
 
Annealing and cloning of shRNA DNA-oligonucleotides 
shRNA DNA-oligos were dissolved in H2O at a concentration of 100 pmol/μl. The 
annealing reaction contained 
   2 l of sense shRNA DNA-oligonucleotides  
   2 μl of antisense shRNA DNA-oligonucleotides  
   46 l of annealing buffer (10 mM potassium acetate, 30 mM  
    Hepes-KOH, pH 7.4, 2 mM magnesium acetate)  
The reaction was incubated at 95oC for 10 min, and slowly cooled to RT. 25 μl of the 
annealed oligos were phosphorylated by T4 DNA polynucleotide kinase (NEB) in a 
total volume of 50 l. The oligos were ligated without further purification overnight at 
16°C with the linearized pTER plasmid as follows: 
5 l of annealing reaction  
1.5 l of T4 DNA Ligase buffer (10x, NEB)  
0.3 μl of T4 DNA Ligase (400 U/μl, NEB)  
1 μl 10 mM ATP 
300 ng of linearized vector DNA  
ddH2O ad 15 μl. 
Cloning was performed using E. coli DH5 cells and insertion of the DNA-
oligonucleotides into the vector was verified by analytical restriction enzyme digestion 
with Hind III and Bgl II. 
 
2.2.1.3 5’-end labeling of oligonucleotides with -32P-ATP 
20 pmol of oligonucleotides were incubated at 37°C for 1 h with 2 μl of 10x T4 DNA 
polynucleotide kinase buffer (NEB), 5 U of T4 DNA polynucleotide kinase (NEB), and 
5 μl of -32P-ATP (10 mCi/ml, Perkin Elmer). To remove unincorporated radioactive 
nucleotides the reaction was purified using the Nucleotide Removal kit (Qiagen). 
Radiolabeled oligonucleotides were eluted with 100 μl of H2O. 
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2.2.1.4 Sequencing of DNA 
Plasmid DNA was sequenced using the Thermosequenase cycle sequencing kit (USB). 
For each reaction 20 pmol of sequence specific primer was radiolabeled at the 5’ end as 
described in 2.2.1.3. 1 μl of this reaction was directly used for the following sequencing 
reaction without any further purification:  
Radiolabeled primer 1 l 
10 x Thermosequenase buffer 2 l 
Thermosequenase (4 U/l) 1 l 
DNA 500 ng 
ddH2O ad 17.5 l  
4 l of this mixture were added to PCR tubes containing 4 l of ddATP, ddTTP, ddCTP 
or ddGTP (each consisting of 150 M dNTPs and 1.5 M of the corresponding ddNTP). 
The conditions of the PCR were as follows: initial denaturation at 94°C for 2 min 
followed by 40 cycles each consisting of 30 sec at 94°C, 30 sec at 52oC and 1 min at 
72°C. The reaction was stopped by adding 3 l of Stop solution (400 mM NH4Acetate, 
0.4 % SDS, 0.2 mg/ml yeast tRNA). After denaturation for 3 min at 95°C, 3 l of each 
sample were analyzed on 6% (w/v) PAA/8 M urea denaturing gel. The radioactive 
signals were visualized using a PhosphorImager (FUJIFILM-BAS 1800 II). 
 
2.2.2 Biochemical methods 
2.2.2.1 Determination of protein concentration and SDS-polyacrylamide gel 
            electrophoresis  
Protein concentration was determined using the colorimetric assay described by 
Bradford (1976). SDS-polyacrylamide gel electrophoresis (SDS-PAGE) was performed 
using the Bio-Rad Mini protein gel system. Separating and stacking gels were prepared 
according to Sambrook et al. (1989). Protein samples were mixed with Laemmli sample 
buffer, denatured at 95°C for 5 min and directly loaded onto the gels. Electrophoresis 
was performed at 180 V. The molecular weight of proteins was estimated by running 
pre-stained (Dual colour standards, Bio-Rad) or non-stained (Unstained protein 
standard, Bio-Rad) marker proteins.  
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2.2.2.2 Staining of proteins gels 
Coomassie staining 
Proteins were separated by SDS-PAGE, and protein gels were incubated in coomassie 
staining solution (0.1% (w/v) coomassie brilliant blue R 250, 45% (v/v) methanol, 10% 
(v/v) acetic acid) with gentle agitation at RT for 15-20 min. To remove unspecific 
staining, gels were incubated in destaining solution (10% (v/v) methanol, 10% (v/v) 
acetic acid) overnight at RT. 
 
Silver staining 
Prior to staining, protein gels were incubated at RT overnight in fixation solution 
containing 40% (v/v) ethanol and 10% (v/v) acetic acid. Gels were washed twice for 20 
min each with 30% (v/v) ethanol, and soaked in 0.02% (w/v) sodium thiosulfate 
solution for 1 min. After rinsing with water three times each for 20 sec, gels were 
stained in 0.2% (w/v) silver nitrate solution for 1-2 h at RT, and washed with water as 
described above. Next gels were incubated in developing solution (3% (w/v) sodium 
carbonate, 0.05% (v/v) formaldehyde and 0.0004% (w/v) sodium thiosulfate) for 5-10 
min, washed in water for 5 min, and incubated in 0.5% (v/v) glycerin for 5 min to stop 
the developing reaction. Finally, gels were washed in water for 30 min and stored in 
hot-seal bags until protein bands were cut for mass spectrometry analysis.  
 
2.2.2.3 Western blot analysis 
Proteins were separated by SDS-PAGE and transferred to nitrocellulose filters (Protran, 
Schleicher&Schuell) using the Bio-Rad ”Trans-Blot Semi Dry Apparatus” for 45 min at 
14 V. For transfer, gels were sandwiched between gel-sized-Whatman 3 MM papers 
soaked in anode or cathode buffers as follows: 
- 6 pieces of Whatman paper soaked in anode buffer I (300 mM Tris-HCl, pH 10.4)  
- 3 pieces of Whatman paper soaked in anode buffer II (25 mM Tris-HCl, pH 10.4) 
- nitrocellulose membrane soaked in ddH2O  
- SDS-polyacrylamide gel 
- 3 pieces of Whatman paper soaked in cathode buffer (25 mM Tris-HCl, pH 9.4, 40 mM 6-
aminohexan acid) 
After transfer, membranes were incubated in blocking solution (PBS/milk: 1xPBS 
containing 5% (w/v) dried milk, and 0.2% (v/v) Tween-20) for 1 h at RT. Primary 
antibodies were diluted in PBS/milk and incubated with membrane-bound proteins 
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either for 1 h at RT or overnight at 4°C. Filters were washed in PBS/milk for 1 h at RT 
and then incubated for 1 h at RT with the appropriate secondary antibody coupled to 
horseradish peroxidase (diluted in PBS/milk). Filters were washed twice with PBS/milk, 
twice with PBS, and protein-antibody complexes were detected using Enhanced Chemi-
Luminescence (ECL, Amersham Pharmacia Biotech) according to the manufacturer’s 
instructions.  
 
2.2.2.4 Extraction of hCdc14B for Western blot analysis 
3x105 cells were lysed in 150 μl of buffer AM-300 containing 0.5% (v/v) NP-40, 2 mM 
MgCl2, 0.5 mM PMSF, and protease inhibitor (Complete, Roche) or in Laemmli sample 
buffer containing 2 mM MgCl2, 0.5 mM PMSF, and protease inhibitor Complete 
(Roche). Samples were sonicated for 5 min using a Bioruptor (Diagonade, setting: high, 
15 sec on, 15 sec off), treated with 12.5 U of Benzonase (Merck) for 15 min at room 
temperature and clarified by centrifugation at 13000 rpm for 10 min. 30 μg of the 
lysates were separated on 10% SDS-PAA gels and analyzed by Western blotting using 
-Cdc14B antibodies (Zymed). 
 
2.2.2.5 Expression of recombinant proteins in E.coli 
The E.coli strain BL21-DE3 codon plus was transformed with the expression plasmid 
and cultured in 50 ml of LB medium with the appropriate antibiotic overnight at 37°C. 
The overnight culture was diluted 1:100 in 800 ml of LB medium containing the 
antibiotic and 1% of glucose, and cultured at 37°C until cell density reached OD600 of 
0.2. To induce expression of the recombinant protein 1 mM IPTG (f.c.) was added and 
the culture was incubated overnight at 16°C. 
 
2.2.2.6 Purification of GST-tagged proteins 
Cells from an 800 ml bacterial culture were harvested and washed with PBS. The cell 
pellet was resuspended in lysis buffer (20 mM Hepes, pH 8.0, 100 mM NaCl, 1 mM 
EDTA pH 8.0, 2 mg/ml lysozyme) containing 0.5% (v/v) NP-40 and protease inhibitors, 
incubated on ice for 10 min and sonicated (6 times, each 30 sec, amplitude 30%, 
Branson sonifier). The cell extracts were clarified by centrifugation at 13000 rpm for 30 
min at 4°C, and incubated at overnight 4°C with 200 μl of Glutathione-Sepharose (GT-
Sepharose, Amersham). Beads were washed 4 times in buffer AM-200 containing 0.2% 
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NP-40, and finally resuspended in washing buffer (1:2 ratio of beads and washing 
buffer). 5 μl of the 50% slurry was separated by SDS-PAGE, and bead-bound proteins 
were stained with coomassie to determine the amount of immobilized proteins. Beads 
were either stored at 4°C or bead-bound proteins were eluted. For elution, beads were 
washed in 50 mM Tris-HCl, pH 8.0 containing protease inhibitors, before incubation 
with 400 l elution buffer (50 mM Tris-HCl, pH 8.0, 20 mM glutathione, protease 
inhibitors) at 4°C for 1 h. Elution was repeated twice, and 7 μl of each eluate were 
analyzed by SDS-PAGE and coomassie staining. The eluted fractions were dialyzed 
against buffer AM-100/20% glycerol and stored at -80°C.  
 
2.2.2.7 In-vitro translation 
In-vitro translation was carried out using the ‘TNT coupled reticulocyte lysate system’ 
(Promega) and 35S-labeled methionine. The translated proteins were analyzed by SDS-
PAGE and visualized using a PhosphorImager (FUJIFILM-BAS 1800 II). 
 
2.2.2.8 GST pull-down assay 
GST-tagged proteins or GST were immobilized on GT-Sepharose, and incubated for 4 h 
at 4°C with 20 l of rabbit reticulocyte lysates containing the 35S-labeled proteins and 
80 l of buffer AM-120 supplemented with 0.2% (v/v) NP-40 and protease inhibitors. 
Beads were washed 3 times with buffer AM-120/0.2% (v/v) NP-40. Bead-bound 
proteins were separated by SDS-PAGE and radiolabeled proteins were detected using a 
PhosphorImager. 
 
2.2.2.9 Preparation of nuclear extracts from HeLa cells 
1x107 HeLa cells were harvested, washed in PBS, and resuspended in 500 μl of 
hypotonic buffer (10 mM Hepes, pH 8.0, 10 mM KCl, 1.5 mM MgCl2, 0.5 mM DTT, 
complete protease inhibitor cocktail). After incubation on ice for 10 min, cells were 
dounce homogenized (30 strokes, tight pestle) and nuclei were collected by 
centrifugation at 4000 rpm for 5 min at 4°C. The nuclei were resuspended in 1 ml of 
buffer S1 (0.25 mM sucrose, 10 mM MgCl2, protease inhibitors), layered on top of a 1 
ml cushion of buffer S2 (0.35 mM sucrose, 0.5 mM MgCl2, protease inhibitors) and 
centrifuged at 2500 rpm for 5 min at 4°C. The nuclei were lysed in 150 μl of buffer 
AM-400 supplemented with 1% (v/v) NP-40 and 50 U of DNase I and incubated for 30 
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min at 4°C. After sonication for 10 min with the Bioruptor (setting: high, 30 sec on/off), 
the sample was clarified by centrifugation at 13000 rpm for 10 min at 4°C, and the 
supernatant was transferred to a fresh eppendorf tube. The chromatin pellet was 
resuspended in 150 μl of buffer AM-0 and treated as described above. After 
centrifugation, both supernatants were combined, 300 μl of buffer AM-0 were added to 
dilute the salt concentration of the extract to 100 mM, and the extract was stored at -
80°C.  
 
2.2.2.10 Gel filtration of nuclear extracts 
600 μl of HeLa nuclear extract (4 mg/ml) were loaded onto a Superose 6 prep grade 
column (Amersham, column volume 50 ml) equilibrated with buffer AM-100. 
Chromatography was performed at a flow rate of 0.5 ml/min. Fractions of 500 μl were 
collected, proteins of the individual fractions precipitated with TCA and analyzed by 
Western blotting. For calibration of the column, thyroglobulin (670 kDa), apoferritin 
(440 kDa), alcohol dehydrogenase (150 kDa) and BSA (66 kDa) were used. 
 
2.2.2.11 Cellular fractionation  
1x106 of HeLa cells were washed twice in PBS. The cell pellet was resuspended in 100 
μl of buffer A (10 mM Hepes, pH 8.0, 10 mM KCl, 1.5 mM MgCl2, 0.34 M Sucrose, 
10% glycerol, 1 mM DTT, 0.1% Triton X-100 and protease inhibitors), incubated on ice 
for 5 min, and the nuclei were collected by low speed centrifugation (4000 rpm for 5 
min at 4°C). The supernatant (cytosolic fraction) was further clarified by centrifugation 
at 13000 rpm for 15 min at 4°C. The nuclei were washed once in buffer A, and then 
resuspended in 100 μl of buffer B (10 mM Hepes, pH 8.0, 150 mM NaCl, 3 mM EDTA, 
pH 8.0, 0.2 mM EGTA, pH 8.0, 1 mM DTT, 0.1 mM sodium vanadate and protease 
inhibitors), passed 10 times through a 22-gauge needle, incubated on ice for 30 min, and 
centrifuged at 3400 rpm and 4°C for 4 min. The soluble nucleoplasmic fraction was 
transferred to a fresh eppendorf tube. The pellet, which contains the chromatin-
associated fraction was washed once in buffer B, resuspended in 100 μl of Laemmli 
sample buffer supplemented with 2 mM MgCl2, and sonicated for 5 min using the 
Bioruptor (settings: high, 15 sec on/off). To release chromatin-bound proteins, 12 U of 
Benzonase were added and the sample was incubated for 15 min at RT. The reaction 
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was stopped by addition of 10 mM EDTA and the sample centrifuged at 13000 rpm for 
10 min at RT. Fractions were analyzed by Western blotting. 
 
2.2.2.12 Chromatinimmunoprecipitation 
Protein-DNA complexes of 2x107 cells were crosslinked in the presence of 1% 
formaldehyde for 10-15 min at RT. Adding 0.125 M glycine stopped the crosslinking. 
Cells were harvested, rinsed twice in PBS, resuspended in 300 μl of hypotonic buffer (5 
mM Hepes pH 8.0, 85 mM KCl, 0.5 % (v/v) NP-40, protease inhibitors), incubated on 
ice for 10 min, and collected by centrifugation at 5000 rpm for 5 min at 4°C. Pellets 
were resuspended in 500 μl of nuclei lysis buffer (1% (w/v) SDS, 10 mM EDTA, 50 
mM Tris-HCl pH 8.1, protease inhibitors), incubated on ice for 10 min, sonicated 
(Branson; 7 times, each 90 sec, amplitude constant), and microcentrifuged. The 
chromatin solution was precleared by incubating with 20 μl of packed protein A-
Agarose (500 μl of packed beads were blocked with 500 g of E.coli DNA and 500 g 
of bovine serum albumin) for 30 min at 4°C. Precleared chromatin from 0.5x107 cells 
was incubated with 5 g of antibodies against hCdc14B, hUBF or rabbit IgG at 4°C 
overnight. 20% of the precleared chromatin was saved as total input chromatin and was 
processed with the eluted immunoprecipitates at the de-crosslinking step. Protein-DNA-
antibody complexes were incubated with 20 μl of packed to protein A-beads a 4°C for 1 
h, and unspecifically bound proteins were removed by washing once with 1 ml of low 
salt buffer (0.1% (w/v) SDS, 1% (v/v) Triton X-100, 2 mM EDTA, 20 mM Tris-HCl pH 
8.0, 150 mM NaCl), once with high salt buffer (500 mM NaCl in the same buffer as 
above), once with LiCl buffer (10 mM Tris-HCl pH 8.0, 250 mM LiCl, 1% (v/v) NP-40, 
1% (w/v) deoxycholic acid, 1 mM EDTA), and twice with TE buffer each for 10 min at 
RT. Protein-DNA crosslinks were reversed in the presence of 200 mM NaCl at 65°C for 
4-5 h. To remove RNA 10 g of RNase A were added during de-crosslinking. Samples 
were precipitated at -20°C overnight by adding 2.5 vol. of 96% ethanol and pelleted by 
microcentrifugation. Pellets were resuspended in proteinase K buffer, incubated with 30 
μg of proteinase K at 45°C for 2 h, extracted once with phenol-chloroform-isoamyl 
alcohol (25:24:1), once with chloroform-isoamyl alcohol (24:1), and DNA was 
precipitated with 1/10 volume of 3 M NaOAc (pH 5.3), 5 g of glycogen, and 2.5 vol. 
of 96% ethanol at -80°C for 1 h. DNA was collected by microcentrifugation, 
resuspended in 30 l of H2O, and analyzed by PCR. PCR was carried out with 0.5 and 2 
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l of the co-immunoprecipitated DNA samples or from a 1:300 dilution of the total 
input sample in the presence of -32P-dCTP. The conditions for PCR were as follows: 
initial denaturation at 94oC for 5 min followed by 28 cycles each consisting of 30 sec at 
92oC, 30 sec at 52oC, and 30 sec at 72oC. PCR products were run on 8% (w/v) PAA gels 
and visualized by PhosphorImager.  
 
2.2.2.13 Immunopurification of Flag-hCdc14B  
Flag-hCdc14B was either transiently overexpressed in U2OS cells or stably 
overexpressed in U2OS or HeLa S3 cells. 1x106 cells were lysed in 200 l of buffer A 
(50 mM Tris-HCl, pH 7.5, 400 mM NaCl, 0.2% (v/v) Triton X-100, 1 mM DTT, 2 mM 
MgCl2 and protease inhibitors), incubated for 30 min at 4°C and sonicated for 5 min 
(Bioruptor, settings: high 15 sec on/off). 50 U of Benzonase were added for 30 min at 
4°C, the lysate was sonicated as above, and centrifuged at 13000 rpm and 4°C for 20 
min. The supernatant was transferred to a fresh eppendorf tube and diluted with 1 
volume of buffer AM-0 containing 10 mM EDTA. For immunoprecipitation, 300 μg of 
the lysate were incubated at 4°C for 3-4 h with 7 μl of packed -Flag agarose beads 
(M2-beads, Sigma). The beads were washed three times with buffer AM-200 substituted 
with 0.1% (v/v) Triton X-100, and once with phosphatase assay buffer.  
 
2.2.2.14 Tandem affinity purification of hCdc14B complexes  
U2OS cells stably expressing TAP-hCdc14BPD in a tetracycline-inducible manner were 
grown on fifteen 15 cm dishes. At a cell density of 70%, expression of TAP-hCdc14BPD 
was induced overnight by addition of 2 μg/ml doxycycline. Cells were washed two 
times with PBS, harvested in 4.5 ml of buffer A (10 mM Hepes, pH 7.9, 1.5 mM MgCl2, 
10 mM KCl, 0.5 mM DTT and protease inhibitors), and incubated for 15 min at 4°C. 
The cell pellet was collected by centrifugation at 5000 rpm for 5 min, resuspended in 2 
ml of buffer B (20 mM Hepes, pH 7.9, 420 mM NaCl, 1.5 mM MgCl2, 25% glycerol, 
0.2 mM EDTA and protease inhibitors), dounce homogenized with 30 strokes (tight 
pestle) and incubated for 30 min at 4°C. The lysate was clarified by centrifugation at 
13000 rpm for 30 min at 4°C and dialyzed against buffer AM-100. Batch purification 
via the IgG binding domain of the tagged proteins was performed using 300 μl of IgG-
Sepharose 6 resin (Amersham) equilibrated in buffer AM-100. Precipitation was 
performed at 4°C for 6 h and beads were washed three times in TEV-cleavage buffer 
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(25 mM Tris-HCl, pH 8.0, 150 mM NaCl, 0.1% (v/v) NP-40, 0.5 mM EDTA, 1 mM 
DTT). For TEV-cleavage, beads were rotated overnight at 4°C in TEV-cleavage buffer 
containing 70 U of TEV-protease (Invitrogen). The supernatant from the TEV-cleavage 
reaction was collected, substituted with 2 mM (f.c.) CaCl2, diluted with 3 volumes of 
calmodulin binding buffer (25 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1 mM Mg-acetate, 
1 mM imidazole, 2 mM CaCl2, 10 mM -mercaptoethanol, 0.1% (v/v) NP-40, protease 
inhibitors), and incubated with 100 μl of packed calmodulin beads (Stratagene) for 4 h 
at 4°C. The beads were washed three times in the calmodulin binding buffer and eluted 
three times with calmodulin elution buffer (25 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1 
mM Mg-Acetate, 1 mM imidazole, 10 mM EGTA, 10 mM -mercaptoethanol, 0.02% 
(v/v) NP-40 and protease inhibitors). The eluted fractions were analyzed by Western 
blotting. 
 
3.2.2.15 Isolation of hCdc14B complexes by sequential immunoprecipitation  
Fifteen 15 cm dishes of 293T cells were transfected with Flag-HA-hCdc14BWT or Flag-
HA-hCdc14BPD expression plasmids (3 μg of expression plasmid per dish). 48 h after 
transfection cells were harvested and nuclear extracts were prepared as described in 
2.2.2.9. For the first immunoprecipitation, nuclear extracts were incubated overnight at 
4°C with 200 μl of packed M2-beads. The beads were washed four times in buffer AM-
200 containing 0.2% NP-40, and the bead-bound proteins were eluted three times at 4°C 
for 1 h with 500 μl of buffer AM-250 containing 0.2% NP-40 and 0.2 mg/ml Flag-
peptide (DYKDDDDK). The eluates were combined, diluted with 1 volume of buffer 
AM-0 containing 0.2% NP-40, and incubated overnight at 4°C with 150 μl of packed -
HA agarose beads (HA-beads, Sigma). Beads were washed 6 times in buffer AM-200 
containing 0.2% NP-40. Bead-bound proteins were eluted three times for 1 h at RT each 
with 400 μl of buffer AM-400 containing 0.2 % NP-40, complete protease inhibitor 
cocktail and 0.2 mg/ml HA peptide (YPYDVPDYA). Aliquots of the eluted fractions 
were analyzed by Western blotting, and the residual material was precipitated with TCA 
and subjected to SDS-PAGE on 4-15% (w/v) Tris-HCl gels (Bio-Rad). Proteins were 
detected by silver staining and analyzed by mass spectrometry.  
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3.2.2.16 Co-immunoprecipitation of hCdc14B and its interacting proteins 
Flag-hCdc14B was transiently overexpressed either in U2OS or HEK-293T cells. 3x106 
cells were harvested and lysed in 200 l of buffer AM-120 containing 0.5% NP-40, 10 
mM MgCl2, 20 μg of DNase I, 10 μg of RNase A and 25 U of Benzonase. Lysates were 
sonicated for 5 min with a Bioruptor (Diagonade, setting: high, 15 sec on, 15 sec off), 
and clarified by centrifugation at 13000 rpm for 20 min at 4°C. The lysates were 
incubated overnight at 4°C with 10 μl of packed M2-beads. Beads were washed twice 
with buffer AM-120 containing 0.2% NP-40, and twice with buffer AM-100 substituted 
with 0.2 % NP-40. Bead-bound proteins were analyzed by Western blotting using -
hCdc14B, -HA and -GFP antibodies. 
 
3.2.2.17 Determination of phosphatase activity 
pNPP (p-Nitrophenyl Phosphate) assay 
1-10 l of soluble bead-bound GST-hCdc14BWT or GST-hCdc14BPD, or 1 to 0.01 U of 
calf intestine alkaline phosphatase (Roche) were incubated for 30 min at 37°C in 
phosphatase assay buffer (50 mM Tris, pH 6.8, 2 mM EDTA, 5 mM DTT, 0.01 % 
Triton X-100, 2% glycerol, 150 mM NaCl containing 50 mM pNPP (Calbiochem)). The 
final of volume of the reaction was 50 μl. The reactions were stopped by addition of 950 
l of 0.25 M NaOH, and the yellow, reaction product was measured by 
spectrophotometer at =405 nm. 
 
OMFP assay 
Expression of Flag-hCdc14BWT in HeLa-Flag-hCdc14BWT cells, lysate preparation and 
binding to M2-agarose was done as described (2.2.2.13). 1.6 mg of cell lysate were 
incubated with 5 μl of packed M2-beads for 2-3 h at 4°C. 4 μl of packed M2-Flag-
hCdc14B beads were incubated in 30 l of phosphatase assay buffer (see above) 
containing 0.7 mM OMFP (Sigma) at 37°C for 30 min. The reaction was stopped by 
addition of 70 μl of 0.2 M NaOH and transferred to a 96-well microtiter plate, and the 
absorbance of the hydrolysis product OMF was measured at =477 nm using an ELISA 
reader.  
 
2.2.2.18 In vitro dephosphorylation of GST-Cdc25 by hCdc14B 
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GST-tagged Cdc25A, B and C were expressed in E.coli and immobilized on GT-beads 
as described in 2.2.2.6. The GT-beads were incubated with nuclear extract from mitotic 
HeLa cells for 30 min at 30°C in kinase buffer (50 mM Tris, pH 7.5, 10 mM MgCl2, 1 
mM EGTA, 1 mm DTT and 10 mM ATP) containing 5 Ci -32P-ATP. Beads were 
then washed three times with 1 ml of phosphatase assay buffer (see 2.2.2.17) containing 
14 mM DMAP (Sigma). GST-hCdc14BWT or GST-hCdc14BPD was added and the 
samples were incubated in phosphatase assay buffer for 40 min at 37oC. The reactions 
were stopped by adding Laemmli sample buffer and boiled for 5 min. The samples were 
resolved by SDS-PAGE, and radiolabeled proteins were visualized by PhosphoImager.  
 
2.2.2.19 Immunoprecipitation of Cdk1/cyclin B from HeLa cells  
3x105 HeLa cells were harvested, washed in PBS, and resuspended in 200 μl of lysis 
buffer (50 mM Tris-HCl, pH 7.4, 250 mM NaCl, 0.1 % Triton X-100, 50 mM NaF, 5 
mM EDTA, 1 mM DTT) containing protease inhibitors. After incubation for 30 min at 
4°C, the lysate was sonicated for 5 min with a Bioruptor (setting: high, 15 sec on/off) 
and centrifuged at 13000 rpm for 10 min at 4oC. The protein concentration of the lysate 
was determined by Bradford assay. 350 μg of the lysate were mixed with 10 μl of 
mouse IgG conjugated Dynabeads (Dynal Biotech) or -cyclin B antibody pre-bound to 
Dynabeads. After incubation for 2-3 h at 4°C, Dynabeads were washed three times in 
lysis buffer, and the precipitated Cdk1/cyclin B activity was measured using the in vitro 
peptide-based assay (see 2.2.2.21). 
 
2.2.2.20 Purification of Cdk1/cyclin B from Sf9 cells 
1.5x108 Sf9 cells were co-infected with baculoviruses encoding myc-cyclin B and HA-
Cdk1. 2 days after infection cells were harvested, washed in PBS and lysed in 12 ml of 
lysis buffer (80 mM -glycerophosphate, 15 mM EGTA, 10 mM MgCl2, 1 mM DTT) 
containing protease inhibitors. After sonication (Branson; output 30%, four cycles: each 
15 sec), the lysate was incubated for 15 min on ice, and clarified by centrifugation at 
55000 rpm (Beckman TLA 100.4 rotor) for 30 min at 4°C. The lysate was fractionated 
by ammoniumsulfate precipitation (45%). Precipitated proteins were collected by 
centrifugation at 30000 rpm for 30 min at 4°C in (Beckman TLA 100.4 rotor), 
resuspended in 500 μl of Buffer B (5 mM -glycerophosphate, 1 mM EGTA, 1,5 mM 
MgCl2, 1 mM DTT, and protease inhibitors), loaded onto a NAP-5 column equilibrated 
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with Buffer B, and eluted with Buffer B. In total, 8 eluates of each 500 μl were 
collected and the protein concentration was determined by Bradford assay. The peak 
protein fractions were combined and loaded onto a DEAE-sepharose column (column 
volume: 7 ml) equilibrated with 10 volumes of Buffer B and with 10 volumes of Buffer 
C (5 mM -glycerophosphate, 1 mM EGTA, 1.5 mM MgCl2, 1 mM DTT, 35 mM NaCl, 
and protease inhibitors). After loading of the samples, the column was washed with 5 
volumes of Buffer C, and proteins were eluted with 10 volumes of Buffer B containing 
200 mM NaCl. In total 16 fractions of 300 μl were collected and stored at -80°C after 
addition of glycerol (ad 20%). Fractions were analyzed by Western blotting for the 
presence of cyclin B and Cdk1, and Cdk1/cyclin B activity was determined using the 
peptide-based assay (see 3.2.2.21).  
 
2.2.2.21 Cdk1/cyclin B kinase assay 
Purified Cdk1/cyclin B complexes or partially purified fractions containing Cdk1/cyclin 
B were incubated with 10 μg of Cdk1-specific substrate peptide (PKTPKKAKKL) and 
2 Ci -32P-ATP in kinase buffer (50 mM Tris, pH 7.5, 10 mM MgCl2, 1 mM EGTA, 1 
mM dithiothreitol, 10 M ATP) in a total volume of 10 μl for 30 min at 30°C. To 
monitor the autophosphorylation activity, incubation was done in the absence of the 
substrate peptide. The reactions were stopped by adding 10 μl of 30% acetic acid and 
spotted onto 2x2 cm pieces of Whatman P81 phosphocellulose paper. Filters were 
washed four times in 15% acetic acid, dried and incorporation of 32P into the peptides 
was measured by scintillation counting.  
 
2.2.3 Cell culture techniques 
2.2.3.1 Cell culture and maintenance of cell lines 
U2OS, HEK-293T and HeLa cells were grown in Dulbecco’s Modified Eagle’s 
Medium (DMEM, Invitrogen) supplemented with heat inactivated 10% FCS, 4 mM N-
acetyl-L-glutamine, 63 mg/l penicillin, 100 mg/l streptomycin (Lenaris) and 1 mM 
sodiumpyruvate (Biochrom). Cells stably expressing recombinant hCdc14B in a 
tetracycline-inducible manner were cultured in DMEM supplemented with 10% TET-
system approved FCS (Clontech), 125 μg/ml zeocin (Invitrogen) and 2.5 μg/ml 
blasticidin HCl (Invitrogen). HeLa ‘Kyoto’ cells expressing H2B-GFP were cultured in 
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DMEM/10% FCS containing 500 μg/ml G418. Cells were trypsinized and subcultivated 
2-3 times a week by 1:4-1:6 ratios. 
Sf9 (Spodoptera frugifera) cells were cultured in suspension in TC-100 medium 
(Cambrex) containing 10% FCS, 4 mM N-acetyl-L-glutamine, 63 mg/l penicillin, 100 
mg/l streptomycin at 27°C. The cell density was kept between 5x105 and 1.2x106 
cells/ml.  
 
2.2.3.2 Synchronization of culture cells 
Exponentially growing U2OS and HeLa cells were synchronized at different phases of 
the cell cycle phase as follows: 
Double thymidine block: Cells were treated with 2 mM thymidine for 19 h, released into 
fresh medium for 12 h, and again treated with 2 mM thymidine for 17 h to arrest at G1/S. 
For release from the G1/S arrest, the cells were extensively washed with PBS before 
adding fresh medium. At various time points after release the cells were harvested and 
the cell cycle profiles were analyzed by flow cytometry. 
Nocodazole arrest: Cells were treated with 40 ng/ml of nocodazole for 20 h. The 
mitotically arrested cells were collected by mitotic shake-off. For release, the mitotic 
cells were extensively washed with PBS before seeding in fresh medium. Cells were 
harvested at various time points after release, and the cell cycle profiles were 
determined by flow cytometry. 
 
2.2.3.3 Flow cytometry analysis 
1x106 cells were trypsinized, washed twice with cold PBS and resuspended in 1 ml of 
cold PBS. For fixation, 3 volumes of ice-cold 96% ethanol were added drop-wise and 
cells were incubated overnight at 4°C. The fixed cells were washed with cold 
PBS/0.01% FCS, resuspended in 100 μl of PBS and passed through a 21-gauge needle 
into a FACS analysis tube containing 1 ml of FACS staining solution (0.1% sodium 
citrate, 0.1% NP-40, 50 μg/ml of propidium iodide (Sigma), 50 μg/ml RNase A). The 
suspension was incubated in the dark at 4°C for at least 1 h. The probes were analyzed 
using the Becton Dickinson FACScan and the software Cell Quest. Quantitation was 
performed with the software ModFit LT. 
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2.2.3.4 TUNEL assay 
The TUNEL assay was performed to detect apoptosis-dependent DNA breaks using the 
In Situ Cell Death Detection Kit, TMR red (Roche) according to the manufacturer’s 
protocol.  
 
2.2.3.5 Transfection of plasmid DNA 
Plasmid transfections were performed according to the calcium phosphate precipitation 
method of Graham and van der Eb (1973). 24 h before transfection, cells were plated 
onto 10 cm plates at a density of 30%. 4 h prior to transfection fresh DMEM/HAMSF12 
medium supplemented with 10% FCS was added to the cells. The transfection mixture 
(final volume 1 ml) contained 20 μg of DNA, 50 μl of 2.5 M CaCl2 and 430 μl of 1/10 
TE (1 mM Tris-HCl, pH 8.0 and 0.1 mM EDTA) that had been mixed with 500 μl of 
2xHBS buffer (280 mM NaCl, 50 mM Hepes, 1.5 mM Na2HPO4, pH 7.09) in a drop-
wise manner. After incubation for 20-30 min at RT the transfection mixture was added 
to the cells. 16 h post-transfection the medium was replaced with fresh DMEM/10% 
FCS. 
 
2.2.3.6 Establishment of tetracycline-inducible stable cell lines 
U2OS cells that express recombinant hCdc14B in a tet-inducible manner, were 
generated by transfection of pcDNA4/TO-Flag-hCdc14BWT, pcDNA4/TO-Flag-
hCdc14BPD or pcDNA4/TO-TAP-hCdc14BPD expression plasmids together with the 
pcDNA6/TR (Invitrogen) plasmid at DNA ration of 6:1. Clones were selected in the 
presence of 250 g/ml zeocin (Invitrogen) and 5g/ml blasticidin HCl (Invitrogen), 
individual clones were picked and grown in DMEM supplemented with 10% TET-
system approved FCS (Clontech) and the selection markers. To induce expression of the 
recombinant proteins, 2 g/ml of doxycycline (Sigma) were added to the culture 
medium.  
To generate tet-inducible HeLa cells, transfections were done as described above. 
Positive clones were selected in tetracycline-free medium supplemented with 100 g/ml 
zeocin and 1 g/ml blasticidin HCl. Individual cell clones were further cultured in 
DMEM containing 50 μg/ml zeocin and 0.5 μg/ml blasticidin HCl. To induce 
expression of the recombinant hCdc14B proteins, 2 g/ml of doxycycline were added to 
the culture medium. 
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2.2.3.7 Transfection of siRNA 
siRNAs were introduced into human cells using Lipofectamine 2000 and a reverse 
transfection procedure. The following protocol is optimized for transfection of 1.4x105 
HeLa cells seeded in 12-well dishes. 6 μl of 20 μM siRNA were spotted onto a 12-well 
plate and mixed with 120 μl of unsupplemented DMEM. 3 μl of Lipofectamine 2000 
(Invitrogen) were diluted by gently pipetting with 120 μl of unsupplemented DMEM in 
an eppendorf tube and incubated at RT for 15 min. The diluted Lipofectamine 2000 was 
added to the siRNAs and gently mixed. After an incubation at RT for 20-30 min, 760 μl 
of the cell suspension (1.4x105 cells) was added to the siRNA:Lipofectamine 2000 
mixture and incubated at 37°C for 9-14 h. Fresh DMEM containing 10% FCS, 
glutamine and sodiumpyruvate, but no antibiotics replaced the medium. 24 h later cells 
were trypsinized and transfected with siRNA as described above. 72-120 h after the first 
transfection the cells were harvested and analyzed by Western Blotting. 
 
2.2.3.8 Infection of Sf9 cells with baculoviruses 
3x107 Sf9 cells were seeded on a 15 cm dish. After cells had attached, the medium was 
removed and about 5 ml of amplified-baculovirus stock was added onto the cells. After 
incubation on a rocking platform for 1.5 h at RT, 20 ml of supplemented TC-100 
medium was added, the cells were incubated in a wet chamber at 27°C and harvested 2 
days after infection. 
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3. Results 
3.1 Functional analysis of hCdc14B during the cell cycle 
In the budding yeast, the phosphatase yCdc14 is required for mitotic exit (Stegmeier 
and Amon, 2004). Interestingly, both human homologues, hCdc14A and B, can 
functionally complement yeast strains, in which the yCdc14 gene has been deleted 
(Vazquez-Novelle et al., 2005). This suggests that essential functions of the Cdc14 
phosphatase family have been conserved among eukaryotes and that Cdc14 is also 
required for mitotic events in human cells. Consistent with this, previous studies have 
pointed to a role of hCdc14A in cytokinesis and centrosome splitting (Kaiser et al., 
2002; Mailand et al., 2002b). Much less is known about the second isoform, hCdc14B.  
Time-lapse fluorescent microscopy has shown that U2OS cells transiently 
overexpressing GFP-tagged wildtype hCdc14B (hCdc14BWT) failed to divide and died 
when hCdc14BWT was overexpressed for more than 72 h (Tumurbaatar, 2003). 
Subsequent studies revealed that the mitotic index of U2OS cells expressing GFP-
hCdc14BWT was decreased to 1.75% in comparison to 4% in cells expressing GFP. In 
contrast, overexpression of a GFP-tagged, phosphatase-dead mutant of hCdc14B, 
termed hCdc14BPD, raised the mitotic index from 4% to 11% (Fritsch, 2003). 
hCdc14BPD carries two point mutations within the catalytic site at residues C324 and 
A326 that are essential for the phosphatase activity of hCdc14B (Taylor et al., 1997) 
(Fig. 3.1.A).  
 
3.1.1 Generation of U2OS cells stably overexpressing Flag-hCdc14B
WT
 or 
Flag-hCdc14B
PD 
 
As a first approach for deciphering the functional role of hCdc14B in cell cycle 
progression, U2OS cell lines were established that stably overexpress hCdc14BWT or 
hCdc14BPD. Previous studies in our group have shown that constitutive overexpression 
of hCdc14B in different human and mouse cells, such as HeLa, U2OS, HEK-293T, or 
NIH-3T3, is lethal (Tumurbaatar, 2003; Fritsch, 2003). Therefore, stable expression of 
ectopic hCdc14B was performed under the control of a tetracycline-inducible promoter. 
U2OS cells were co-transfected with plasmids that encode the tet-repressor 
(pcDNA6/TR) and plasmids that contain the tet-operator, a CMV-promoter and cDNAs 
for either Flag-tagged hCdc14BWT (pcDNA4/TO-Flag-hCdc14BWT) or the phosphatase-
dead mutant hCdc14BPD (pcDNA4/TO-Flag-hCdc14BPD). Co-transfected cells were 
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selected in the presence of zeocin (for pcDNA4/TO-Flag-hCdc14B plasmid) and 
blasticidin HCl (for pcDNA6/TR plasmid), individual clones were isolated and cultured 
in tetracycline-free medium supplemented with the selection markers. Expression of the 
recombinant hCdc14B proteins was induced by adding the tetracycline derivative 
doxycycline at a final concentration of 2 μg/ml to the culture medium for 4-16 h. The 
level of the recombinant hCdc14B proteins was monitored by Western blotting. As 
shown in Fig. 3.1.B, Flag-hCdc14B proteins were expressed within 4 h after the 
addition of doxycycline, and were not detected in non-induced cells. For subsequent 
functional analysis, the clones 6-WT and 7-WT that express Flag-hCdc14BWT, and 
clones 1-PD, 4-PD and 12-PD that express Flag-hCdc14PD were chosen.   
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dox  0  4  8 16 h  0  4   8  16  0  4  8 16 
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Figure 3.1. Tetracycline-induced expression of Flag-hCdc14B proteins in different clones of U2OS-
Flag-hCdc14
WT
 and U2OS-Flag-hCdc14B
PD
 cell lines. A) Amino acid sequence comparison of the 
catalytic site in different Cdc14 orthologues. The localization of the catalytic site of hCdc14B is presented 
in green (top). The conserved C324 and A326 residues are highlighted in red. The two amino acid 
residues exchanged in hCdc14BPD are shown in green (bottom). B) Induction of Flag-hCdc14B 
expression by doxycycline. Individual clones of stably transfected U2OS cells were incubated with 
doxycycline (dox, 2 g/ml) for the indicated times (h) and Flag-hCdc14B proteins were detected on 
immunoblots using -hCdc14B antibodies. The Western blots were reprobed with antibodies specific to 
actin to monitor equal protein loading.  
 
3.1.3 Cell cycle progression is altered in U2OS cells overexpressing Flag-
hCdc14B
WT
 or Flag-hCdc14B
PD 
 
To analyze cell cycle progression, U2OS-Flag-hCdc14BWT and U2OS-Flag-hCdc14BPD 
and parental U2OS cells were arrested at G1/S by a double thymidine block and released 
into the cell cycle. Expression of Flag-hCdc14B was induced in the presence of 2 μg/ml 
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of doxycycline 4 h before release from G1/S (Fig. 3.2.A). To monitor progression 
through G2- , M- , and the next G1-phase, cells were harvested at different time points 
after release and analyzed by flow cytometry (Fig. 3.2.B). At least two different clones 
of each cell line that express Flag-hCdc14BWT or Flag-hCdc14BPD were used in these 
studies. Cell clones that express similar amounts of the same recombinant hCdc14B had 
the same phenotype (data not shown). Therefore, results from cell clones 6-WT 
expressing Flag-hCdc14BWT, and 1-PD expressing Flag-hCdc14BPD are shown, 
representatively.  
 As shown in Fig. 3.2.B, accumulation of cell population with 4N DNA content, 
and thus migration to G2/M occurred at the same time in U2OS-Flag-hCdc14B
WT, 
U2OS-Flag-hCdc14BPD and parental cells, e.g. 12 h after release. 16 h after release from 
G1/S, all of the parental cells had entered the G1- and S-phase of the next cell cycle 
indicated by accumulation of the 2N DNA containing cell population and the absence of 
cells with 4N DNA content. Interestingly, at the same time point 27% of the U2OS-
Flag-hCdc14BWT cells and 14% of the U2OS-Flag-hCdc14BPD cells were contained in 
G2/M as indicated by the 4N DNA content. This suggests that overexpression of Flag-
hCdc14BWT and Flag-hCdc14BPD prolonged either the G2-phase and/or the M-phase.  
 
3.1.3 Overexpression of hCdc14B
WT
 and hCdc14B
PD
 delays mitotic entry 
         and progression through mitosis 
To distinguish, whether the G2- or the M-phase was affected by overexpression of 
hCdc14B, immunoblotting analysis was performed using antibodies against pY15-Cdk1. 
Cdk1 is phosphorylated at T14/Y15 from G1- until late G2-phase and thereby 
inactivated. At late G2-phase Cdc25 phosphatases remove these inhibitory phosphates 
and thereby activate Cdk1/cyclin B (Nilsson and Hoffmann, 2000). In addition, level of 
histone H3-pSer10 was monitored on immunoblots. The phosphorylation of histone H3 
at Ser10 starts at onset of mitosis, reaches the highest level at metaphase and declines 
during late mitosis (Nowak and Corces, 2004).  
 U2OS-Flag-hCdc14BWT and U2OS-Flag-hCdc14BPD cells were synchronized and 
Flag-hCdc14B proteins were expressed as described above. At different time points 
after release cells were harvested, lysed and analyzed by immunoblotting (Fig. 3.2.C). 
Y15-Cdk1 was phosphorylated and histone H3-Ser10 was unphosphorylated at G1/S (0 
h, lanes 1, 7 and 13). 12 h after release, the parental cells had entered mitosis as 
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indicated by the decline of pY15-Cdk1 and the presence of H3-pSer10 (lane 2). 15 h 
after release H3-pSer10 was almost completely lost, and at 18 h phosphorylation of 
Y15-Cdk1 increased again, demonstrating that cells had completed mitosis and 
progressed through the next cell cycle. This is consistent with the results from FACS 
analysis demonstrating that 18 h after release, parental cells had reached the next G1- 
and S-phase (Fig. 3.2.B). 
 Pronounced differences were observed in the kinetics of 
phosphorylation/dephosphorylation of Y15-Cdk1 and H3-Ser10 in U2OS-Flag-
hCdc14BWT and U2OS-Flag-hCdc14BPD cells. In U2OS-Flag-hCdc14BWT cells, 
dephosphorylation of Y15-Cdk1 was prolonged until 14 h after release from G1/S (lane 
9) suggesting that activation of Cdk1/cyclin B, and hence entry into mitosis was 
impaired. This is supported by the delayed increase of H3-pSer10, which peaks at 14 h 
(lane 9). The decrease of H3-pSer10 levels at later time points indicates that cells 
successfully progressed through mitosis and exited mitosis without any further delay 
(lanes 10-12).  
 Notably, U2OS-Flag-hCdc14BPD cells showed a different phenotype. These cells 
entered mitosis at the same time as parental cells according to the decline of pY15-Cdk1 
and the appearance of H3-pSer10 at 12 h after release from the thymidine-block. 
However, phosphorylation of H3-Ser10 persisted until 18 h after release (lanes 14-18) 
indicating that progression through mitosis was prolonged. In support of this, no re-
phosphorylation of Y15-Cdk1 was observed at later time points (lanes 14-18).  
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Figure 3.2. Overexpression of hCdc14B alters mitotic entry and progression. A) A schematic 
presentation of the protocol used for cell cycle synchronization and induction of Flag-hCdc14B 
expression. Parental U2OS cells, U2OS-Flag-hCdc14BWT (clone 6-WT) and U2OS-Flag-hCdc14BPD 
(clone 1-PD) cells were synchronized at G1/S by double thymidine-block, and Flag-hCdc14B expression 
was induced with doxycycline (2 g/ml). Cells were released for the indicated time points, harvested and 
subjected to FACS analysis (B) and immunoblotting (C). B) FACS analysis of U2OS, U2OS-Flag-
hCdc14BWT or U2OS-Flag-hCdc14BPD cells. The percentage of cells at different phases of the cell cycle 
is indicated. C) Overexpression of Flag-hCdc14WT delays mitotic entry, overexpression of Flag-hCdc14PD 
prolongs mitosis. Cell lysates were analyzed by immunoblotting with antibodies against pY15-Cdk1 (G2-
phase marker), Cdk1, H3-pSer10 (M-phase marker), the Flag epitope and actin. The upper bands in the -
Cdk1 blot represent pY15-Cdk1.  
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3.1.4 Cdk1/cyclin B activity is altered in U2OS cells overexpressing Flag- 
          hCdc14B
WT
 or Flag-hCdc14B
PD
  
The different kinetics of Cdk1-Y15 phosphorylation/dephosphorylation in U2OS-Flag-
hCdc14BWT and U2OS-Flag-hCdc14BPD cells suggested that ectopic hCdc14B affects 
Cdk1/cyclin B activity. To test this, the kinase activity was determined in both kinds of 
cells that had been synchronized, treated with doxycycline and released into the cell 
cycle as described in 3.1.2. Cdk1/cyclin B complexes were immunoprecipitated using 
-cyclin B antibodies coupled to magnetic beads (anti-mouse Dynabeads), and 
immunoprecipitates were analyzed for Cdk1/cyclin B activity using a peptide-based 
kinase assay. Indeed, in U2OS-Flag-hCdc14BWT cells Cdk1/cyclin B activity peaked 3 
h later (15 h time point) than in the parental cells (12 h time point) (Fig. 3.3.). This is 
consistent with the high level of pY15-Cdk1 until 14 h after release from G1/S in these 
cells (see Fig. 3.2.C). On the other hand, in U2OS-Flag-hCdc14BPD cells Cdk1/cyclin B 
was most active 12 h after release, e.g. the same time point as in the parental cells, but 
Cdk1/cyclin B activity declined more slowly. These results suggest that hCdc14B 
regulates Cdk1/cyclin B activity.  
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Figure 3.3. Overexpression of hCdc14B affects Cdk1/cyclin B activity. U2OS, U2OS-Flag-
hCdc14BWT and U2OS-Flag-hCdc14BPD cells were synchronized at G1/S by a double thymidine-
block and expression of Flag-hCdc14B proteins was induced. At different time points after release 
from G1/S, cells were harvested, Cdk1/cyclin B was immunoprecipitated by -cyclin B antibodies, 
and the immunoprecipitated kinase activity was assayed in vitro using Cdk1-specific peptides and 
32P-ATP. The bar diagram shows results from two independent experiments. Values were 
normalized to the activity of Cdk1/cyclin B in G1/S cells. 
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3.1.5 Establishment of conditions for hCdc14B knock-down by RNAi  
To confirm the putative role of hCdc14B in mitosis, cell cycle studies were performed 
with cells depleted of hCdc14B. To knock-down cellular hCdc14B, first, a plasmid-
based RNAi approach was used. I designed four short hairpin RNAs (shRNAs) directed 
against 19-nt long sequences of different regions of the hCdc14B mRNA (nt positions 
510, 640, 651 and 892 of the coding region, Appendix 1). These shRNAs were obtained 
as ds-DNA oligonucleotides containing sense and antisense sequences of the target 
region separated by a hairpin loop, and were cloned into the expression plasmid pTER+ 
downstream of the human Pol III-dependent H1 promoter. Upon transfection the 
recombinant plasmids express 63 nt long shRNAs, which are converted into 19 nt short 
interference dsRNAs (siRNAs) by the cellular RISC complex.  
 hCdc14B-shRNAs were first tested for knock-down efficiency of hCdc14B in 
HEK-293T cells that had been co-transfected with GFP-hCdc14B and pTER-hCdc14B-
sh510, -sh640, -sh651, or -sh892 plasmids. 48 h post-transfection the amount of GFP-
hCdc14B was analyzed on Western blots. In cells co-transfected with pTER-hCdc14B-
sh510 and pTER-hCdc14B-sh640 plasmids the level of GFP-hCdc14B was reduced by 
80-100% compared to cells transfected with the empty pTER+ plasmid (Fig. 3.4.A). 
This indicates that hCdc14B-shRNAs expressed by these plasmids silenced expression 
of the GFP-hCdc14B proteins. The pTER-hCdc14B-sh510 and -sh640 plasmids were 
further tested for their ability to knock-down endogenous hCdc14B in U2OS cells. 
Despite numerous efforts, no knock-down of the endogenous hCdc14B was observed 
(Fig. 3.4.B).  
 As an alternative approach, hCdc14B-siRNAs were used to knock-down cellular 
hCdc14B. A pool of three siRNAs specific to hCdc14B was designed and obtained from 
Dharmacon. For control, a pool of three irrelevant siRNAs (non-targeting siRNA pool 1, 
Dharmacon) was used. HeLa cells were transfected with hCdc14B specific or control 
siRNAs and the amount of hCdc14B was analyzed by Western blotting. However, the 
reduction of the hCdc14B level was too low for further functional analysis, being only 
20-30% less than in control cells (Fig. 3.4.C).  
 Finally, three siRNAs termed hCdc14B-siRNA #1, 2 and 3, were designed and 
obtained from Eurogentec (Appendix 2). These siRNAs were used to transfect HeLa 
“Kyoto” cells that express GFP-tagged histone H2B. As control, GFP-siRNA and the 
non-targeting siRNA pool 1 (Dharmacon) were used. As shown in Fig. 3.4.D, the most 
efficient and reproducible knock-down of endogenous hCdc14B was achieved by 
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transfecting ‘Kyoto’ cells twice with hCdc14B-siRNAs #2 and #3 using Lipofectamine 
2000 and a reverse transfection protocol. These siRNAs specifically knocked-down 
hCdc14B, since the cellular level of hCdc14A or actin was not affected (Fig. 3.4.D, 
bottom panels). 
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Figure 3.4. Knock-down of hCdc14B by RNAi. A) Knock-down of hCdc14B in HEK-293T cells by 
shRNA expression plasmids. HEK-293T cells were seeded in 6-well plates and co-transfected with 100 
ng of pEGFP-hCdc14B expression plasmid and 1 μg of either empty pTER+ or pTER-hCdc14B-shRNA 
expression plasmids targeting the regions around nt position 510, 640, 651 and 892 of the coding region 
of hCdc14B mRNA (for details, see Appendix 1). 48 h after transfection cells were harvested, and cell 
lysates were probed by Western blotting for hCdc14B and actin. B) Knock-down of endogenous 
hCdc14B in U2OS cells by pTER-hCdc14B-sh510/-sh610. U2OS cells were seeded on 6-well plates and 
transfected with increasing amounts of pTER-hCdc14B-sh510 or pTER+-hCdc14B-sh640 plasmids. As 
control, U2OS cells were transfected with the pTER+ plasmid. 72 h after transfection cells were harvested 
and analyzed by Western blotting as in (A). C) Knock-down of hCdc14B in HeLa cells by siRNA pool 
from Dharmacon. HeLa cells were transfected with 75 and 150 nM of either non-targeting (Ctrl) or 
hCdc14B-specific siRNAs. 72 h after transfection cells were harvested and the level of endogenous 
hCdc14B was analyzed as in (A). D) Knock-down of hCdc14B in HeLa cells by three distinct hCdc14B-
siRNAs from Eurogentec. HeLa “Kyoto” cells were transfected twice with 120 nM of siRNAs that target 
GFP or hCdc14B (#1, 2, 3), or with a pool of non-targeting siRNAs. 96 h after the first transfection cells 
were harvested and analyzed by immunoblotting with the indicated antibodies.  
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3.1.6 Depletion of hCdc14B leads to mitotic arrest 
To study cell cycle progression in cells depleted of hCdc14B, “Kyoto” cells were 
transfected with hCdc14B-siRNAs or non-targeting control siRNAs, synchronized at 
G1/S by double thymidine block, and released for 10-15 h (Fig. 3.5.A). The effect of 
hCdc14B depletion on cell cycle progression could be studied only in synchronized 
cells because many of the cells productively transfected with hCdc14B-siRNAs were 
lost due to cell death in the asynchronous cell population. At different time points after 
release from G1/S, entry and progression through mitosis were monitored by 
fluorescence microscopy of live cells, and the mitotic index was determined (Fig. 3.5.B 
and C). Cells depleted of hCdc14B, entered mitosis 12 h after release, e.g. at the same 
time as control cells. However, cells treated with hCdc14B siRNAs stayed in mitosis as 
indicated by the high mitotic index of 42.8% 16 h after release from G1/S. Control cells, 
on the other hand, progressed through mitosis into next G1, since the mitotic index 
declined to 15% (Fig. 3.5.C). Fluorescence microscopy of GFP-tagged histone H2B 
revealed that a considerable amount of cells that were depleted of hCdc14B was 
arrested in metaphase of mitosis (Fig. 3.5.B). This result strongly suggests that 
hCdc14B is required for mitotic progression beyond metaphase.  
 
3.1.7 Cdk1/cyclin B activity is elevated upon RNAi-mediated depletion of 
hCdc14B  
Given that overexpression of Flag-hCdc14BWT delayed activation of Cdk1/cyclin B, and 
overexpression of Flag-hCdc14BPD delayed inactivation of Cdk1/cyclin B, I 
investigated whether depletion of hCdc14B would up-regulate Cdk1/cyclin B activity. 
For this, HeLa ‘Kyoto’ cells were transfected with siRNAs targeting hCdc14B or GFP 
and arrested at G1/S. 13, 14 and 15 h after release from G1/S, e.g. at time points when 
mock-transfected cells had progressed through mitosis (see Fig. 3.5.B and C), cells were 
harvested, Cdk1/cyclin B was immunoprecipitated and the kinase activity measured 
using the Cdk1 peptide-based assay. Consistent with the elevated Cdk1/cyclin B activity 
in Flag-hCdc14BPD expressing cells, cellular depletion of hCdc14B caused a two-fold 
increase of Cdk1/cyclin B activity in comparison to control cells that were transfected 
with GFP-siRNAs (Fig. 3.6., 13 h time point). Moreover, in control cells, Cdk1/cyclin B 
activity dropped between 13 and 15 h after release as cells progressed through M- into 
G1-phase of the next cell cycle. In contrast, in cells depleted of hCdc14B, Cdk1/cyclin B 
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activity dropped slowly being 4-fold higher than in control cells 15 h after release. This 
suggests that hCdc14B is required for inactivation of Cdk1/cyclin B and thereby 
regulates progression through mitosis.  
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Figure 3.5. Depletion of hCdc14B leads to mitotic arrest. A) A schematic presentation of the protocol 
used for siRNA transfection and cell cycle synchronization. HeLa “Kyoto” cells were transfected twice 
with 120 nmol of non-targeting control siRNA or hCdc14B specific siRNA #3, synchronized at G1/S by a 
double thymidine-block, released into fresh medium, and analyzed at different time points after release. 
B) Depletion of hCdc14B leads to mitotic arrest. Phase contrast (magnification x100) and GFP-
fluorescence (magnification x200) images were taken from live cells at 10, 12 and 15 h post release from 
G1/S arrest. Progression through mitosis was determined by chromatin condensation that was visualized 
by histone H2B-GFP fluorescence. The GFP-fluorescence images shown represent a magnification of the 
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regions marked by the rectangles in the phase contrast images. C) Determination of the mitotic index. 
Numbers are derived from two independent experiments and from counting 300 cells. 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.1.8 Cyclin B is stabilized in cell depleted of hCdc14B 
The activity of Cdk1 is regulated by different mechanisms including inhibitory 
phosphorylation at T14/Y15, activating phosphorylation at T161, and association with 
cyclin A or B (Morgan, 1995). Cyclin B levels increase up to late G2-phase. As cells 
progress through late mitosis, cyclin B is ubiquitinated and degraded. Knowing that 
Cdk1/cyclin B activity is elevated in cells depleted of hCdc14B, I asked whether this 
reflects inhibition of proteasome-dependent degradation and stabilization of cyclin B. 
To test this, the level of cyclin B was analyzed by Western blotting using synchronized 
HeLa ‘Kyoto’ cells that were transfected with hCdc14B or GFP specific siRNAs as 
described before (see Fig. 3.5.A). As shown in Fig. 3.7., in cells depleted of hCdc14B 
the amount of cyclin B was significantly elevated (lane 2 and 3) compared to 
untransfected cells (lane 4) and cells treated with the GFP-siRNA (lane 1), which did 
not affect the cellular level of hCdc14B. This indicates that hCdc14B is required for 
cyclin B degradation during late mitosis.  
 
 
 
 
 
 
 
 
Figure 3.6. Knock-down of 
hCdc14B elevates Cdk1/cyclin B 
activity. HeLa ‘‘Kyoto’’ cells were 
transfected with GFP- or hCdc14B-
siRNAs (#2), arrested at G1/S, and 
released for 13, 14 or 15 h. 
Cdk1/cyclin B was precipitated from 
150 g of cell lysate using -cyclin 
B antibodies bound to Dynabeads. 
The kinase activity was measured in 
a Cdk1 peptide-based assay. The bar 
diagrams represent the results from 
two independent experiments. 
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3.1.8 Cells depleted of hCdc14B undergo cell death 
The previous experiments have indicated that depletion of hCdc14B leads to 
accumulation of mitotic cells (see Fig. 3.5.B and C). To investigate whether those cells 
would re-enter the cell cycle with delay or die, cell viability was determined by TUNEL 
assays. HeLa ‘Kyoto’ cells transfected with non-targeting siRNAs or hCdc14B-siRNAs, 
were synchronized at G1/S, released for 24 h and analyzed by fluorescence microscopy. 
As shown in Fig. 3.8.A, the majority of cells transfected with hCdc14B-siRNAs stained 
positive in the TUNEL assay that detects dead cells with fragmented chromatin. This 
demonstrates that prolonged depletion of hCdc14B leads to cell death. Moreover, 
analysis of the cells by phase contrast microscopy revealed a significant, 10-fold 
accumulation of large cells with two or more nuclei in comparison to control cells (Fig. 
3.8.B). This indicates that correct cell cycle progression requires a distinct amount of 
hCdc14B phosphatase and that proper cell division is impaired beyond a critical 
threshold of hCdc14B.  
Figure. 3.7. Cyclin B is stabilized in cells 
depleted of hCdc14B. HeLa ’Kyoto’ cells 
were transfected twice with 120 nM GFP-, 
hCdc14B (#2)- and (#3)-siRNAs or left 
untransfected (control). Cells were 
synchronized at G1/S by double thymidine-
block and released. 16 h after release cells 
were harvested and cell lysates were analyzed 
by Western blotting using antibodies against 
cyclin B and hCdc14B. To control equal 
protein loading the blot was reprobed to actin. 
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Figure 3.8. Depletion of hCdc14B causes cell death and accumulation of multinucleated cells. A) 
TUNEL assay of cells depleted of hCdc14B. HeLa ‘Kyoto’ cells were transfected twice with 120 nmol of 
non-targeting control siRNA or hCdc14B specific siRNA #3, synchronized at G1/S by a double 
thymidine-block, and released into fresh medium. 24 h after release cells were fixed, and analyzed by 
TUNEL assay using the In Situ Cell Death Detection Kit (Roche). TMR-dUTP labeled DNA fragments 
were visualized using fluorescent microscopy (magnification x100). B) Multinucleated cells accumulate 
upon depletion of hCdc14B. HeLa ‘Kyoto’ cells were transfected with non-targeting siRNAs or 
hCdc14B-siRNA #3 and synchronized as in (A). 24 h after release, phase contrast images were taken 
from live cells (magnification x400).  
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3.2 hCdc14B down-regulates Cdk1/cyclin B activity via Cdc25  
3.2.1 hCdc14B inactivates Cdk1/cyclin B indirectly 
Given that Cdk1 activation is delayed in cells overexpressing Flag-hCdc14BWT and that 
Cdk1/cyclin B activity is elevated in cells depleted of hCdc14B, I asked whether 
hCdc14B directly down-regulates Cdk1/cyclin B. To test this, Sf9 cells were co-infected 
with baculoviruses encoding His-Cdk1 and myc-cyclin B. Cdk1/cyclin B complexes 
were purified by ammonium sulfate precipitation, ion exchange chromatography and 
finally immobilized onto anti-cyclin B antibody-coupled Dynabeads (Heix et al., 1998). 
Bead-bound Cdk1/cyclin B complexes were incubated with increasing amounts of GST-
hCdc14BWT, before the kinase activity was determined. As shown in Fig. 3.9., pre-
incubation of Cdk1/cyclin B with active GST-hCdc14B did not affect the kinase activity 
in the peptide-based assay. This indicates that hCdc14B-mediated inhibition of 
Cdk1/cyclin B is not direct and suggests that hCdc14B inactivates an upstream regulator 
of Cdk1/cyclin B. 
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Figure 3.9. hCdc14B down-regulates Cdk1/cyclin B activity indirectly. Recombinant Cdk1/cyclin B 
complexes were expressed and purified from Sf9 cells, and immobilized onto anti-cyclin B antibody-
coupled Dynabeads. Bead-bound Cdk1/cyclin B was incubated with increasing amounts of GST-
hCdc14B for 30 min at 30°C before the kinase activity was assayed using Cdk1-specific peptides and 
32P-ATP. The bar diagram represents results from three independent experiments. The activity of GST-
hCdc14BWT was measured using the pNPP-based phosphatase assay. Calf intestine alkaline phosphatase 
(CIAP, Roche) was used as a standard in the phosphatase assay.  
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3.2.2 hCdc14B targets Cdc25 phosphatases 
In cycling cells, activation of Cdk1/cyclin B at G2/M requires dephosphorylation of 
pT14/pY15-Cdk1 by the Cdc25 family of phosphatases. Mammalian cells have three 
isoforms of Cdc25 named Cdc25A, B and C, all of which can activate Cdk1/cyclin B. 
Cdk1/cyclin B contributes to its own up-regulation by phosphorylating and activating 
Cdc25 phosphatases, thereby creating a positive feedback loop (Donzelli and Draetta, 
2003). Therefore, it is conceivable that hCdc14B dephosphorylates Cdc25, and thereby 
disrupts the positive feedback loop between Cdc25 and Cdk1/cyclin B and promotes 
inactivation of Cdk1.  
 
3.2.2.1 hCdc14B dephosphorylates Cdc25 phosphatases in vitro 
To test this hypothesis, in vitro dephosphorylation experiments were performed. 
Bacterially expressed GST-Cdc25 proteins were immobilized on GT-Sepharose, and 
phosphorylated using cell extracts prepared from mitotic HeLa cells and 32P-ATP. 
After removal of the mitotic extract, 32P-labeled GST-Cdc25 proteins were incubated 
with either GST-hCdc14BWT or GST-hCdc14BPD for 45 min at 37oC. The samples were 
subjected to SDS-PAGE, and 32P-labeled Cdc25 was visualized by a PhosphorImager. 
As shown in Fig. 3.10.A (32P panels), GST-hCdc14BWT, but neither the same activity of 
alkaline phosphatase (lanes 8-10) nor the same amount of GST-hCdc14BPD (lanes 5-7) 
dephosphorylated all three isoforms of Cdc25. To prove that hCdc14B removes the 
phosphates from the Cdk1/cyclin B target sites of Cdc25, bead-bound GST-Cdc25 was 
phosphorylated using Cdk1/cyclin B complexes purified from Sf9 cells and 32P-ATP, 
before incubation with GST-hCdc14BWT or GST-hCdc14BPD. Again, GST-hCdc14BWT 
but not GST-hCdc14BPD dephosphorylated GST-Cdc25 (Fig. 3.10.B, compare lanes 2 
and 3 in 32P panels).  
 These results are further supported by GST pull-down protein interaction 
experiments using in vitro translated, 35S-labeled Flag-hCdc14BWT and GST-Cdc25A, B, 
and C bound to GT-Sepharose. Recombinant Flag-hCdc14BWT was retained by all three 
Cdc25 isoforms indicating that hCdc14B and Cdc25 directly interact with each other 
(Fig. 3.10.C).  
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3.2.2.2 hCdc14B dephosphorylates Cdc25 phosphatases in vivo 
Having shown that hCdc14B dephosphorylates Cdc25, I next investigated whether 
hCdc14B can also dephosphorylate Cdc25 in vivo. HA-Cdc25A, HA-Cdc25B or GFP-
Cdc25C was co-expressed with Flag-hCdc14BWT or Flag-hCdc14BPD in HEK-293T 
cells. 24 h after transfection, cells were synchronized in mitosis by addition of 
nocodazole for 20 h, harvested, and phosphorylation of Cdc25 was monitored on 
immunoblots. After co-expression of Flag-hCdc14BWT, but not Flag-hCdc14BPD, the 
low mobility, hyperphosphorylated forms of all Cdc25 phosphatases disappeared, and 
Figure 3.10. hCdc14B dephosphorylates 
and interacts with Cdc25 phosphatases 
in vitro. A) In vitro dephosphorylation of 
GST-Cdc25 by hCdc14B. GST-tagged 
Cdc25 proteins were immobilized on GT-
Sepharose and phosphorylated in vitro 
using extracts from mitotic HeLa cells and 
32P-ATP. After removal of the mitotic 
extract, beads were incubated for 45 min at 
37°C with 0.025, 0.05, and 0.125 units of 
calf intestine alkaline phosphatase (CIAP), 
with the corresponding activity of GST-
hCdc14BWT or with an amount of GST-
hCdc14BPD corresponding to the protein 
amount of GST-hCdc14BWT as indicated. 
Samples were separated by 8% SDS-
PAGE, stained with Coomassie Blue (C 
panels) and 32P-labeled Cdc25 (32P panels) 
was detected by a PhosphorImager. B) 
hCdc14B dephosphorylates Cdk1/cyclin B-
target sites of GST-Cdc25. GT-bead bound 
GST-Cdc25 was phosphorylated using 
Cdk1/cyclin B expressed and purified from 
Sf9 cells and 32P-ATP. 32P-GST-Cdc25 
proteins were dephosphorylated by 
hCdc14B and analyzed as described in (A). 
C) hCdc14B interacts with all three 
isoforms of Cdc25 in vitro. GST or GST-
Cdc25A, B, and C were incubated for 4 h 
at 4°C with 35S-labeled, in vitro translated 
Flag-hCdc14BWT. Bead-bound proteins 
were separated by SDS-PAGE, and 
radioactive signals visualized using a 
PhosphorImager. The input lane contains 
10% of the rabbit reticulocyte lysate. 
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only the hypophosphorylated forms that have a higher mobility on SDS-PAA gels were 
clearly detected (Fig. 3.11.A). This indicates that excess amounts of phosphatase-active 
hCdc14B led to dephosphorylation of all three isoforms of Cdc25 in mitotic cells. To 
strengthen this result, co-immunoprecipitation experiments were performed using 
lysates from U2OS cells that co-express Flag-hCdc14BPD and HA-Cdc25A, HA-
Cdc25B or GFP-Cdc25C. Flag-hCdc14BPD was precipitated using anti Flag M2-beads, 
and bead-bound proteins were analyzed on Western blots. As shown in Fig. 3.11.B, 
Flag-hCdc14BPD interacted preferentially with Cdc25B, and albeit less efficient, with 
Cdc25C and Cdc25A. These results are in accordance with the in vitro studies showing 
that recombinant hCdc14B interacts with and dephosphorylates Cdc25 in a direct 
manner. This proposes that hCdc14B antagonizes Cdk1/cyclin B-dependent 
phosphorylations on Cdc25 phosphatases, and thereby disrupts the positive feedback 
loop that ensures high Cdk1 activity during early stages of mitosis. 
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Figure 3.11. hCdc14B dephosphorylates and interacts with Cdc25 phosphatases in vivo. A) hCdc14B 
dephosphorylates Cdc25 in vivo. 1x106 HEK-293T cells were transfected with 2.5 μg of plasmids 
encoding HA-Cdc25A, HA-Cdc25B or GFP-Cdc25C together with plasmids encoding Flag-hCdc14BWT 
or Flag-hCdc14BPD (1 and 2 μg). 24 h after transfection, cells were treated with nocodazole for 20 h. Cell 
lysates were analyzed by Western blotting using -HA or -GFP antibodies to detect Cdc25 proteins, and 
-Flag antibodies to visualize ectopic hCdc14B. Lower mobility bands in the HA-Cdc25A, -Cdc25B, and 
GFP-Cdc25C blots represent the hyperphosphorylated forms of Cdc25. Equal protein loading was 
monitored using -actin antibodies. B) hCdc14B interacts with Cdc25 in vivo. U2OS cells were co-
transfected with expression plasmids for HA-Cdc25A/B, or GFP-Cdc25C and Flag-hCdc14BPD as 
indicated. 44 h post transfection, Flag-hCdc14B was immunoprecipitated and co-precipitation of HA-
Cdc25A and B and GFP-Cdc25C was analyzed on Western blots. To monitor IP efficiency, 30% of the 
immunoprecipitate were probed with -Cdc14B antibodies and compared to 10% of input levels.  
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3.3 Regulation of hCdc14B during the cell cycle 
3.3.1 Expression level of hCdc14B during the cell cycle 
This work has established an important role of hCdc14B activity during mitosis. It is 
conceivable that hCdc14B is tightly regulated during the cell cycle to prevent 
unscheduled activation und dephosphorylation of targets. To investigate whether the 
cellular level of hCdc14B fluctuates during the cell cycle, HeLa cells were synchronized 
at G1/S by a double-thymidine block, or at prometaphase by nocodazole. Mitotic cells 
were collected by mitotic shake-off, seeded into fresh medium and harvested at different 
time points after release from the nocodazole-arrest. Determination of the amount of 
hCdc14B by immunoblotting with antibodies specific to hCdc14B indicated that the 
cellular level of hCdc14B did not change during the phases of the cell cycle tested (Fig. 
3.12.). 
 
 
 
 
 
 
 
 
 
3.3.2 Determination of hCdc14B phosphatase activity during the cell cycle  
3.3.2.1 Establishment of HeLa cells stably expressing Flag-hCdc14B
WT
 
To examine, whether the enzymatic activity of hCdc14B fluctuates during the cell cycle, 
hCdc14B was precipitated from lysates of cells synchronized at different phases of the 
cell cycle and assayed for phosphatase activity in vitro. Because the -Cdc14B antibody 
poorly precipitates endogenous hCdc14B under non-denaturing conditions, I had to 
express recombinant Flag-tagged hCdc14B at a moderate level and to perform 
immunoprecipitation with M2-beads. Since the U2OS-Flag-hCdc14BWT cell lines used 
in this study expressed Flag-hCdc14BWT at a high level, new cell lines were to be 
generated that express the recombinant hCdc14B at low level. Therefore, HeLa cells 
that stably express Flag-hCdc14BWT in a tet-inducible manner were established. 
Individual clones of this cell line were isolated and tet-inducible expression of Flag-
Figure 3.12. The cellular level of 
hCdc14B at different phases of the cell 
cycle. HeLa cells were arrested at G1/S by 
double-thymidine block or synchronized in 
mitosis by nocodazole treatment, released 
for indicated time points and harvested. 
The cell lysates were separated by SDS-
PAGE and hCdc14B was detected using -
Cdc14B antibodies. As a loading control, 
-actin antibody was used.  
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hCdc14BWT was analyzed on Western blots. Only one cell clone, 17, expressed Flag-
hCdc14BWT at a level comparable to the level of endogenous hCdc14B (Fig. 3.13.A and 
B). This clone was used for further functional studies. 
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Figure 3.13. Tetracycline-induced expression of Flag-hCdc14B
WT
 in different HeLa-Flag-hCdc14
WT
 
cell clones. A) Analysis of Flag-hCdc14BWT expression in different HeLa cell clones. Individual cell 
clones were incubated with doxycycline (dox, 2 g/ml) for 16 h and Flag-hCdc14BWT expression levels 
were monitored on immunoblots using -Flag antibodies. The Western blot was reprobed with antibodies 
specific to actin to monitor equal protein loading. B) Analysis of the expression level of Flag-hCdc14BWT 
in clone 17 of HeLa-Flag-hCdc14BWT. Flag-hCdc14BWT expression was induced as described in (A) and 
the cell lysate was analyzed by Western blotting using -Flag and -Cdc14B antibodies. 
 
 
3.3.2.2 Phosphatase acitivity of hCdc14B from HeLa cells expressing  
Flag-Cdc14
WT
 
Expression of Flag-hCdc14BWT in HeLa-Flag-hCdc14BWT cells (clone 17) and 
synchronization at G1/S was performed in the presence of doxycycline and thymidine 
for 25 h, respectively. For mitotic arrest, cells were cultured in the presence of 
doxycycline and nocodazole for 20 h, mitotic cells were collected by shake-off, and 
released by transfer to fresh medium for 1 h. Synchronized cells were harvested, one 
half of the sample was processed for FACS analysis to monitor efficiency of 
synchronization, the second half was used to assay hCdc14B activity. As shown in Fig. 
3.14.A, after treatment with thymidine the majority of cells had DNA content between 
2N and 4N indicating that cells were arrested in S-phase. Cells treated with nocodazole 
had 4N DNA content demonstrating mitotic arrest. 1 h after release from nocodazole 
arrest, the G2/M population was reduced and cells with 2N DNA content increased 
indicating completion of mitosis and entry into the next G1-phase.  
Flag-hCdc14BWT was immunoprecipitated from whole cell lysates and assayed 
for phosphatase activity. As shown in Fig. 3.14.B, hardly any changes of hCdc14B 
activity were observed under these experimental conditions. This confirms results 
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obtained by Kaiser et al. (2002), who precipitated endogenous hCdc14B from cells 
synchronized at different phases of the cell cycle, and tested its ability to 
dephosphorylate in vitro 32P-labeled Cdh1. In their assay, hCdc14B activity did not 
change throughout the cell cycle either.  
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Figure 3.14. The activity of hCdc14B does not change during the cell cycle. A) FACS analysis of 
synchronized HeLa cells stably expressing Flag-hCdc14BWT. HeLa-Flag-hCdc14BWT cells were cultured 
in the presence of 2 g/ml doxycycline to induce expression of Flag-hCdc14BWT and 2 mM thymidine for 
25 h (S-phase arrest) or 40 ng/ml nocodazole for 16 h (mitotic arrest). Mitotic cells were collected by 
shake-off and released for 1 h. Cells were harvested and analyzed by FACS. B) Activity of Flag-
hCdc14BWT in synchronized cells. Flag-hCdc14BWT was immunoprecipitated from lysates of 
synchronized cells using M2-beads. Activity of bead-bound Flag-hCdc14BWT was determined by 
measuring hydrolysis of OMFP. Absorbance of OMF, the product of OMFP hydrolysis, was measured at 
=477 nm using an ELISA reader. Data were normalized to the amount of Flag-hCdc14Bwt in the input 
according to quantitative Western blotting.  
 
 
3.3.3 Nucleolar sequestration of hCdc14B fluctuates during the cell cycle 
3.3.3.1 hCdc14B is associated with rDNA during interphase but not during mitosis  
Though previous immunofluorescence studies have shown that endogenous and 
recombinant hCdc14B localize to nucleoli during interphase (Kaiser et al., 2002; 
Mailand et al., 2002b), it is not known whether nucleolar sequestration involves binding 
to the repetitive rDNA elements, which represent a main component of nucleoli. To 
elucidate whether hCdc14B is associated with rDNA, chromatin immunoprecipitation 
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(ChIP) was used. A single rDNA repeat has a length of app. 43 kb and consists of the 
rDNA promoter, the transcribed region, and the intergenic spacer (IGS) that separates 
individual rDNA repeats. After crosslinking, protein-DNA complexes were precipitated 
with antibodies against hCdc14B, hUBF or rabbit IgGs, and co-immunoprecipitated 
DNA was amplified in a semi-quantitative manner using primers specific to different 
regions of rDNA repeat, e.g. sequences of the 5’-IGS which are located proximal to the 
promoter (A), the promoter region (B), the 3’ end of the 28S rRNA transcribed region 
(C) and the 3’-IGS (D) (Fig. 3.15.A). As shown in Fig. 3.15.B, hCdc14B was associated 
with the intergenic sequences of the rDNA, but not with the promoter or the transcribed 
region (lanes 5 and 6). Remarkably, rDNA occupancy was only observed in 
asynchronously growing cells, but not in nocodazole-treated cells that are arrested at 
prometaphase of mitosis. This suggests that hCdc14B is associated with rDNA during 
interphase being released not later than prometaphase. Consistent with previous reports 
(Mais et al., 2005), the RNA polymerase I specific transcription factor hUBF was 
mainly detected at the promoter, promoter-proximal 5’ upstream regions, and the 
transcribed regions of rDNA throughout the cell cycle (Fig. 3.15.B, lanes 7 and 8).  
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Figure 3.15. hCdc14B is associated with rDNA. A) A scheme depicting the organisation of the human 
rDNA repeat and the positions of the PCR primers relative to the transcription start site (arrow). B) ChIP 
analysis using asynchronous or nocodazole-treated HeLa cells. Protein-DNA complexes were cross-
linked by 1% formaldehyde and precipitated using antibodies against hCdc14B and hUBF or rabbit IgGs 
as indicated. 0.5 and 2 l of the precipitated DNA was amplified by PCR using -32P-dCTP and primers 
that amplify the following regions of the human rDNA: -1017/-924 (A), -48/+32 (B), +12855/+12970 
(C), +27365/+27475 (D). PCR products were separated by PAA-gel electrophoresis and the radioactive 
signals visualized by a PhosphorImager. The input lanes contain PCR products obtained from 
amplification of 0.05% and 0.2% of the total non-precipitated input chromatin.  
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3.3.3.2 hCdc14B is released from chromatin during mitosis  
Knowing that binding of hCdc14B to rDNA chromatin is lost during mitosis, I next 
investigated the timing of release and reassociation of hCdc14B to chromatin during 
mitosis and at G1. To address this, extracts from synchronized HeLa cells were 
fractionated to yield cytoplasmic, nucleoplasmic and chromatin fractions (Watrin et al., 
2006), and probed for hCdc14B.  
HeLa “Kyoto” cells were either synchronized at G1/S by double thymidine-block 
and released for 6 h into S-/G2-phase, or at prometaphase by nocodazole and released 
into late stages of mitosis and the next G1-phase. To monitor cell cycle progression, 
FACS analysis, fluorescence microscopy, and immunoblotting analysis of cyclin A, 
cyclin E and H3-pSer10 were performed. FACS analysis showed that 6 h after release 
from G1/S, cells had passed through S-phase as indicated by the accumulation of the 4N 
DNA content cells (Fig. 3.16.A). Consistent with this, cyclin E levels dropped and 
cyclin A levels increased, whereas H3-pSer10 was not detected indicating that cells had 
not yet entered mitosis (Fig. 3.16.B). Western blotting analysis of the cytoplasmic, 
nucleoplasmic and chromatin fractions showed that at G1/S-, S- and G2-phase, the 
majority of hCdc14B was contained in the chromatin fraction demonstrating that 
hCdc14B is tightly bound to rDNA during interphase (Fig. 3.16.C, lower panels). In 
contrast, hCdc14A was exclusively detected in the cytoplasmic fraction and absent from 
the nucleoplasmic and chromatin fractions (Fig. 3.16.C, upper panels). This is in 
agreement with the centrosomal localization of hCdc14A (Kaiser et al., 2002; Mailand 
et al., 2002b). Synchronization at prometaphase by nocodazole and progression through 
mitosis and the next G1-phase upon release from the nocodazole-arrest was monitored 
by live cell fluorescence microscopy of histone H2B-GFP (Fig. 3.16.D) and by Western 
blot analysis of cyclin A, cyclin E and H3-pSer10 (Fig. 3.16.E). 40 min after release, the 
majority of cells had reached metaphase as indicated by the fully condensed chromatin 
that was located at the cellular equator (Fig. 3.16.D, second panel). 80 min after release, 
sister chromatids had separated to the two poles indicative of anaphase/telophase (Fig. 
3.16.D, third panel). Cells exited mitosis and entered G1-phase of the next cell cycle 
within 120 min after release, as indicated by the decondensation of chromatin, 
dephosphorylation of Ser10 on histone H3 and drop of the cyclin A level (Fig. 3.16.D, 
fourth panel and 3.16.E). In agreement with results from ChIP analysis, only trace 
amounts of hCdc14B were contained in the chromatin fraction during prometaphase, 
whereas the majority of hCdc14B was soluble (Fig. 3.16.F, lower panels). Enrichment 
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of hCdc14B in the soluble fraction was observed until anaphase/telophase. At later time 
points, e.g. 120 min and beyond, hCdc14B had re-associated with chromatin (Fig. 
3.16.F, lower panels). Taken together, these results demonstrate that hCdc14B is 
tethered to rDNA chromatin during interphase, released from chromatin from 
prometaphase until telophase, and rebound to chromatin in early G1-phase (Fig. 3.16.C 
and F, lower panels). This suggests that nucleolar sequestration and release of hCdc14B 
is linked to the physiological role of hCdc14B during mitosis. hCdc14A, on the other 
hand, is never associated with chromatin and mainly contained in the cytoplasmic 
fraction throughout the cell cycle (Fig. 3.16.C and F, upper panels), indicating that the 
localization of both human Cdc14 phosphatases is regulated in an isoform-specific 
manner.  
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Figure. 3.16. Cellular distribution of hCdc14B during the cell cycle. A) HeLa ‘Kyoto’ cells expressing 
histone H2B-GFP were arrested at G1/S by double thymidine-block, released for the indicated times and 
analyzed by FACS. B) Western blot analysis of cells synchronized and released from G1/S using 
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antibodies against cyclin A, E and H3-pSer10. C) hCdc14B is retained in the chromatin fraction during 
interphase. Cells were synchronized and released from G1/S as described in (A), and harvested at the 
indicated time points. Cell lysates were separated into cytosolic, nucleoplasmic and chromatin fractions, 
and analyzed on Western blots using antibodies against hCdc14A and B. D) Flourescence microscopy of 
H2B-GFP labeled chromatin in HeLa ‘Kyoto’ cells arrested by nocodazole in pro-metaphase and released 
for the indicated time (magnification x400). E) Western blot analysis of HeLa ‘Kyoto’ cells arrested by 
nocodazole and released for the indicated time. The cell lysate was probed to antibodies against cyclin A, 
E and H3-pSer10. F) hCdc14B is released from chromatin during prometaphase until anaphase/telophase. 
HeLa ‘Kyoto’ cells synchronized as described in (D) were fractionated into soluble and chromatin 
fractions. Western blot analysis was performed as indicated in (C). 
 
 
3.3.4 Determination of the native size of hCdc14B  
In yeast, Cdc14p is a subunit of the 280 kDa RENT complex, which contains Net1 (190 
kDa) and the histone deacetylase Sir2 (60 kDa), and tethers yCdc14 to the rDNA (Shou 
et al., 1999; Visintin et al., 1999). Like yCdc14, hCdc14B is bound to rDNA in human 
cells and released during mitosis from nucleoli. It was tempting to speculate that also 
hCdc14B is tethered to rDNA via a multisubunit complex similar to RENT. hCdc14B 
has a molecular weight of 54 kDa, but its native size is unknown.  
To determine the native size of hCdc14B, nuclear extracts prepared from HeLa 
cells were fractionated by gel filtration on a Superose 6 column that was calibrated with 
the following molecular size standards: thyroglobulin (670 kDa) eluting at fraction 62, 
apoferritin (443 kDa) eluting at fraction 68, alcohol dehydrogenase (150 kDa) eluting at 
fraction 76, and bovine serum albumin (66 kDa) eluting at fraction 81. Fractions 
ranging from 52-82 were collected, the proteins of each fraction were precipitated with 
TCA and analyzed on Western blots using antibodies against hCdc14B and the RNA 
polymerase I subunit RPA116 (Fig. 3.17.). RNA polymerase I has a native size of ~600 
kDa (Carles and Riva, 1998). In agreement with this, RPA116 was enriched in fractions 
60-66 (Fig. 3.17.A, upper panel). hCdc14B eluted with two peaks comprising fractions 
60-74 and fraction 82 (Fig. 3.17.A, lower panel). The first hCdc14B protein peak 
corresponds to a molecular size of 400-600 kDa. The second peak contains most likely 
monomeric hCdc14B, since its calculated size is smaller than 66 kDa. This indicates 
that the majority of cellular hCdc14B is bound within a high molecular weight complex.  
The native size of hCdc14B was strikingly different in mitotic HeLa cells (Fig. 
3.17.B, lower panel). The bulk of hCdc14B eluted in fractions 76-80 corresponding to a 
molecular weight of app. 50-100 kDa. Besides this, a part of hCdc14B was also 
contained in high molecular weight fractions having apparent molecular masses of 
about 500 kDa (fractions 66-68), and bigger than 1 MDa (fraction 52). The elution 
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behaviour of RPA116 was not altered (Fig. 3.17.B, upper panel). These results suggest 
that during mitosis, hCdc14B is either monomeric or associated with cellular complexes 
of different molecular masses rather than with one distinct complex.  
α-RPA116
α-Cdc14B
 52  54  56   58  60   62  64  66  68  70  72  74  76   78  80  82
Extract from non-synchronized HeLa cells
  670 kDa   150 kDa   66 kDa
Extract from mitotic HeLa cells
fraction  In
α-RPA116
α-Cdc14B
 52  54  56  58  60  62  64  66 68  70  72  74  76  78  80  82 fraction  In
  670 kDa   150 kDa   66 kDa
  440 kDa
  440 kDa
B
A
 
 
Figure 3.17. Fractionation of hCdc14B on a Superose 6 sizing column. 2.4 mg of nuclear extract from 
non-synchronized (A) or whole cell extracts from mitotic cells (B) were fractionated on a Superose 6 
column. Fractions from 52 to 82 were collected, and proteins of each fraction were precipitated with TCA. 
Samples of every second fraction were analyzed on Western blots using -RPA116 and -hCdc14B 
antibodies. 5% of input were loaded in separate lanes. The elution of the molecular weight standards is 
indicated at the bottom of the blots.  
 
 
3.3.5 hCdc14B is phosphorylated by Cdk1/cyclin B  
ChIP and analysis of biochemically fractionated cells showed that hCdc14B is released 
from nucleoli between prometaphase of mitosis and early G1-phase. However, the 
mechanism underlying the release of hCdc14B is unknown. In S. cerevisiae Net1 binds 
to the catalytic core of yCdc14 and sequesters it to the nucleolus. In early anaphase 
Cdk1 phosphorylates Net1, which induces release of Cdc14p and thereby activates 
yCdc14 (Pereira et al., 2002; Yoshida and Toh-e, 2002). In S .pombe, nucleolar release 
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of Cdc14/Clp1 occurs during early mitosis (Cueille et al., 2001; Trautmann et al., 2001 
and 2004). Upon initial release, Clp1 is phosphorylated and inhibited by mitotic 
Cdk/cyclin complexes. It has been suggested that Clp1 autocatalytically reverses its 
phosphorylation and restores full activity as Cdk1 activity decreases during anaphase 
progression (Wolfe et al., 2006).  
 
hCdc14B         5 SERRSSWAAAPPCSRRCSSTSPGVKKIRSSTQQDPRRRDPQDDVYLD----ITDRLCFAI 
hCdc14A         1 -------------------------------------MAAESGELIGACEFMKDRLYFAT 
yCdc14(S.c.)    1 --------------------------------------MRRSVYLDNTIEFLRGRVYLGA 
Clp1(S.p.)      1 -------------------------------------MDYQDDGLGEMIEFLEDKLYYTS 
 
hCdc14B        61 LYSRP--KSASNVHYFSIDNELEYENFYADFGPLNLAMVYRYCCKINKKLKSITMLR--K 
hCdc14A        24 LRNRP--KSTVNTHYFSIDEELVYENFYADFGPLNLAMVYRYCCKLNKKLKSYSLSR--K 
yCdc14(S.c.)   23 YDYTP--EDTDELVFFTVEDAIFYNSFHLDFGPMNIGHLYRFAVIFHEILNDPENAN--K 
Clp1(S.p.)     24 LSQPPKAELYPHMHFFTIDDELIYNPFYHDFGPLNVSHLIRFAVIVHGIMGKHRQAKKSK 
 
hCdc14B       117 KIVHFTGSDQRKQANAAFLVGCYMVIYLGRTPEEAYRILIFG-ETSYIPFRDAAYGSCNF 
hCdc14A        80 KIVHYTCFDQRKRANAAFLIGAYAVIYLKKTPEEAYRALLSGSNPPYLPFRDASFGNCTY 
yCdc14(S.c.)   79 AVVFYSSASTRQRANAACMLCCYMILVQAWTPHQVLQPLAQV-DPPFMPFRDAGYSNADF 
Clp1(S.p.)     84 AIVLYSSTDTRLRANAACLLACYMVLVQNWPPHLALAPLAQA-EPPFLGFRDAGYAVSDY 
 
hCdc14B       176 YITLLDCFHAVKKAMQYGFLNFNSFNLDEYEHYEKAENGDLNWIIPDRFIAFCGPHS--- 
hCdc14A       140 NLTILDCLQGIRKGLQHGFFDFETFDVDEYEHYERVENGDFNWIVPGKFLAFSGPHP--- 
yCdc14(S.c.)  138 EITIQDVVYGVWRAKEKGLIDLHSFNLESYEKYEHVEFGDFNVLTP-DFIAFASPQEDHP 
Clp1(S.p.)    143 YITIQDCVYGLWRARESSILNIRNIDVHDYETYERVENGDFNWISP-KFIAFASPIQAGW 
  
hCdc14B       233 --RARLESGYHQHSPETYIQYFKNHNVTTIIRLNKRMYDAKRFTDAGFDHHDLFFADGST 
hCdc14A       197 --KSKIENGYPLHAPEAYFPYFKKHNVTAVVRLNKKIYEAKRFTDAGFEHYDLFFIDGST 
yCdc14(S.c.)  197 KGYLATKSSHLNQPFKSVLNFFANNNVQLVVRLNSHLYNKKHFEDIGIQHLDLIFEDGTC 
Clp1(S.p.)    202 N-HASTRPKKLPQPFAIVLDYFVANKVKLIVRLNGPLYDKKTFENVGIRHKEMYFEDGTV 
 
hCdc14B       291 PTDAIVKEFLDICENAEG---AIAVHCKAGLGRTGTLIACYIMKHYRMTAAETIAWVRIC 
hCdc14A       255 PSDNIVRRFLNICENTEG---AIAVHCKAGLGRTGTLIACYVMKHYRFTHAEIIAWIRIC 
yCdc14(S.c.)  257 PDLSIVKNFVGAAETIIKRGGKIAVHCKAGLGRTGCLIGAHLIYTYGFTANECIGFLRFI 
Clp1(S.p.)    261 PELSLVKEFIDLTEEVEE-DGVIAVHCKAGLGRTGCLIGAYLIYKHCFTANEVIAYMRIM 
  
hCdc14B       348 RPGSVIGPQQQFLVMKQTNLWLEGDYFRQKLKGQENGQHRAAFSKLLSGVDDISING--- 
hCdc14A       312 RPGSIIGPQQHFLEEKQASLWVQGDIFRSKLKNRPSSEG--SINKILSGLDDMSIGGNLS 
yCdc14(S.c.)  317 RPGMVVGPQQHWLYLHQNDFR---EWKYTTRISLKPSEAIGGLYPLISLEEYRLQKKKLK 
Clp1(S.p.)    320 RPGMVVGPQQHWLHINQVHFR---AYFYEKAMGRAIQQAT-AAEPLATPPRHPLN----- 
                 
hCdc14B       405 -VENQDQQEPEPYSDD--DEINGVTQGDRLRALKSRRQSKTN------------------ 
hCdc14A       370 KTQNMERFGEDNLEDDDVEMKNGITQGDKLRALKSQRQPRTSPSCAFRSDDTKGHPRAVS 
yCdc14(S.c.)  374 DDKRVAQNNIEGELRDLTMTPPS--NGHGALSARNSSQPSTANN---------------- 
Clp1(S.p.)    371 ATNGTSQSNISTPLPEPTPGQPRKVSGHNPPSARRLPSASSVKF---------------- 
                   
hCdc14B       444 -AIPLTVILQSSVQSCKTSEPNISGSAGITKRTTRSASRKSSVKSLSISR---------- 
hCdc14A       430 QPFRLSSSLQGSAVTLKTSKMALSPSATAKRINRTSLSSGATVRSFSINSRLASSLGNLN 
yCdc14(S.c.)  416 -GSNSFKSSAVPQTSPGQPRKGQNGSNTIEDINNNRNPTSHANRKVVIESNNSDDESMQD 
Clp1(S.p.)    415 -NEKLKNASKQSIQNENKASYSSYEDSEIQNDDETRTVGTPTETISVVRLRRSSSQSNIE 
 
hCdc14B           ------------------------------------------------------------ 
hCdc14A       490 AATDDPENKKTSSSSKAGFTASPFTNLLNGSSQPTTRNYPELNNNQYNRSSNSNGGNLNS 
yCdc14(S.c.)  475 -------------------------------TNGTSNHYPKVSRKKNDISSASSSRMEDN 
Clp1(S.p.)    474 -------------------------------PNGVR--SPTSSPTGSPIRRTSGNRWSS- 
  
hCdc14B       493 -----------TKTVLR------------------------------- 
hCdc14A       550 PPGPHSAKTEEHTTILRPSYTGLSSSSARFLSRSIPSLQSEYVHY--- 
yCdc14(S.c.)  504 EPSATNINNAADDTILRQLLPKNRRVTSGRRTTSAAGGIRKISGSIKK 
Clp1(S.p.)    500 --GSSHSKKSAQRSVSMSSLNN---TSNGRVAKPKPSKSRLIS----- 
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Figure 3.18. Putative Cdk1/cyclin B phosphorylation sites of hCdc14B. NetPhos 2.0 analysis of 
putative Cdk1/cyclin B target sites in hCdc14B. The candidate phosphorylation sites are highlighted in 
red and the target sites conserved in other Cdc14 orthologues are boxed in grey.  
 
 
Whether Cdk1/cyclin B targets hCdc14B is not known. The hCdc14B polypeptide chain 
contains four sites, which perfectly correspond to the minimal Cdk consensus 
phosphorylation site Ser/Thr-Pro (Fig. 3.18.). Three of these sites T147, S244 and T290, 
are located in the catalytic core domain and one site, S25, is located in the amino-
terminal nucleolar localization domain (see also Fig. 1.3.A). To test whether hCdc14B 
is phosphorylated by Cdk1/cyclin B, GST-hCdc14BWT and GST–hCdc14BPD were 
incubated with 32P-ATP and recombinant Cdk1/cyclin B purified from Sf9 cells. 
Purified Flag-hUBF1 was used as a positive control for Cdk1/cyclin B-specific 
phosphorylation. The RNA polymerase I transcription factor UBF is phosphorylated by 
Cdk1/cyclin B during mitosis (Klein and Grummt, 1999). Both GST-hCdc14BWT and 
GST-hCdc14BPD were phosphorylated by Cdk1/cyclin B like hUBF (Fig. 3.19.A). This 
shows that hCdc14B serves as a substrate for Cdk1/cyclin B in vitro. To further support 
this, I tested in GST pull-down assays whether hCdc14B and Cdk1/cyclin B interact 
with each other. For this, GST-hCdc14BWT was incubated with in vitro translated, 35S-
labeled Cdk1 or 35S-labeled cyclin B. As shown in Fig. 3.19.B, GST-hCdc14BWT 
retained Cdk1 but not cyclin B. Taken together, these data provide the first evidence 
that hCdc14B is a target for Cdk1/cyclin B. Future studies have to address the 
functional implications of Cdk1/cyclin B-dependent phosphorylation of hCdc14B in 
vivo.  
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Figure 3.19. Cdk1/cyclin B phosphorylates hCdc14B in vitro. A) In vitro phosphorylation of GST-
hCdc14B by Cdk1/cyclin B. Flag-hUBF1, GST-hCdc14BWT and GST-hCdc14BPD were phosphorylated 
in vitro using Cdk1/cyclin B and 32P-ATP. After incubation for 30 min at 30°C, the reaction was stopped 
by addition of SDS-sample buffer. The samples were separated by 10% SDS-PAGE, stained with 
Coomassie Blue (C panel), and 32P-labeled hUBF1 and GST-hCdc14B were visualized by 
PhosphorImager (32P panel). B) GST-hCdc14B directly interacts with Cdk1. GST and GST-hCdc14BWT 
were immobilized on GT-beads and incubated with 35S-labeled Cdk1 (upper panel) or cyclin B (lower 
panel) for 4 h at 4°C. Bead-bound proteins were separated by SDS-PAGE, and radioactive signals 
visualized using a PhosphorImager. The input lanes contain 10% of the lysate. The lower bands in the 
35S-Cdk1 gel contain a degradation form of 35S-Cdk1. 
  
 
3.4 Identification of novel hCdc14B substrates 
To gain further insight into the function of hCdc14B, it is important to identify proteins 
that interact with hCdc14B and that either serve as substrates of the phosphatase or 
mediate nucleolar sequestration of hCdc14B. For this, hCdc14B complexes should be 
isolated and components of the complex identified by mass spectrometry. As a first 
approach, tandem affinity purification (TAP) was chosen, since this method has been 
already successfully applied by several groups for isolation of protein complexes from 
eukaryotic cells (Gavin et al., 2002; Bertwistle et al., 2004). The classical TAP-tag 
consists of the IgG binding domain of protein A, followed by a protease cleavage site 
for the tobacco etch virus (TEV) protease, and the calmodulin binding domain (Fig. 
3.20.A). The protein of interest is expressed as a fusion protein with the TAP-tag being 
positioned either at the amino- or the carboxy-terminus. For isolation, the fusion protein 
is first bound to IgG-Sepharose, and released from the beads by digestion with TEV 
protease. Then, the supernatant is bound to calmodulin beads, and the protein is eluted 
in the presence of EGTA (Fig. 3.20.B).  
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Figure 3.20. Strategy of TAP-tag purification. A) Components of the TAP-tag. ProtA: IgG-binding 
domain of protein A; TEV: a protease cleavage of TEV protease; CBP: calmodulin binding domain. B) 
Overview of the sequential steps for TAP-tag purification. First, the recombinant protein is bound to IgG-
Sepharose via the IgG domain of protein A. After washing the resin, the IgG-Sepharose is treated with 
TEV-protease to release the recombinant protein that is next bound to the calmodulin binding resin in the 
presence of 2 mM CaCl2 via the calmodulin binding domain present in the TAP-tag. Calmodulin beads 
are washed and the recombinant protein along with its interaction partners is eluted with a buffer 
containing 10 mM EGTA (Puig et al., 2001).  
 
 
3.4.1 TAP-tag purification of the hCdc14B complex  
3.4.1.1 Generation of U2OS cells stably expressing TAP-hCdc14B
PD
  
Since catalytically inactive enzymes often show a higher binding affinity towards their 
substrates, the cDNA of the phosphatase-dead mutant hCdc14BPD was cloned into 
pcDNA4/TO-TAP. The recombinant plasmid pcDNA4/TO-TAP-hCdc14BPD encodes 
N-terminally TAP-tagged hCdc14BPD under the control of a tet-inducible promoter. 
U2OS cells were co-transfected with the pcDNA/6TR plasmid encoding the 
tetracycline-repressor and pcDNA4/TO-TAP-hCdc14BPD or pcDNA4/TO-TAP. Co-
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transfected cells were selected with zeocin and blasticidin HCl, individual clones were 
isolated, and cultured as described in 3.1.1. U2OS-TAP cells and four clones of U2OS-
TAP-hCdc14BPD cells were cultured for 16 h in medium containing 2 μg/ml of 
doxycycline to induce expression of the TAP tag and TAP-hCdc14BPD, respectively, 
and the expression of the recombinant TAP-hCdc14BPD was analyzed by Western 
blotting. In the presence of doxycycline, all four clones of U2OS-TAP-hCdc14BPD cells 
expressed TAP-hCdc14BPD, which has a molecular weight of app. 75 kDa (TAP tag: 20 
kDa + hCdc14B: 54 kDa) (Fig. 3.21.B, lanes 2, 4, 6, 8). TAP-hCdc14BPD was hardly 
detected in uninduced cells (lanes 1, 3, 5, 7), and absent from cells expressing the TAP-
tag alone (Fig. 3.21.A). Since the expression level of TAP-hCdc14BPD was lowest in 
clone 4, this cell line was used for large-scale expression and purification of TAP-
tagged hCdc14BPD complexes.  
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Figure 3.21. Western blot analysis of U2OS-TAP and U2OS-TAP-hCdc14
PD
 cell lines. U2OS-TAP 
cells (A) and individual clones of U2OS-Tap-hCdc14BPD cells (B) were cultured in the absence (lanes 1, 
3, 5, 7) or the presence of doxycycline (lanes 2, 4, 6, 8). The recombinant and the endogenous hCdc14B 
proteins were detected on Western blots using antibodies specific to hCdc14B. Positions of molecular 
weight standards are indicated.  
 
 
3.4.1.2 TAP-tag purification of hCdc14B complexes from U2OS-TAP-hCdc14B
PD
 
            cells 
Nuclear extracts were prepared from 1x108 U2OS-TAP and U2OS-TAP-hCdc14PD cells 
that were cultured in the presence of doxycycline for 16 h. The TAP purification was 
performed as shown in Fig. 3.20.B. The efficiency of each purification step was 
monitored by analyzing 10% of a given sample on Western blots using -hCdc14B 
antibodies. As shown in Fig. 3.22.A, the binding of the fusion protein to IgG-Sepharose 
was highly efficient (lanes 3-6). However, elution efficiency upon TEV cleavage was 
low (lanes 7-10). Incubation with the TEV protease resulted in fusion proteins devoid of 
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the IgG domain with a molecular weight of app. 60 kDa. Only one-third of the total 
bound proteins was released from the IgG-Sepharose as judged by comparison of the 
amount of the 60 kDa, released hCdc14BPD with the amount of recombinant hCdc14BPD 
retained in the bead (lanes 8 and 10). Recovery of the protein was also low during the 
next purification steps. In total, only app. 7% of the recombinant hCdc14BPD present in 
the nuclear extracts were finally eluted from calmodulin beads (compare lane 2 and 18). 
The eluted proteins were precipitated with TCA, separated by SDS-PAGE and 
visualized by silver staining. As shown in Fig. 3.22.B, there was no difference between 
the proteins retrieved from control cells and cells expressing TAP-hCdc14BPD even 
though the recombinant hCdc14B was clearly visible. This suggests that TAP-
hCdc14BPD associated proteins were either lost during the purification or that the 
efficiency of TAP purification was too low to allow detection of interacting proteins.  
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Figure 3.22. TAP-tag purification of TAP-hCdc14B
PD
. A) Control of efficiency of the different 
purification steps by Western Blot analysis. TAP-hCdc14BPD was expressed in U2OS-TAP-hCdc14BPD 
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cells by culturing in the presence of doxycycline (2 μg/ml) for 16 h. As a control U2OS-TAP cells were 
used. 10% of the input and 10% of the fractions from each purification steps were analyzed on Western 
Blot using antibodies specific to hCdc14B. The positions of hCdc14BPD containing the full-length TAP-
tag (75 kDa) and cleaved TAP-tag (60 kDa) are indicated. B) Silver staining of TAP-tag purified proteins. 
The eluates from calmodulin beads were precipitated with TCA, separated by SDS-PAGE and stained 
with silver. As a protein size marker Broad Range SDS-PAGE standards (BioRad) were used. Each 
marker protein band contains 100 ng. 
 
 
3.4.2 Isolation of hCdc14B complexes by double immunoprecipitation  
3.4.2.1 Isolation of hCdc14B complex from HeLa cells stably expressing Flag-HA-
hCdc14B
PD
 
Since no hCdc14B complexes could be retrieved by tandem affinity purification, I next 
tried to purify hCdc14B complexes by double immunoprecipitation using hCdc14B 
proteins fused to Flag- and HA-tags. First, the hCdc14BPD cDNA was cloned into a 
vector containing the tet-operator, a CMV-promoter, followed by sequences encoding 
the Flag- and the HA-tag. The obtained plasmid, pcDNA4/TO-Flag-HA-hCdc14BPD 
was used to generate Tet-inducible HeLa-Flag-HA-hCdc14BPD cells. Induction of 
expression of Flag-HA-hCdc14BPD was analyzed in different individual clones by 
adding 2 μg/ml doxycycline to the culture medium for 16 h. Out of six clones tested, 
only clones 13 and 16 expressed Flag-HA-hCdc14BPD in a tet-inducible manner (Fig. 
3.23.A). The expression level of Flag-HA-hCdc14BPD in clone 13 was app. 50% of the 
level of the endogenous protein as shown by Western blot analysis (Fig. 3.23.B). This 
clone was chosen for large-scale purification.  
Nuclear extracts were prepared from 1.5x108 HeLa-Flag-HA-hCdc14BPD cells 
cultured in medium containing doxycycline. The recombinant protein was isolated using 
the sequential immunoprecipitation protocol depicted in Fig. 3.23.C. The efficiency of 
each purification step was monitored by analyzing 10% of obtained samples on Western 
blots with -hCdc14B antibodies. As shown in Fig. 3.23.D, the purification efficiency 
was so low that Flag-HA-hCdc14PD was not detectable in the eluates from the -HA-
beads. This is probably due to the low expression level of the recombinant protein in the 
HeLa-Flag-HA-hCdc14BPD cells. 
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Figure 3.23. Double immunoprecipitation of Flag-HA-hCdc14B
PD
 from HeLa-Flag-HA-hCdc14B
PD 
cells. A) Expression of Flag-HA-hCdc14BPD in individual HeLa cell clones. HeLa cells stably co-
transfected with pcDNA4/TO-Flag-HA-hCdc14BPD and pcDNA6TR plasmids were selected in zeocin 
(125 μg/ml) and blasticidin HCl (2 μg/ml) containing medium. Individual clones were isolated and 
incubated in presence of 2 μg/ml dox for 16 h, and the expression of the recombinant protein was 
analyzed on Western Blots using antibodies against the Flag-epitope, the HA-epitope and actin. B) Flag-
HA-hCdc14BPD expression level in clone 13 of HeLa-Flag-HA-hCdc14BPD cells. The recombinant protein 
was expressed as described in (A) and analyzed on Western blots using antibodies against the Flag-
epitope, the HA-epitope and hCdc14B. The recombinant hCdc14B is marked with asterisk (*) in the 
hCdc14B blot. C) Schematic overview of the double immunoprecipitation protocol. Double-tagged 
hCdc14B is precipitated using M2-beads from nuclear extracts of HeLa cells expressing Flag-HA-
hCdc14BPD. After washing, the bead-bound proteins are eluted with the Flag peptide and bound to -HA-
beads. After the final elution from -HA-beads with the HA peptide, the eluted proteins are analyzed on 
Western Blot. D) Analysis of double-immunoprecipitation efficiency of the recombinant hCdc14B. HeLa-
Flag-HA-hCdc14BPD cells cultured for three days in the presence of doxycycline were harvested and 
nuclear extract was prepared. The recombinant protein was isolated by double immunoprecipitation, and 
10% of the input and 10% of the fractions from each purification steps were analyzed on Western Blot 
using antibodies specific to hCdc14B.  
 
 
3.4.2.2 Isolation of hCdc14B complexes from HEK-293T cells expressing Flag-HA-
hCdc14B
PD
 
As a third approach for isolation of hCdc14B complexes, Flag-HA-hCdc14BPD was 
transiently overexpressed in HEK-293T cells. 48 h after transfection with the expression 
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plasmid pcDNA4/TO-Flag-HA-hCdc14BPD, the cells were harvested, and nuclear 
extract was prepared. Double immunoprecipitation was performed as depicted in Fig. 
3.23.C. Western blot analysis showed that sufficient amounts of Flag-HA-hCdc14BPD 
were retrieved at each step of purification (Fig. 3.24.A). The final eluates were pooled, 
the proteins were precipitated with TCA, separated by SDS-PAGE on a 4-15% PAA gel 
and stained with silver. As shown in Fig. 3.24.B, at least 10 distinct proteins could be 
visualized, which co-eluted with Flag-HA-hCdc14BPD and were absent in the eluates 
from mock transfected cells. Gel slices containing these proteins were digested with 
trypsin, and subjected to mass spectrometry. The peptide masses obtained were further 
analyzed using the Mascot search engine to identify the respective proteins. In total, 4 
protein bands could be assigned to specific proteins. These were APC1 (MW: 215 kDa) 
the biggest subunit of the anaphase promoting complex/cyclosome (APC/C), the RNA 
polymerase II elongation factor Elp1 (MW: 128 kDa), the heat shock protein hsp70 
(MW: 70 kDa), and hCdc14B itself (Fig. 3.25.).  
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Figure 3.24. Isolation of hCdc14B containing complex by double immunoprecipitation. A) Western 
Blot analysis of Flag-HA-hCdc14BPD isolation. HEK-293T cells were transfected with Flag-HA-
hCdc14BPDexpression plasmid. 60 h post-transfection cells were harvested and Flag-HA-hCdc14BPD 
along with interaction partners was isolated according to double-immunoprecipitation protocol 
represented in Fig. 3.23.C. 10% of samples obtained from each purification steps were analyzed on 
Western Blot using -hCdc14B antibodies. B) Silver staining of proteins co-purified with Flag-HA-
hCdc14BPD. The proteins eluted from -HA-beads were precipitated with TCA, separated by SDS-PAGE 
and protein gels were silver stained. As a protein size marker, unstained Broad Range SDS-PAGE 
standards (Bio-Rad) were used. Each marker protein marker band represents 100 ng. The proteins 
identified by mass spectrometry are indicated behind each corresponding protein bands. 
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APC1 subunit of APC/C complex 
 
     1    MSNFYEERTT MIAARDLQEF VPFGRDHCKH HPNALNLQLR QLQPASELWS SDGAAGLVGS  
     61   LQEVTIHEKQ KESWQLRKGV SEIGEDVDYD EELYVAGNMV IWSKGSKSQA LAVYKAFTVD  
     121  SPVQQALWCD FIISQDKSEK AYSSNEVEKC ICILQSSCIN MHSIEGKDYI ASLPFQVANV  
     181  WPTKYGLLFE RSASSHEVPP GSPREPLPTM FSMLHPLDEI TPLVCKSGSL FGSSRVQYVV  
     241  DHAMKIVFLN TDPSIVMTYD AVQNVHSVWT LRRVKSEEEN VVLKFSEQGG TPQNVATSSS  
     301  LTAHLRSLSK GDSPVTSPFQ NYSSIHSQSR STSSPSLHSR SPSISNMAAL SRAHSPALGV  
     361  HSFSGVQRFN ISSHNQSPKR HSISHSPNSN SNGSFLAPET EPIVPELCID HLWTETITNI  
     421  REKNSQASKV FITSDLCGQK FLCFLVESQL QLRCVKFQES NDKTQLIFGS VTNIPAKDAA  
     481  PVEKIDTMLV LEGSGNLVLY TGVVRVGKVF IPGLPAPSLT MSNTMPRPST PLDGVSTPKP  
     541  LSKLLGSLDE VVLLSPVPEL RDSSKLHDSL YNEDCTFQQL GTYIHSIRDP VHNRVTLELS  
     601  NGSMVRITIP EIATSELVQT CLQAIKFILP KEIAVQMLVK WYNVHSAPGG PSYHSEWNLF  
     661  VTCLMNMMGY NTDRLAWTRN FDFEGSLSPV IAPKKARPSE TGSDDDWEYL LNSDYHQNVE  
     721  SHLLNRSLCL SPSEASQMKD EDFSQNLSLD SSTLLFTHIP AIFFVLHLVY EELKLNTLMG  
     781  EGICSLVELL VQLARDLKLG PYVDHYYRDY PTLVRTTGQV CTIDPGQTGF MHHPSFFTSE  
     841  PPSIYQWVSS CLKGEGMPPY PYLPGICERS RLVVLSIALY ILGDESLVSD ESSQYLTRIT  
     901  IAPQKLQVEQ EENRFSFRHS TSVSSLAERL VVWMTNVGFT LRDLETLPFG IALPIRDAIY  
     961  HCREQPASDW PEAVCLLIGR QDLSKQACEG NLPKGKSVLS SDVPSGTETE EEDDGMNDMN  
     1021 HEVMSLIWSE DLRVQDVRRL LQSAHPVRVN VVQYPELSDH EFIEEKENRL LQLCQRTMAL  
     1081 PVGRGMFTLF SYHPVPTEPL PIPKLNLTGR APPRNTTVDL NSGNIDVPPN MTSWASFHNG  
     1141 VAAGLKIAPA SQIDSAWIVY NKPKHAELAN EYAGFLMALG LNGHLTKLAT LNIHDYLTKG  
     1201 HEMTSIGLLL GVSAAKLGTM DMSITRLLSI HIPALLPPTS TELDVPHNVQ VAAVVGIGLV  
     1261 YQGTAHRHTA EVLLAEIGRP PGPEMEYCTD RESYSLAAGL ALGMVCLGHG SNLIGMSDLN  
     1321 VPEQLYQYMV GGHRRFQTGM HREKHKSPSY QIKEGDTINV DVTCPGATLA LAMIYLKTNN  
     1381 RSIADWLRAP DTMYLLDFVK PEFLLLRTLA RCLILWDDIL PNSKWVDSNV PQIIRENSIS  
     1441 LSEIELPCSE DLNLETLSQA HVYIIAGACL SLGFRFAGSE NLSAFNCLHK FAKDFMTYLS  
     1501 APNASVTGPH NLETCLSVVL LSLAMVMAGS GNLKVLQLCR FLHMKTGGEM NYGFHLAHHM  
     1561 ALGLLFLGGG RYSLSTSNSS IAALLCALYP HFPAHSTDNR YHLQALRHLY VLAAEPRLLV  
     1621 PVDVDTNTPC YALLEVTYKG TQWYEQTKEE LMAPTLLPEL HLLKQIKVKG PRYWELLIDL  
     1681 SKGTQHLKSI LSKDGVLYVK LRAGQLSYKE DPMGWQSLLA QTVANRNSEA RAFKPETISA  
     1741 FTSDPALLSF AEYFCKPTVN MGQKQEILDL FSSVLYECVT QETPEMLPAY IAMDQAIRRL  
     1801 GRREMSETSE LWQIKLVLEF FSSRSHQERL QNHPKRGLFM NSEFLPVVKC TIDNTLDQWL  
     1861 QVGGDMCVHA YLSGQPLEES QLSMLACFLV YHSVPAPQHL PPIGLEGSTS FAELLFKFKQ  
     1921 LKMPVRALLR LAPLLLGNPQ PMVM 
 
Elongation complex protein 1-Elp1 
 
     1    MRNLKLFRTL EFRDIQGPGN PQCFSLRTEQ GTVLIGSEHG LIEVDPVSRE VKNEVSLVAE  
     61   GFLPEDGSGR IVGVQDLLDQ ESVCVATASG DVILCSLSTQ QLECVGSVAS GISVMSWSPD  
     121  QELVLLATGQ QTLIMMTKDF EPILEQQIHQ DDFGESKFIT VGWGRKETQF HGSEGRQAAF  
     181  QMQMHESALP WDDHRPQVTW RGDGQFFAVS VVCPETGARK VRVWNREFAL QSTSEPVAGL  
     241  GPALAWKPSG SLIASTQDKP NQQDIVFFEK NGLLHGHFTL PFLKDEVKVN DLLWNADSSV  
     301  LAVRLEDLQR EKSSIPKTCV QLWTVGNYHW YLKQSLSFST CGKSKIVSLM WDPVTPYRLH  
     361  VLCQGWHYLA YDWHWTTDRS VGDNSSDLSN VAVIDGNRVL VTVFRQTVVP PPMCTYQLLF  
     421  PHPVNQVTFL AHPQKSNDLA VLDASNQISV YKCGDCPSAD PTVKLGAVGG SGFKVCLRTP  
     481  HLEKRYKIQF ENNEDQDVNP LKLGLLTWIE EDVFLAVSHS EFSPRSVIHH LTAASSEMDE  
     541  EHGQLNVSSS AAVDGVIISL CCNSKTKSVV LQLADGQIFK YLWESPSLAI KPWKNSGGFP  
     601  VRFPYPCTQT ELAMIGEEEC VLGLTDRCRF FINDIEVASN ITSFAVYDEF LLLTTHSHTC  
     661  QCFCLRDASF KTLQAGLSSN HVSHGEVLRK VERGSRIVTV VPQDTKLVLQ MPRGNLEVVH  
     721  HRALVLAQIR KWLDKLMFKE AFECMRKLRI NLNPIYDHNP KVFLGNVETF IKQIDSVNHI  
     781  NLFFTELKEE DVTKTMYPAP VTSSVYLSRD PDGNKIDLVC DAMRAVMESI NPHKYCLSIL  
     841  TSHVKKTTPE LEIVLQKVHE LQGNAPSDPD AVSAEEALKY LLHLVDVNEL YDHSLGTYDF  
     901  DLVLMVAEKS QKDPKEYLPF LNTLKKMETN YQRFTIDKYL KRYEKAIGHL SKCGPEYFPE  
     961  CLNLIKDKNL YNEALKLYSP SSQQYQDISI AYGEHLMQEH MYEPAGLMFA RCGAHEKALS  
     1021 AFLTCGNWKQ ALCVAAQLNF TKDQLVGLGR TLAGKLVEQR KHIDAAMVLE ESAQDYEEAV  
     1081 LLLLEGAAWE EALRLVYKYN RLDIIETNVK PSILEAQKNY MAFLDSQTAT FSRHKKRLLV  
     1141 VRELKEQAQQ AGLDDEVPHG QESDLFSETS SVVSGSEMSG KYSHSNSRIS ARSSKNRRKA  
     1201 ERKKHSLKEG SPLEDLALLE ALSEVVQNTE NLKDEVYHIL KVLFLFEFDE QGRELQKAFE  
     1261 DTLQLMERSL PEIWTLTYQQ NSATPVLGPN STANSIMASY QQQKTSVPVL DAELFIPPKI  
     1321 NRRTQWKLSL LD 
 
Heat shock protein Hsp70 
 
     1    MAKAAAIGID LGTTYSCVGV FQHGKVEIIA NDQGNRTTPS YVAFTDTERL IGDAAKNQVA  
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     61   LNPQNTVFDA KRLIGRKFGD PVVQSDMKHW PFQVINDGDK PKVQVSYKGD TKAFYPEEIS  
     121  SMVLTKMKEI AEAYLGYPVT NAVITVPAYF NDSQRQATKD AGVIAGLNVL RIINEPTAAA  
     181  IAYGLDRTGK GERNVLIFDL GGGTFDVSIL TIDDGIFEVK ATAGDTHLGG EDFDNRLVNH  
     241  FVEEFKRKHK KDISQNKRAV RRLRTACERA KRTLSSSTQA SLEIDSLFEG IDFYTSITRA  
     301  RFEELCSDLF RSTLEPVEKA LRDAKLDKAQ IHDLVLVGGS TRIPKVQKLL QDFFNGRDLN  
     361  KSINPDEAVA YGAAVQAAIL MGDKSENVQD LLLLDVAPLS LGLETAGGVM TALIKRNSTI  
     421  PTKQTQIFTT YSDNQPGVLI QVYEGERAMT KDNNLLGRFE LSGIPPAPRG VPQIEVTFDI  
     481  DANGILNVTA TDKSTGKANK ITITNDKGRL SKEEIERMVQ EAEKYKAEDE VQRERVSAKN  
     541  ALESYAFNMK SAVEDEGLKG KISEADKKKV LDKCQEVISW LDANTLAEKD EFEHKRKELE  
     601  QVCNPIISGL YQGAGGPGPG GFGAQGPKGG SGSGPTIEEV D 
 
hCdc14B 
 
     1    MKRKSERRSS WAAAPPCSRR CSSTSPGVKK IRSSTQQDPR RRDPQDDVYL DITDRLCFAI 
     61   LYSRPKSASN VHYFSIDNEL EYENFYADFG PLNLAMVYRY CCKINKKLKS ITMLRKKIVH 
     121  FTGSDQRKQA NAAFLVGCYM VIYLGRTPEE AYRILIFGET SYIPFRDAAY GSCNFYITLL 
     181  DCFHAVKKAM QYGFLNFNSF NLDEYEHYEK AENGDLNWII PDRFIAFCGP HSRARLESGY 
     241  HQHSPETYIQ YFKNHNVTTI IRLNKRMYDA KRFTDAGFDH HDLFFADGST PTDAIVKEFL  
     301  DICENAEGAI AVHCKAGLGR TGTLIACYIM KHYRMTAAET IAWVRICRPG SVIGPQQQFL 
     361  VMKQTNLWLE GDYFRQKLKG QENGQHRAAF SKLLSGVDDI SINGVENQDQ QEPEPYSDDD 
     421  EINGVTQGDR LRALKSRRQS KTNAIPLTVI LQSSVQSCKT SEPNISGSAG ITKRTTRSAS 
     481  RKSSVKSLSI SRTKTVLR 
 
 
Figure 3.25. Identification of APC1, Elp1, Hsp70 and hCdc14B by mass spectrometry. Protein bands 
were cut out from the silver stained gel, the gel slices were digested with trypsin, the peptides extracted 
from the gel and analyzed by mass spectrometry. Data were analyzed using the Mascot database search 
engine. Matched peptides are shown in red. 
 
 
3.4.3 hCdc14B interacts with APC/C  
The anaphase promoting complex/cyclosome (APC/C) is a multisubunit ubiquitin ligase 
that consists of 12 subunits in mammalian cells. Upon binding of the co-activators 
Cdc20 or Cdh1, APC/C catalyzes the ubiquitination of specific substrates such as 
securin, cyclin A, cyclin B, Plk1, Cdc20 and UbcH10, thereby targeting them for 
degradation by the 26S proteasome (reviewed in Peters, 2006). APC/C triggers the 
transition from metaphase to anaphase by initiating the degradation of securin thereby 
activating separase, which in turn cleaves cohesin that holds the sister chromatids 
together. APC/C also regulates late mitotic events and promotes mitotic exit by 
targeting cyclin A, B, Plk1, Cdc20 to proteasome-mediated degradation (Shteinberg et 
al., 1999; Rudner and Murray, 2000).  
 Mass spectrometry analysis of proteins co-purifying with Flag-HA-hCdc14BPD 
identified APC1, a subunit of APC/C. To confirm this result, I performed 
immunoprecipitation experiments using lysates from HEK-293T cells that were 
transfected with the pcDNA4/TO-Flag-hCdc14BPD expression plasmid. Flag-
hCdc14BPD was precipitated using M2-beads and co-precipitation of APC1 was 
detected on Western blots using antibodies specific to APC1. Indeed, APC1 was co-
precipitated by M2-beads, but not by mouse IgG and protein A-agarose (Fig. 3.26.A) 
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indicating that hCdc14B and APC1 interact with each other. To further test whether 
hCdc14B interacts with the APC/C complex, HEK-293T cells were either mock 
transfected or transfected with the Flag-HA-hCdc14BPD expression plasmids. 48 h post 
transfection, Flag-HA-hCdc14BPD was isolated by double immunoprecipitation using 
M2-beads and -HA-beads. Proteins co-precipitating with Flag-HA-hCdc14BPD were 
separated by SDS-PAGE and analyzed on Western blots using antibodies against the 
APC/C subunits APC1 and Cdc27, and the co-activators Cdc20 and Cdh1. As shown in 
Fig 3.26.B, besides APC1, hCdc14B immunoprecipitates also contained Cdc27 (APC3), 
the third largest subunit of APC/C suggesting that hCdc14B associates with the intact 
APC/C. Moreover, the co-activator Cdh1, but not Cdc20 was detected suggesting that 
hCdc14B specifically interacts with APC/CCdh1, which assembles during late mitosis.  
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Figure 3.26. hCdc14B interacts with APC/C. A) Co-immunoprecipitation of hCdc14B and APC1. 
HEK-293T cells were transfected with the pcDNA4/TO-Flag-hCdc14BPD expression plasmid. 48 h post 
transfection cells were harvested and Flag-hCdc14BPD was precipitated using -Flag M2 beads. 
Precipitated proteins were analyzed on Western blots using -hCdc14B and -APC1 antibodies. B) 
hCdc14B interacts with APC/CCdh1. HEK-293T cells were transfected and harvested as in (A). Flag-HA-
hCdc14BPD was isolated by double precipitation and co-precipitated proteins were analyzed on 
immunoblots using antibodies against APC1, Cdc27, Cdc20 and Cdh1. Input lanes contain 10% of the 
lysates used for precipitation.  
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4 Discussion 
Exit from mitosis and cytokinesis are highly regulated to ensure faithful cell division. 
Yeast Cdc14 (yCdc14) phosphatase is a key player that regulates mitotic exit by 
antagonizing mitotic phosphorylations of Cdk1 target proteins and promoting 
degradation of mitotic regulators (reviewed in Stegmeier and Amon, 2004). Clp1/Flp1, 
a homologue of the yCdc14 in S. pombe, is not essential for mitotic exit but is required 
for cytokinesis. It has been shown that clp1/flp1-/- cells exhibit defects in chromosome 
segregation and cytokinesis (Trautmann et al, 2001; 2004). Unlike yeast, human cells 
have two Cdc14 phosphatases, hCdc14A and B. hCdc14A is involved in centrosome 
regulation and cytokinesis (Kaiser et al., 2002; Mailand et al., 2002b). The present work 
has demonstrated that hCdc14B regulates mitotic progression. This conclusion is 
supported by following results: (i) overexpression of wildtype hCdc14B delays mitotic 
entry; (ii) overexpression of phosphatase deficient hCdc14B delays mitotic progression; 
(iii) depletion of hCdc14B results in mitotic arrest. 
 
hCdc14B promotes progression to late mitosis 
The main finding of this thesis was that hCdc14B is required for proper mitotic 
progression. Overexpression of wildtype hCdc14B prevents timely activation of 
Cdk1/cyclin B, whereas overexpression of phosphatase-deficient hCdc14B delayed 
Cdk1/cyclin B inactivation. This strongly suggests that hCdc14B down-regulates 
Cdk1/cyclin B. It is well established that in budding yeast yCdc14 regulates mitotic exit 
by inhibiting Cdk1 activity. However, the mitotic events regulated by hCdc14B and 
yCdc14 do not seem to be identical. Cells carrying a temperature-sensitive CDC14 
mutation arrest in late anaphase with 2N DNA content and an elongated mitotic spindle 
when cultured at the non-permissive temperature (Visintin et al., 1998). In contrast, 
cells depleted of hCdc14B show a complex phenotype including arrest in mitosis, 
stabilization of cyclin B, elevated Cdk1/cyclin B activity, formation of bi- and 
multinucleated cells and cell death. Fluorescence microscopy revealed that significant 
number of cells had condensed chromatin that was arranged at the equatorial plate 
indicating arrest in metaphase. This suggests that transition from metaphase to anaphase 
was defective in these cells. Metaphase-anaphase transition occurs when separase 
cleaves the cohesion complex that holds the sister chromatids together. Separase is 
activated at the end of metaphase when APC/CCdc20 ubiquitinates securin, an inhibitor of 
  Discussion 
 79
separase, and targets it for degradation. The spindle assembly checkpoint (SAC) 
regulates metaphase-anaphase transition (reviewed in Musacchio and Hardwick, 2002). 
It is possible that hCdc14B depletion activated the SAC and thereby prevented 
metaphase-anaphase transition.  
Progressive loss of Cdk1/cyclin B activity is essential for successful completion 
of mitosis (reviewed in Pines et al., 2006). Down-regulation of Cdk1/cyclin B starts 
during metaphase-anaphase transition by APC/CCdc20-mediated degradation of cyclin B 
(Clute and Pines, 1999). It is possible that in cells depleted of hCdc14B SAC activation 
led to stabilization of cyclin B and elevation of Cdk1/cyclin B activity. When cells were 
treated with siRNAs specific for hCdc14B for a prolonged period of time most of the 
cells died, presumably due to irreversible arrest in mitosis. Moreover, bi- and 
multinucleated cells accumulated. There are two possible mechanisms, which led to 
multinucleation: (i) Cells may have bypassed SAC-mediated arrest by mitotic slippage 
that allows exit from mitosis without cell division. During mitotic slippage nuclear 
envelops form around random groups of chromosomes as they decondense producing 
multinuclei. Cells bypass SAC due to slow but continuous degradation of cyclin B that 
ultimately drives the cell out of mitosis (Brito and Rieder, 2006). It has been suggested 
that inhibition of transcription during mitosis is sufficient to trigger mitotic exit 
(reviewed in Blagasklonny, 2007): (ii) Chromosome segregation and cytokinesis may 
be defective in these cells. This would implicate that hCdc14B is involved in 
cytokinesis like hCdc14A. However, hCdc14A and B must act on different events 
targeting different substrates because endogenous hCdc14A, which was not affected by 
hCdc14B-siRNAs, could not rescue depletion of hCdc14B. This points to non-
redundant functions of human Cdc14 phosphatases.  
 
Nucleolar sequestration of hCdc14B 
Examination of the cellular localization of hCdc14B by indirect immunofluorescence 
has revealed that hCdc14B localizes to nucleoli in interphase cells (Kaiser et al., 2002; 
Cho et al., 2005). In the present work I show by ChIP that hCdc14B binds to the 
intergenic spacer of rDNA but not to the promoter and transcribed regions. Likewise, in 
budding yeast yCdc14 is enriched in the centre of the non-transcribed spacer 1 (NTS1) 
and absent from the promoter and transcribed regions of rDNA (Stegmeier et al., 2004). 
During late mitosis, yCdc14 is transiently released from rDNA by two signalling 
networks. The FEAR network initiates release of yCdc14 during early anaphase, the 
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MEN network accomplishes full release of yCdc14 during late mitosis and maintains it 
in the released state until exit from mitosis (Jaspersen et al., 1998; Stegmeier et al., 
2002; Azzam et al., 2004). yCdc14 itself is a component of MEN, which 
dephosphorylates and thereby activates several phosphoproteins of the MEN network 
(Pereira et al., 2002). Similar to yCdc14, hCdc14B is released from rDNA during 
mitosis as shown by ChIP analysis and chromatin association (Fig. 3.15. and 3.16.). 
Currently nothing is known about the regulatory networks leading to the temporal 
release of human Cdc14B and presumably to its temporal activation. In higher 
eukaryotes, the existence of a network analogous to the FEAR network has not been 
demonstrated yet. On the other hand, various components of the MEN network are 
conserved in mammals including Dbf2, Mob1, Nud1, Bub2, Cdc5 and finally Cdc14 
itself. Interestingly, it has been shown that several of these proteins function in 
cytokinesis rather than in Cdk1/cyclin B inactivation in higher eukaryotes. In this regard, 
also the role of Cdc14 appears to be conserved through evolution, as inactivation of 
Cdc14 in S. pombe and C. elegans, and of Cdc14A in humans leads to defects in 
cytokinesis (Cueille et al., 2001; Trautmann et al., 2001; Gruneberg et al., 2002; 
Mailand et al., 2002b). RNAi experiment using hCdc14B siRNA resulted in formation 
of bi- or multinucleated cells suggesting that hCdc14B is also involved in faithful 
completion of cytokinesis. 
 
The cellular hCdc14B complex  
The protein complex responsible for the nucleolar localization of yCdc14 has been 
identified as the RENT complex (Shou et al., 1999). RENT consists of Net1, yCdc14 
and the NAD-dependent deacetylase Sir2 (Shou et al., 1999). Net1 tethers yCdc14 to 
rDNA by tightly binding to the core domain of yCdc14, where the phosphatase motif is 
located (Shou et al., 1999; Traverso et al., 2001). In addition to its function in RENT, 
Net1 regulates RNA polymerase I transcription by directly binding to the polymerase 
and stimulating its transcriptional activity (Shou et al., 2001). Net1 is also required for 
nucleolar stabilization (Shou et al., 2001).The nucleolar protein Fob1 recruits RENT to 
rDNA (Huang and Moazed, 2003, Stegmeier et al., 2004). Fob1 seems to be a negative 
regulator of the FEAR network and prevents release of yCdc14 prior to anaphase 
(Stegmeier et al., 2004). It is not known whether a protein complex similar to RENT 
exists in human cells. A Net1 homologue has not been identified in other eukaryotes 
including fission yeast. 
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This work has shown by gel filtration that hCdc14B is organized in a complex of 
a molecular weight of 400-600 kDa during interphase. It is likely that this protein 
complex mediates sequestration of hCdc14B to rDNA. In order to characterize this 
complex, TAP-tagged or double-tagged hCdc14B was expressed in human cells and 
isolated by TAP-tag purification or sequential immunoprecipitation. Unfortunately, 
mass spectrometry analysis of co-purifying proteins did not identify any known 
nucleolar protein. One reason why this approach failed might be that the nucleolar 
hCdc14B complex was not sufficiently extracted from rDNA during extract preparation. 
In future, to circumvent this problem nucleolar extract of cells expressing recombinant 
hCdc14B should be used.  
yCdc14 is released during early mitosis by Cdk1-dependent phosphorylation of 
Net1 and during late mitosis by Cdc5-dependent phosphorylation of Net1. hCdc14B is 
also regulated by release during mitosis. As revealed by gel filtration of extracts 
prepared from mitotic cells the majority of hCdc14B is monomeric during mitosis. This 
is consistent with the idea that hCdc14B is released from rDNA during mitosis and 
becomes able to target its substrates. A small portion of hCdc14B was contained in 
protein complexes of different higher molecular weights suggesting that during mitosis 
hCdc14B transiently interacts with different protein complexes. Interestingly, previous 
analysis of the native size of hCdc14A has shown that this isoform is contained in a 
cellular complex of a size of 500 kDa throughout the cell cycle (Bembenek and Yu, 
2001). This suggests that hCdc14A and hCdc14B are associated with distinct complexes 
and target different proteins.  
 
Cdc25 is a physiological target of hCdc14B 
Several previous reports have shown that in vitro both hCdc14 isoforms can 
dephosphorylate a number of proteins at their Cdk1/cyclin B targets sites including p53 
(Li et al., 2000), cyclin E (Furstenthal et al., 2001), Cdh1 (Bembenek and Yu, 2001) and 
INCENP (Gruneberg et al., 2004). Structural analysis of hCdc14B demonstrated that the 
hydrophobic pocket at the catalytic site of hCdc14B has a clear specificity for a 
phospho-Ser/phospho-Thr-Pro sequence motif (Gray et al., 2003), e.g. sites modified by 
Cdks and MAP kinases. Therefore, it is not surprising that in vitro hCdc14A and B 
preferentially dephosphorylate proteins modified by proline-directed kinases. So far, the 
in vivo targets of hCdc14B had not been identified. Cho et al. (2005) have shown that 
hCdc14B interacts with and stabilizes microtubules. However, this microtubule-
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stabilizing function of hCdc14B was independent of its phosphatase activity. 
This work has identified Cdc25 as a physiological substrate of hCdc14B. 
hCdc14B interacts with all three human Cdc25 isoforms and dephosphorylates them at 
Cdk1/cyclin B target sites both in vitro and in vivo. Members of the Cdc25 phosphatase 
family have been well characterized as inducers of mitosis. Cdc25 dephosphorylates 
Cdk1 at pT14/pY15, thereby activates Cdk1/cyclin B and promotes mitotic entry 
(Dunphy and Kumagai, 1991; Honda et al., 1993; Sebastian et al., 1993). Active 
Cdk1/cyclin B phosphorylates Cdc25 and increases its activity and stability, and triggers 
its nuclear translocation (reviewed in Trinkle-Mulcahy and Lamond, 2006; Boutros et 
al., 2006). During late mitosis, the positive phosphorylations of Cdc25 must be removed 
to down-regulate Cdc25. This in turn down-regulates activity of Cdk1/cyclin B and 
leads to accumulation of inactivate Cdk1/cyclin B. Two lines of experimental evidence 
suggest that hCdc14B is the cellular phosphatase that inactivates Cdc25 during late 
mitosis and thereby acts as a negative regulator of Cdk1/cyclin B. Overexpression of 
hCdc14B prevented timely dephosphorylation of Cdk1-pY15 presumably by 
counteracting phosphorylation-dependent activation of Cdc25 at G2/M, and delays 
mitotic entry. Similarly, ablation of Cdc25B by RNAi has been shown to lead to high 
levels of inactive Cdk1/cyclin B complexes and prolonged G2-phase (Lindqvist et al., 
2005). On the other hand, overexpression of the phosphatase-deficient hCdc14B mutant 
prolonged mitosis, probably because dephosphorylation-dependent inactivation of 
Cdc25 was impaired and Cdk1 remained active. These findings fit to our working 
hypothesis that hCdc14B regulates progression through mitosis by inactivating 
Cdk1/cyclin B. Although all three isoforms of human Cdc25 activate Cdk1/cyclin B, 
they have apparently distinct roles in regulating cell cycle transitions. Results from 
RNAi studies implicate Cdc25B and C in the regulation of the G2/M transition 
(Karlsson et al., 1999; Lindqist et al., 2005). Cdc25A appears to play a more general 
role, regulating both early (G1/S) and late (G2/M) cell cycle transitions (Molinari et al., 
2000; Zhou et al., 2002; Lindqvist et al., 2005). Phosphorylation-dependent activation 
of Cdc25B increases at the end of G2-phase, whereas Cdc25C activity peaks later 
(Lammer et al., 1998). Co-immunoprecipitation experiments showed that hCdc14B 
interacts with a preference for Cdc25B and Cdc25C than Cdc25A. This could suggest 
that Cdc25B and C are better substrates of hCdc14B. Strikingly, recent studies pointed 
to a similar regulation mechanism in S. pombe. It has been shown that the fission yeast 
Clp1/Flp1 down-regulates Cdk1 activity in late mitosis by dephosphorylating Cdc25 
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(Wolfe and Gould, 2004). This suggests that inactivation of Cdk1 and Cdc25 by 
Clp1p/hCdc14B is a highly conserved mechanism restricting activity of the mitotic 
inducers to early M-phase. 
 
hCdc14B interacts with the anaphase-promoting complex/cyclosome (APC/C) 
To decipher the cellular function of hCdc14B, hCdc14B interacting proteins were 
isolated by sequential co-immunoprecipitation from cells that express double-tagged 
hCdc14B, and subjected to mass spectrometry. This analysis led to the identification of 
APC1, the biggest subunit of APC/C. Further biochemical analysis showed that 
antibodies against overexpressed hCdc14B co-precipitated APC1, and the APC/C 
subunits Cdc27 and Cdh1. Cdh1 is a co-activator of APC/C. The finding that Cdh1, but 
not the second co-activator, Cdc20, was contained in the complex interacting with 
hCdc14B strongly suggests a selective association of hCdc14B with APC/CCdh1. Cdh1 is 
phosphorylated during the S-, G2- and early M-phase by Cdk2/cyclin A and Cdk1/cyclin 
B at multiple sites, which prevents association with APC/C (Lukas et al, 1999; 
Listovsky et al, 2000). During anaphase, Cdh1 must be dephosphorylated to allow 
association with APC/C and its activation (reviewed in Peters, 2006). APC/CCdh1 
ubiquitinates different mitotic regulators including cyclin B, cyclin A, securin, and Plk1 
and targets them for proteasome-dependent degradation during late mitosis and G1-
phase. As shown in this work, cyclin B levels were highly elevated in cells depleted of 
hCdc14B by RNAi. This suggests that hCdc14B activity is required for degradation of 
cyclin B. Therefore, it is likely that hCdc14B is the cellular phosphatase, which 
dephosphorylates and activates Cdh1 at the cyclin-dependent phosphorylation sites and 
triggers formation of APC/CCdh1. Consistent with this idea yCdc14 dephosphorylates 
Cdh1 and activates APC/CCdh1 in S. cerevisiae (Visintin et al., 1998). Besides cyclin B, 
APC/CCdh1 targets a variety of additional mitotic regulators for degradation. Future 
studies have to address, whether also the stability of those proteins is altered in 
hCdc14B-depleted cells. Alternatively, it may be possible that APC/CCdh1 interacts with 
hCdc14B to target it for degradation. However, this is very unlikely, since the level of 
hCdc14B does not fluctuate during the cell cycle (Kaiser et al., 2002; this work). 
Though previous studies have shown that hCdc14A is able to dephosphorylate Cdh1 in 
vitro and stimulate activity of APC/CCdh1 in vitro (Bembenek and Yu, 2001), there is no 
evidence for the functional importance in vivo.  
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Putative role of hCdc14B in mitotic regulation of transcription  
In higher eukaryotes, transcription is switched off at the onset of mitosis and resumes 
rapidly upon exit from mitosis. Mitotic repression of RNA polymerase II (Pol II) 
transcription is achieved by inhibition of transcription initiation as well as elongation. 
During mitosis, the Pol II transcription initiation factor TFIID is phosphorylated and its 
activity is repressed (Segil et al., 1996). Moreover, the elongating Pol II complex is 
released from DNA suggesting that components required for transcription elongation 
are mitotically inactivated (Parsons 1997; Jiang et al., 2004). Elp1, a Pol II elongation 
factor was identified to co-purify with hCdc14B. Therefore, it is tempting to speculate 
that hCdc14B interacts with the Pol II elongation complex and enables Pol II-dependent 
transcription elongation. This has to be addressed in future studies. 
 Recent unpublished work of our lab has demonstrated that hCdc14B activates 
mitotically repressed RNA polymerase I (Pol I) transcription. hCdc14B specifically 
dephosphorylates TAFI110, a subunit of Pol I transcription initiation factor SL1. 
hCdc14B targets phospho-Thr852 of TAFI110, the site that is phosphorylated by 
Cdk1/cyclin B and restores Pol I transcription.  
It is not known whether hCdc14B is involved in RNA polymerase III 
transcription. Pol III transcription inhibition is achieved by mitotic phosphorylation of 
Pol III transcription initiation factor TFIIIB (Gottesfeld et al., 1994; Fairley et al., 2003). 
It would be interesting to study whether hCdc14B reverses mitotic phosphorylation of 
TFIIIB and activates Pol III transcription initiation, too. Thus, hCdc14B could be the 
main activator of transcription at M/G1 transition.  
 
Cdk1/cyclin B targets hCdc14B 
It is not known whether mechanisms besides nucleolar sequestration regulate hCdc14B. 
An intriguing possibility is that Cdk1/cyclin B phosphorylation of hCdc14B is 
important for its regulation. The hCdc14B polypeptide chain contains four sites, which 
perfectly correspond to the minimal Cdk consensus phosphorylation site Ser/Thr-Pro. 
The findings that Cdk1 interacts with hCdc14B in vitro and Cdk1/cyclin B 
phosphorylates hCdc14B in vitro argue for the regulation of hCdc14B by Cdk1/cyclin B. 
Three of the putative Cdk1/cyclin B phosphorylation sites of hCdc14B are located in the 
catalytic core domain. Thus, Cdk1/cyclin B might phosphorylate the catalytic domain of 
hCdc14B and alter its activity. Studies from fission yeast showed that Cdk1 
phosphorylates and inactivates Clp1/Flp1 during early anaphase (Wolfe et al., 2006). 
  Discussion 
 85
However, no significant alterations in the phosphatase activity of hCdc14B during the 
cell cycle were observed. In these assays overexpressed recombinant hCdc14B was used 
to measure the phosphatase activity. Whether this reflects the activity of endogenous 
hCdc14B is not clear. It is also possible that during the immunoprecipitation procedure 
important protein modifications or protein-protein interactions were lost. Another 
possibility is that hCdc14B activity indeed does not fluctuate throughout cell cycle and 
nucleolar sequestration is the only and efficient mechanism of hCdc14B regulation. The 
molecular mechanism underlying the release of hCdc14B from nucleoli is not identified. 
It might involve hCdc14B phosphorylation by Cdk1/cyclin B. One putative Cdk target 
site of hCdc14B is S25, which is located at the N-terminal domain of hCdc14B that is 
required for nucleolar localization (Kaiser et al., 2002). Cdk1/cyclin B might 
phosphorylate the nucleolar targeting domain of hCdc14B and thereby trigger release of 
hCdc14B during prometaphase. To test the regulation of hCdc14B by Cdk1/cyclin B, 
the putative Cdk1/cyclin B target sites should be mutated and biochemical properties of 
mutant hCdc14B must be analyzed.  
 
Model for hCdc14B function 
Based on the results produced during this work the following model for hCdc14B 
function is proposed (Fig. 4.1.). During interphase hCdc14B is sequestered to nucleoli 
by rDNA association and inactivated. At late G2-phase Cdc25 activates Cdk1/cyclin B 
by removing inhibitory phosphatases from T14/Y15 of Cdk1. In turn, Cdk1/cyclin B 
phosphorylates and activates Cdc25, thereby initiating a feedback activation loop to 
ensure rapid G2/M-phase transition. Cdk1/cyclin B phosphorylates a large number of 
proteins and regulates early mitotic events. During late mitosis hCdc14B is activated 
upon release from rDNA and down-regulates Cdk1/cyclin B by two pathways. In one 
pathway, it targets Cdc25 removing Cdk1/cyclin B-mediated phosphorylations and 
thereby disrupts the positive feedback between Cdk1/cyclin B and Cdc25. This leads to 
accumulation of inactive Cdk1/cyclin B phosphorylated at T14/Y15 of Cdk1. In the 
other pathway, hCdc14B activates APC/CCdh1, that ubiquitinates cyclin B targeting it to 
proteasome-dependent degradation and disassembles Cdk1/cyclin B complex. In 
addition, hCdc14B might reverse mitotic repression of transcription to restore 
transcriptional activity upon mitotic exit. 
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Figure 4.1. A model for hCdc14B function. At G2/M, hCdc14B is sequestered within the nucleolus. 
Entry into mitosis requires activation of Cdk1 by Cdc25-mediated dephosphorylation. In turn, 
Cdk1/cyclin B phosphorylates and activates Cdc25, initiating a positive feedback loop. Cdk1/cyclin B 
regulates early mitotic events by phosphorylating a large number of proteins. Upon release from rDNA 
hCdc14B inactivates Cdc25 and activates APC/CCdh1, thereby down-regulating Cdk1 and promoting exit 
from mitosis. In addition, hCdc14B may reverse mitotic repression of transcription and restore cellular 
transcription.  
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6 Appendix 
 
6.1 Position of hCdc14B-shRNA target regions 
 
 
1    ATGAAGCGGA AAAGCGAGCG GCGGTCGAGC TGGGCCGCCG CGCCCCCCTG CTCGCGGCGC  
61   TGCTCGTCGA CCTCGCCGGG TGTGAAGAAG ATCCGCAGCT CCACGCAGCA AGACCCGCGC  
121  CGCCGGGACC CCCAGGACGA CGTGTACCTG GACATCACCG ATCGCCTTTG TTTTGCCATT  
181  CTCTACAGCA GACCAAAGAG TGCATCAAAT GTACATTATT TCAGCATAGA TAATGAACTT  
241  GAATATGAGA ACTTCTACGC AGATTTTGGA CCACTCAATC TGGCAATGGT TTACAGATAT  
301  TGTTGCAAGA TCAATAAGAA ATTAAAGTCC ATTACAATGT TAAGGAAGAA AATTGTTCAT  
361  TTTACTGGCT CTGATCAGAG AAAACAAGCA AATGCTGCCT TCCTTGTTGG ATGCTACATG  
421  GTTATATATT TGGGGAGAAC CCCAGAAGAA GCATATAGAA TATTAATCTT TGGAGAGACA  
481  TCCTATATTC CTTTCAGAGA TGCTGCCTAT GGAAGTTGCA ATTTCTACAT TACACTTCTT  
541  GACTGTTTTC ATGCAGTAAA GAAGGCAATG CAGTATGGCT TCCTTAATTT CAACTCATTT  
601  AACCTTGATG AATATGAACA CTATGAAAAA GCAGAAAATG GAGATTTAAA TTGGATAATA  
661  CCAGACCGAT TTATTGCCTT CTGTGGACCT CATTCAAGAG CCAGACTTGA AAGTGGTTAC  
721  CACCAACATT CTCCTGAGAC TTATATTCAA TATTTTAAGA ATCACAATGT TACTACCATT  
781  ATTCGTCTGA ATAAAAGGAT GTATGATGCC AAACGCTTTA CGGATGCTGG CTTCGATCAC  
841  CATGATCTTT TCTTTGCGGA TGGCAGCACC CCTACTGATG CCATTGTCAA AGAATTCCTA  
901  GATATCTGTG AAAATGCTGA GGGTGCCATT GCAGTACATT GCAAAGCTGG CCTTGGTCGC  
961  ACGGGCACTC TGATAGCCTG CTACATCATG AAGCATTACA GGATGACAGC AGCCGAGACC  
1021 ATTGCGTGGG TCAGGATCTG CAGACCTGGC TCGGTGATTG GGCCTCAGCA GCAGTTTTTG  
1081 GTGATGAAGC AAACCAACCT CTGGCTGGAA GGGGACTATT TTCGTCAGAA GTTAAAGGGG  
1141 CAGGAGAATG GACAACACAG AGCAGCCTTC TCCAAACTTC TCTCTGGCGT TGATGACATT  
1201 TCCATAAATG GGGTCGAGAA TCAAGATCAG CAAGAACCCG AACCGTACAG TGATGATGAC  
1261 GAAATCAATG GAGTGACACA AGGTGATAGA CTTCGGGCCT TGAAAAGCAG AAGACAATCC  
1321 AAAACAAACG CTATTCCTCT CACTCTCTCC ATTTCAAGGA CTAAAACAGT CTTGCGTTAA  
 
 
Coding region of hCdc14B mRNA. hCdc14B-shRNA target regions are highlighted in Bold. The target 
regions of hCdc14B-sh640 and –sh651 partially overlap. The overlapping sequence is shown in blue color. 
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6.2 Position of hCdc14B-siRNA target regions 
 
1    CACGGAACAG CCCTCCTGGG GTCCCCACGA GCCGCGTCCT GCTGTGCCCC GGCGCCTACG 
61   CAGCAGCGGC CGCGGCCGCG GTGGGCACGC ACGGTTACCC CGGGCAGCTC CGGCCGCCAG 
121  CTGCAGCCCC GTCGCCTCGG CCGCGCCAGC CGGCTGCGGG CACCTGGGGG CGGGCTGGGG 
181  GCGCCGGCCG CGGCAGGAGG CGCTGTAGCG AGGGCTGCGG CGCCGGTCCT GCGGCGGCCG 
241  CGGGAGGCAG CGGGGCAGGC GCTGTGGGCC GGGCTCCTCC TCCGGCTCCT GCGCGACCGC 
301  CTCCCGCCGG GCTCTGCCGG CGCCCGCCGT CCCCGCAGCG CCGCTCTGCG CCCGCCGCCC 
361  CGAGCGCCCG CGCGGGGCTG GCGGGAGCCT CGGCGGGCGC GCGGGCGCGC GGGGCCATGG 
421  TCGTGGCCCC CTGACGGGCC GCGGCCGCCT CCATGAAGCG GAAAAGCGAG CGGCGGTCGA 
481  GCTGGGCCGC CGCGCCCCCC TGCTCGCGGC GCTGCTCGTC GACCTCGCCG GGTGTGAAGA 
541  AGATCCGCAG CTCCACGCAG CAAGACCCGC GCCGCCGGGA CCCCCAGGAC GACGTGTACC 
601  TGGACATCAC CGATCGCCTT TGTTTTGCCA TTCTCTACAG CAGACCAAAG AGTGCATCAA 
661  ATGTACATTA TTTCAGCATA GATAATGAAC TTGAATATGA GAACTTCTAC GCAGATTTTG 
721  GACCACTCAA TCTGGCAATG GTTTACAGAT ATTGTTGCAA GATCAATAAG AAATTAAAGT 
781  CCATTACAAT GTTAAGGAAG AAAATTGTTC ATTTTACTGG CTCTGATCAG AGAAAACAAG 
841  CAAATGCTGC CTTCCTTGTT GGATGCTACA TGGTTATATA TTTGGGGAGA ACCCCAGAAG 
901  AAGCATATAG AATATTAATC TTTGGAGAGA CATCCTATAT TCCTTTCAGA GATGCTGCCT 
961  ATGGAAGTTG CAATTTCTAC ATTACACTTC TTGACTGTTT TCATGCAGTA AAGAAGGCAA 
1021 TGCAGTATGG CTTCCTTAAT TTCAACTCAT TTAACCTTGA TGAATATGAA CACTATGAAA 
1081 AAGCAGAAAA TGGAGATTTA AATTGGATAA TACCAGACCG ATTTATTGCC TTCTGTGGAC 
1141 CTCATTCAAG AGCCAGACTT GAAAGTGGTT ACCACCAACA TTCTCCTGAG ACTTATATTC 
1201 AATATTTTAA GAATCACAAT GTTACTACCA TTATTCGTCT GAATAAAAGG ATGTATGATG 
1261 CCAAACGCTT TACGGATGCT GGCTTCGATC ACCATGATCT TTTCTTTGCG GATGGCAGCA 
1321 CCCCTACTGA TGCCATTGTC AAAGAATTCC TAGATATCTG TGAAAATGCT GAGGGTGCCA 
1381 TTGCAGTACA TTGCAAAGCT GGCCTTGGTC GCACGGGCAC TCTGATAGCC TGCTACATCA 
1441 TGAAGCATTA CAGGATGACA GCAGCCGAGA CCATTGCGTG GGTCAGGATC TGCAGACCTG 
1501 GCTCGGTGAT TGGGCCTCAG CAGCAGTTTT TGGTGATGAA GCAAACCAAC CTCTGGCTGG 
1561 AAGGGGACTA TTTTCGTCAG AAGTTAAAGG GGCAGGAGAA TGGACAACAC AGAGCAGCCT 
1621 TCTCCAAACT TCTCTCTGGC GTTGATGACA TTTCCATAAA TGGGGTCGAG AATCAAGATC 
1681 AGCAAGAACC CGAACCGTAC AGTGATGATG ACGAAATCAA TGGAGTGACA CAAGGTGATA 
1741 GACTTCGGGC CTTGAAAAGC AGAAGACAAT CCAAAACAAA CGCTATTCCT CTCACAGTAA 
1801 TTCTTCAATC CAGTGTTCAG AGCTGTAAAA CATCTGAACC TAACATTTCT GGCAGTGCAG 
1861 GCATTACTAA AAGAACCACC AGATCTGCTT CAAGGAAAAG CAGTGTTAAA AGTCTCTCCA 
1921 TTTCAAGGAC TAAAACAGTC TTGCGTTAAG TAAAAACCTG TGACCAGAGC TGAAGGAAGA 
 
A part hCdc14B mRNA sequence from nt 1-1980. Target sequences of hCdc14B-siRNAs are highlighted 
in Bold.  
 
 
 
